
<html lang="en"     class="pb-page"  data-request-id="b5b6fc0d-3e4f-4db9-8ca6-339b0241ce84"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2014.57.issue-21;article:article:10.1021/jm500847m"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Novel, Dual Mechanism ERK Inhibitors by Affinity Selection Screening of an Inactive Kinase" /></meta><meta name="dc.Creator" content="Yongqi  Deng" /></meta><meta name="dc.Creator" content="Gerald W.  Shipps, Jr." /></meta><meta name="dc.Creator" content="Alan  Cooper" /></meta><meta name="dc.Creator" content="Jessie M.  English" /></meta><meta name="dc.Creator" content="D. Allen  Annis" /></meta><meta name="dc.Creator" content="Donna  Carr" /></meta><meta name="dc.Creator" content="Yang  Nan" /></meta><meta name="dc.Creator" content="Tong  Wang" /></meta><meta name="dc.Creator" content="Hugh Y.  Zhu" /></meta><meta name="dc.Creator" content="Cheng-Chi  Chuang" /></meta><meta name="dc.Creator" content="Priya  Dayananth" /></meta><meta name="dc.Creator" content="Alan W.  Hruza" /></meta><meta name="dc.Creator" content="Li  Xiao" /></meta><meta name="dc.Creator" content="Weihong  Jin" /></meta><meta name="dc.Creator" content="Paul  Kirschmeier" /></meta><meta name="dc.Creator" content="William T.  Windsor" /></meta><meta name="dc.Creator" content="Ahmed A.  Samatar" /></meta><meta name="dc.Description" content="An affinity-based mass spectrometry screening technology was used to identify novel binders to both nonphosphorylated and phosphorylated ERK2. Screening of inactive ERK2 identified a pyrrolidine an..." /></meta><meta name="Description" content="An affinity-based mass spectrometry screening technology was used to identify novel binders to both nonphosphorylated and phosphorylated ERK2. Screening of inactive ERK2 identified a pyrrolidine an..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 22, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm500847m" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm500847m" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm500847m" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm500847m" /></link>
        
    
    

<title>Discovery of Novel, Dual Mechanism ERK Inhibitors by Affinity Selection Screening of an Inactive Kinase | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm500847m" /></meta><meta property="og:title" content="Discovery of Novel, Dual Mechanism ERK Inhibitors by Affinity Selection Screening of an Inactive Kinase" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/large/jm-2014-00847m_0009.jpeg" /></meta><meta property="og:description" content="An affinity-based mass spectrometry screening technology was used to identify novel binders to both nonphosphorylated and phosphorylated ERK2. Screening of inactive ERK2 identified a pyrrolidine analogue 1 that bound to both nonphosphorylated and phosphorylated ERK2 and inhibited ERK2 kinase activity. Chemical optimization identified compound 4 as a novel, potent, and highly selective ERK1,2 inhibitor which not only demonstrated inhibition of phosphorylation of ERK substrate p90RSK but also demonstrated inhibition of ERK1,2 phosphorylation on the activation loop. X-ray cocrystallography revealed that upon binding of compound 4 to ERK2, Tyr34 undergoes a rotation (flip) along with a shift in the poly-Gly rich loop to create a new binding pocket into which 4 can bind. This new binding mode represents a novel mechanism by which high affinity ATP-competitive compounds may achieve excellent kinase selectivity." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm500847m"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm500847m">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm500847m&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm500847m&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm500847m&amp;href=/doi/10.1021/jm500847m" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 8817-8826</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm500563g" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm500850y" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Novel, Dual Mechanism ERK Inhibitors by Affinity Selection Screening of an Inactive Kinase</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yongqi++Deng">Yongqi Deng</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gerald+W.++Shipps%2C++Jr.">Gerald W. Shipps, Jr.</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan++Cooper">Alan Cooper</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jessie+M.++English">Jessie M. English</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=D.+Allen++Annis">D. Allen Annis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donna++Carr">Donna Carr</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yang++Nan">Yang Nan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tong++Wang">Tong Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hugh+Y.++Zhu">Hugh Y. Zhu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cheng-Chi++Chuang">Cheng-Chi Chuang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Priya++Dayananth">Priya Dayananth</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan+W.++Hruza">Alan W. Hruza</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li++Xiao">Li Xiao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Weihong++Jin">Weihong Jin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Kirschmeier">Paul Kirschmeier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+T.++Windsor">William T. Windsor</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ahmed+A.++Samatar">Ahmed A. Samatar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Merck Research Laboratories, 33 Avenue Louis Pasteur, Boston, Massachusetts 02115, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#c8b1a7a6afb9a1e6acada6af88a5adbaaba3e6aba7a5"><span class="__cf_email__" data-cfemail="60190f0e0711094e04050e07200d0512030b4e030f0d">[email protected]</span></a>. Phone: 617-992-3182.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm500847m&amp;href=/doi/10.1021%2Fjm500847m" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 8817–8826</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 14, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 June 2014</li><li><span class="item_label"><b>Published</b> online</span>22 October 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 November 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm500847m" title="DOI URL">https://doi.org/10.1021/jm500847m</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8817%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYongqi%2BDeng%252C%2BGerald%2BW.%2BShipps%252C%2BAlan%2BCooper%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D21%26contentID%3Djm500847m%26title%3DDiscovery%2Bof%2BNovel%252C%2BDual%2BMechanism%2BERK%2BInhibitors%2Bby%2BAffinity%2BSelection%2BScreening%2Bof%2Ban%2BInactive%2BKinase%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8826%26publicationDate%3DNovember%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm500847m"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2342</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">35</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm500847m" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Novel, Dual Mechanism ERK Inhibitors by Affinity Selection Screening of an Inactive Kinase&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yongqi&quot;,&quot;last_name&quot;:&quot;Deng&quot;},{&quot;first_name&quot;:&quot;Gerald&quot;,&quot;last_name&quot;:&quot;W. Shipps&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;Cooper&quot;},{&quot;first_name&quot;:&quot;Jessie&quot;,&quot;last_name&quot;:&quot;M. English&quot;},{&quot;first_name&quot;:&quot;D.&quot;,&quot;last_name&quot;:&quot;Allen Annis&quot;},{&quot;first_name&quot;:&quot;Donna&quot;,&quot;last_name&quot;:&quot;Carr&quot;},{&quot;first_name&quot;:&quot;Yang&quot;,&quot;last_name&quot;:&quot;Nan&quot;},{&quot;first_name&quot;:&quot;Tong&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Hugh&quot;,&quot;last_name&quot;:&quot;Y. Zhu&quot;},{&quot;first_name&quot;:&quot;Cheng-Chi&quot;,&quot;last_name&quot;:&quot;Chuang&quot;},{&quot;first_name&quot;:&quot;Priya&quot;,&quot;last_name&quot;:&quot;Dayananth&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;W. Hruza&quot;},{&quot;first_name&quot;:&quot;Li&quot;,&quot;last_name&quot;:&quot;Xiao&quot;},{&quot;first_name&quot;:&quot;Weihong&quot;,&quot;last_name&quot;:&quot;Jin&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Kirschmeier&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;T. Windsor&quot;},{&quot;first_name&quot;:&quot;Ahmed&quot;,&quot;last_name&quot;:&quot;A. Samatar&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;22&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;8817-8826&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm500847m&quot;},&quot;abstract&quot;:&quot;An affinity-based mass spectrometry screening technology was used to identify novel binders to both nonphosphorylated and phosphorylated ERK2. Screening of inactive ERK2 identified a pyrrolidine analogue 1 that bound to both nonphosphorylated and phosphorylated ERK2 and inhibited ERK2 kinase activity. Chemical optimization identified compound 4 as a novel, potent, and highly selective ERK1,2 inhibitor which not only demonstrated inhibition of phosphorylation of ERK substrate p90RSK but also demonstrated inhibition of ERK1,2 phosphorylation on the activation loop. X-ray cocrystallography revealed that upon binding of compound 4 to ERK2, Tyr34 undergoes a rotation (flip) along with a shift in the poly-Gly rich loop to create a new binding pocket into which 4 can bind. This new binding mode represents a novel mechanism by which high affinity ATP-competitive compounds may achieve excellent kinase selectivity.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500847m&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500847m" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500847m&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500847m" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500847m&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500847m" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm500847m&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500847m&amp;href=/doi/10.1021/jm500847m" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm500847m" /></input><a href="/doi/pdf/10.1021/jm500847m" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm500847m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm500847m%26sid%3Dliteratum%253Aachs%26pmid%3D25313996%26genre%3Darticle%26aulast%3DDeng%26date%3D2014%26atitle%3DDiscovery%2Bof%2BNovel%252C%2BDual%2BMechanism%2BERK%2BInhibitors%2Bby%2BAffinity%2BSelection%2BScreening%2Bof%2Ban%2BInactive%2BKinase%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D21%26spage%3D8817%26epage%3D8826%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290969" title="Cell and molecular biology">Cell and molecular biology</a>,</li><li><a href="/action/doSearch?ConceptID=290682" title="Post-translational modification">Post-translational modification</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jmcmar.2014.57.issue-21/20141113/jmcmar.2014.57.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/medium/jm-2014-00847m_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/large/jm-2014-00847m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500847m&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">An affinity-based mass spectrometry screening technology was used to identify novel binders to both nonphosphorylated and phosphorylated ERK2. Screening of inactive ERK2 identified a pyrrolidine analogue <b>1</b> that bound to both nonphosphorylated and phosphorylated ERK2 and inhibited ERK2 kinase activity. Chemical optimization identified compound <b>4</b> as a novel, potent, and highly selective ERK1,2 inhibitor which not only demonstrated inhibition of phosphorylation of ERK substrate p90RSK but also demonstrated inhibition of ERK1,2 phosphorylation on the activation loop. X-ray cocrystallography revealed that upon binding of compound <b>4</b> to ERK2, Tyr34 undergoes a rotation (flip) along with a shift in the poly-Gly rich loop to create a new binding pocket into which <b>4</b> can bind. This new binding mode represents a novel mechanism by which high affinity ATP-competitive compounds may achieve excellent kinase selectivity.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33637" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33637" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The Ras/MAPK (RAF/MEK/ERK) pathway plays a central role in regulating mammalian cell growth, differentiation, and survival by relaying extracellular signals from ligand-bound cell surface tyrosine kinase receptors such as ErbB family, IGF-1R, PDGF, and VEGF receptor tyrosine kinase to the nucleus.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5">(1-5)</a> Aberrant activation of this pathway through gain-of-function mutations has been associated with several human cancers. <i>RAS</i> genes are mutated in colorectal (50%), melanoma (20%), and pancreatic (90%) tumors, and mutations in <i>BRAF</i> have been identified in melanomas (60%), thyroid cancers (∼50%), and colorectal cancers.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6-8)</a> No oncogenic mutations have been found in MEK or ERK; however, gain-of-function mutations in RAS or RAF activate MEK and ERK which are downstream of RAS and RAF. Activation/phosphorylation of MEK and ERK promotes tumor growth through transcriptional activation and increased cell cycle progression and survival. Down-regulation of the MAPK pathway through inhibition of BRAF and MEK has been demonstrated to decrease cell growth and tumor formation.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> These observations have promoted the development of several small molecule inhibitors targeting BRAF and MEK, several of which are in clinical trials.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Despite its important role in the MAPK pathway, there are only a few ERK inhibitors reported in the literature and no known ERK inhibitor has been advanced into late stage clinical trials.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12-14)</a> Our initial approach to the discovery of an ERK inhibitor was to screen an activated ERK2 (aERK2) protein using a traditional high-throughput enzymatic assay. While this approach yielded high potency inhibitors, the compounds lacked a satisfactory degree of kinase selectivity and/or cell-based activity. Subsequent efforts to improve selectivity proved to be challenging, and alternative approaches were pursued.</div><div class="NLM_p">Recently, a new class of kinase inhibitors has been identified that bind to the inactive conformation of kinases (type II). The type II class of kinase inhibitors binds to the ATP binding cleft only when the conserved DFG amino acid sequence motif flips to the “out” conformation. The ability to achieve a DFG-out conformation frequently requires the activation loop to be unphosphorylated; thus, type II inhibitors are found by screening inactive kinases. Some of the recently developed type II kinase inhibitors include imatinib, nilotinib, lapatinib, and sorafenib.<a onclick="showRef(event, 'ref15 ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18 ref19">(15-19)</a> These inhibitors in general possess several advantages over active kinase inhibitors (type I) because they do not compete with high levels of intracellular ATP concentrations, have slower off-rates and the potential to have a different selectivity profile than ATP competitive compounds.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> For these reasons, we decided to develop assays to identify compounds that preferentially bound to the inactive state of ERK.</div><div class="NLM_p last">Affinity selection–mass spectrometry (AS–MS) has emerged as an attractive technique for studying protein–ligand interactions and screening biomolecular receptors against pools of potential small molecule ligands.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> One example of this affinity-based approach is known as the automated ligand identification system (ALIS).<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22-24)</a> This method allows interrogation of a ligand binding to protein surface without modification of its structure, does not require immobilization of the protein or the small molecule pool against which the target is screened, and consumes only a few milligrams of purified, soluble protein to screen millions of compounds. The ALIS process involves the incubation of samples containing thousands of small molecules in the presence of a target protein and identifies bound ligands by mass spectrometry following separation of unbound ligands using size exclusion chromatography (SEC). Since ALIS techniques directly measure noncovalent protein–ligand interactions, it is independent of the phosphorylation (activation) state of kinases to be studied and is ideal for screening inactive forms of kinases which may have a wide range of conformational states. Herein, we report a novel series of ERK inhibitors identified through screening of inactive ERK by ALIS technology and their unique binding and inhibition mechanism.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45340" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45340" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Identification of Initial Hits through ALIS Screening</h3><div class="NLM_p">To identify selective small-molecule inhibitors of ERK2, an in-house diverse chemical library of ∼5 million compounds was screened using ALIS. The high throughput screening campaign involved incubation of unphosphorylated ERK2 (apo ERK2) with ∼2000 compounds per well followed by SEC to separate the protein-bound small molecules from the unbounded molecules. Compounds that bound to ERK2 were transferred to the reversed phase column (RPC) where ligands were dissociated from the protein and trapped on the RPC stationary phase. The dissociated ligands were eluted into a high resolution time-of-flight mass spectrometer for molecular weight analysis. The structure of a bound ligand was identified based on its unique mass for a particular well from each library. One of the hits from this screen was compound <b>1</b> which has a pyrrolidine core (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Compound <b>1</b> is ATP competitive as assessed by the decreased binding with the addition of ATP (as indicated by the reduction of returned mass counts); however, ample signal was still evident at 2.5 mM ATP, suggesting that the compounds had favorable affinity to one or more ERK conformations relative to ATP. The binding of <b>1</b> to unphosphorylated ERK2 was confirmed using temperature-dependent fluorescence (TdF), and the <i>K</i><sub>d</sub> was determined to be 1.1 μM.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> TdF studies determined that <b>1</b> also bound to phosphorylated ERK2 (pERK2) with a <i>K</i><sub>d</sub> of 1.9 μM. These studies indicate the ALIS screen has identified a compound that bound to both unphosphorylated and phosphorylated ERK2.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/medium/jm-2014-00847m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/large/jm-2014-00847m_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Initial ALIS screening hit <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/large/jm-2014-00847m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500847m&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Compound Synthesis</h3><div class="NLM_p">Two synthetic routes were developed to make analogues of <b>1</b> with variations on both right- and left-hand sides. Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> depicts the synthesis of <b>1</b> and its derivatives <b>2</b>–<b>11</b>. In this route, reacting commercially available substituted 4-aminophenol <b>17</b> with Boc protected pyrrolidine-3-carboxylic acid <b>18</b> under standard amide formation conditions<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> gave Boc protected pyrrolidine-3-carboxamide derivative <b>19</b>, which was then deprotected using 50% TFA in dichloromethane to give the corresponding pyrrolidine-3-carboxamide <b>20</b> in quantitative yield. The right-hand side ethyl acetate group was introduced by reacting <b>20</b> with ethyl glyoxylate under reductive amination conditions to give pyrrolidine-3-carboxamide acetate <b>21</b>, which was hydrolyzed with lithium hydroxide in THF to give carboxylic acid <b>22</b>. Subsquentely, <b>22</b> was converted to the final compounds <b>1</b>–<b>3</b> by reacting with the corresponding arylpiperidines. The pure enantiomers <b>4</b>–<b>11</b> were synthesized following the same route using the corresponding commercially available <i>R</i> and <i>S</i> Boc protected pyrrolidine-3-carboxylic acids. To make analogues with different substitutions on the left-hand side, a different synthetic route was developed. In Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, the Boc group of <b>23</b> was removed using TFA to give compound <b>24</b>, which was alkylated with <i>tert</i>-butyl chloroacetate to give compound <b>25</b> in 80% yield. Treating <i>tert</i>-butyl ester <b>25</b> with TFA gave carboxylic acid <b>26</b>, which was then reacted with the corresponding piperazine to give <b>27</b> under HATU coupling conditions. The methyl ester of <b>27</b> was hydrolyzed using LiOH in THF to provide <b>28</b>, which was reacted with various substituted aminophenols to give compounds <b>12</b>–<b>16</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/medium/jm-2014-00847m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/large/jm-2014-00847m_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/large/jm-2014-00847m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500847m&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) HATU, DIEA, DMF, rt, overnight; (ii) TFA, rt, 1 h; (iii) HOAc, ethyl glyoxylate, rt, 1 h; then sodium borohydride triacetoxy, rt, overnight; (iv) LiOH, THF, rt, overnight; (v) arylpiperazine, HATU, DIEA, DMF, rt, 2 h.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/medium/jm-2014-00847m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/large/jm-2014-00847m_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/large/jm-2014-00847m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500847m&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) TMSCHN<sub>2</sub>, toluene/MeOH, 0–5 °C, 30 min; (ii) TFA, rt, 1 h; (iii) <i>tert</i>-butyl chloroacetate, DIEA, rt, 1 h; (iv) arylpiperidine, HATU, DIEA, DMF, rt, 2 h; (v) LiOH, THF, rt, 12 h; (vi) aminophenol, HATU, DIEA, DMF, rt, overnight.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Biochemical Activities and SAR</h3><div class="NLM_p">Two enzyme assays were developed to assess the activity of compounds <b>1</b>–<b>16</b> binding to the phosphorylated and unphosphorylated states of ERK2 (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). A conventional active ERK2 assay (aERK2) was used to measure the activity of compounds binding to the phosphorylated state of ERK2. A coupled ERK2 assay (cERK2) was used to assess the activity of compounds binding to the unphosphorylated state. In this coupled assay, unphosphorylated ERK2 was preincubated with the test compounds for 30 min before it was activated by the addition of phosphorylated MEK1 and then was used to phosphorylate the ERK2 polypeptide substrate. Since the cERK2 assay comprises both the processes of activating ERK2 and substrate phosphorylation, the inhibition measured in this assay is a composite of inhibiting both inactive ERK2 and activated ERK2. Control experiments showed that the MEK inhibitor PD0325901,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> which does not bind to ERK, had no activity in the active ERK assay as expected. PD0325901, however, showed good activity in the coupled assay with an IC<sub>50</sub> of 25 nM because it prevented the phosphorylation of ERK2 by MEK. The binding affinity of each of the compounds to both pERK2 and apo ERK2 was also determined by TdF.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. IC<sub>50</sub> Values from the Coupled and Active ERK Assays and TdF <i>K</i><sub>d</sub> Values for Apo ERK2 and Active ERK for Compounds <b>1</b>–<b>16</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/medium/jm-2014-00847m_0007.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/medium/jm-2014-00847m_0008.gif" alt="" id="fx2" /></img><div></div></div><div class="NLM_p">The IC<sub>50</sub> values measured from both the aERK2 and cERK assays as well as the <i>K</i><sub>d</sub> values determined from the TdF assay are listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. The IC<sub>50</sub> values for the aERK2 and cERK2 assays ranged from 0.44 to 20 μM for active compounds, and the <i>K</i><sub>d</sub> values for pERK and apo ERK2 in the TdF assays ranged from 0.07 to 2.65 uM. The relative rank order was consistent for both assay types. A comparison of the IC<sub>50</sub> values determined in the aERK2 and the cERK2 assays indicated compounds <b>1</b>–<b>15</b> have IC<sub>50</sub> values approximately 2- to 4-fold lower in the cERK2 assay. This result suggests that the compounds bind preferentially to the inactive state of ERK2. TdF studies confirmed that the binding affinities of compounds bound to apo ERK2 were 2- to 3-fold higher compared to activated ERK2 (pERK2).</div><div class="NLM_p last">The SAR of this series of compounds revealed that the addition of a chloro group at the 3-postion of the phenol of <b>1</b> improved both its binding affinities and biochemical activities (<b>2</b>). The stereocenter of the pyrrolidine core was found to be important, as the <i>R</i> isomer (<b>4)</b> had a higher affinity and potency than the <i>S</i> isomer <b>5</b>. Relative activities to apo ERK2 and pERK2 were similar. Shifting the chloro group from the 3-position to the 2-position reduced affinity and activity of <b>12</b>, and an additional chlorine at the 5-position was also not tolerated (<b>13</b>). The chlorine of <b>4</b> can be replaced by a bromine (<b>14</b>), but a methyl (<b>16</b>) and a fluoride group (<b>15</b>) was found to be less optimal. On the right-hand side (RHS) of the molecule, replacing the 4-acetylphenyl group in <b>4</b> with 3-chlorophyl group resulted in <b>6</b> with similar affinity and potency. However, replacement of acetyl group in <b>4</b> with bromo, phenyl, 3-thiophenyl, and 3-furanyl groups resulted in compounds with lower activity (<b>7</b>–<b>10</b>). Interestingly, a bicyclic group, benzothiazole, was found to restore the affinity and activity in compound <b>11</b>.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Binding Mode of <b>4</b> and Kinase Selectivity</h3><div class="NLM_p">The X-ray structure of the <b>4</b>/ERK2 complex was determined at a resolution of 1.65 Å (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). As expected, <b>4</b>, an ATP-competitive inhibitor of ERK2, bound at the ATP binding pocket of ERK2, with the hydroxyl of the phenol group forming two hydrogen bonds toward the hinge region with a hydrogen bond donor to the Met106 backbone amide NH and a hydrogen bond acceptor to the backbone carbonyl of Asp104. The 3-Cl phenyl substitution of <b>4</b> appears to interact favorably with Met106 with a distance of 3.43 Å to its carbonyl group. Substitutions of 3-Cl with Br or methyl, as seen in <b>14</b> and <b>16</b>, led to comparable activities and are likely to provide similar favorable interactions. The hydrogen at the 5-position of the phenol is close to the Ile82 with a distance of 3.65 Å, which explains why replacing this hydrogen with a chlorine resulted in the loss of activity in <b>13</b>. The C═O of the left-hand side amide off the phenol group is involved in an extended hydrogen bond network through a water molecule with the gatekeeper Gln103 and the catalytic Lys52. The substitution at 2-position of the phenol in <b>12</b> most likely disrupts this hydrogen bond network by rotating the amide bond relative to the phenol and resulting in a compound that does not bind (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The pyrrolidine N in the center of <b>4</b> is in the neutral form and acts as a hydrogen bond acceptor to Lys52. The right-hand side amide C═O of <b>4</b> also makes a hydrogen bond with Lys52.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/medium/jm-2014-00847m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/large/jm-2014-00847m_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal structure of ERK2 with bound inhibitor <b>4</b>: inhibitor <b>4</b>, carbon atoms, cyan; ERK2 carbon, gray; nitrogen, blue; oxygen, red; chloride, green; sulfur, yellow. The water molecule oxygen atom involved in the hydrogen bond network is in CPK representation. The hydrogen bonds are labeled with dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/large/jm-2014-00847m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500847m&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A novel protein conformational change occurs at the RHS of the <b>4</b>/ERK2 complex (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The Gly-rich loop (green) undergoes a large conformation change (yellow) which flips the aromatic side chain of Tyr34 away from the RHS and toward the hinge binding site. This conformational change opens up a new side pocket (the Tyr34 side pocket) for the RHS of <b>4</b> to extend into. The pyrrolidine ring stacks directly under Tyr34, making a hydrophobic interaction with the aromatic side chain. Asp165 (a component of the DFG motif) serves as a floor beneath the compound at the methyl group connecting the RHS amide. The piperazine functions as a linker to turn the RHS into the side pocket, while the distal acetylphenyl interacts “face to face” with the Tyr62 side chain through an aromatic π–π interaction. Despite the large movement of the Gly-rich loop observed upon <b>4</b> binding to ERK2, no structural change occurs in the activation loop (not shown). In addition, there are no structural changes at the DFG motif where the Phe166 side chain of the DFG motif overlays well with the X-ray structures of unbound apo ERK2 and <b>4</b> bound to ERK2. In comparison to its apo form, Tyr62 shifts right to create extra space upon binding to <b>4</b> to accommodate the acetyl group. The flexibility of Tyr 62 is also evident in that substitutions to the RHS terminal groups are tolerated to some degree. For example, large terminal substitutions are tolerated off the RHS phenyl groups (<b>7</b>–<b>10</b>), while their activities are lower than compound <b>4</b>. Although compound <b>6</b> has the terminal acetyl group eliminated, the 3-Cl substitution appears to provide compensating interactions with Tyr 62 that retains a similar activity as <b>4</b>.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/medium/jm-2014-00847m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/large/jm-2014-00847m_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Superposition of the X-ray crystal structures of apo ERK2 and inhibitor <b>4</b> bound ERK2 complex: apo ERK2, carbon, green; inhibitor <b>4</b> bound ERK2 complex, carbon, gray; inhibitor <b>4</b>, carbon, cyan. Tyr34 in ERK2/<b>4</b> complex is highlighted with carbon atoms in yellow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/large/jm-2014-00847m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500847m&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>4</b> displays good kinase selectivity when counterscreened against a panel of 30 kinases (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> The favorable selectivity may be due in part to the unique binding mode of <b>4</b>. Unlike other ERK2 inhibitors, which bind to the ATP pocket (between the hinge and Tyr34 <a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a>), <b>4</b> binds to ERK2 in an “induced fit” manner enabling the RHS of <b>4</b> to extend further to the right side of the ATP pocket and into a hydrophobic pocket due to the torsional rotation of the polyglycine loop and the side chain of Tyr34. As a result, <b>4</b> is able to occupy an expanded space between the hinge and Tyr62. The large conformational change of the Gly-rich loop caused by the flip of Tyr34 and the formation of a new binding pocket toward Tyr62 is unique and may contribute toward the good kinase selectivity of <b>4</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Kinase Selectivity of Compound <b>4</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ABL</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">MET</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AKT1</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">MST2</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK2</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">NEK2</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B-RAF</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">PKCA</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CHK1</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">PLK3</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CSNK1D</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">ROCK2</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TSSK2</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">RSK2</td><td class="colsep0 rowsep0" align="left">∼27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EPHB4</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">EGFR</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FLT3</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">p38β</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IGF1R</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">MEK1</td><td class="colsep0 rowsep0" align="left">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IKKB</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">VEGFR-1</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IRAK4</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">CDK4</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JAK2</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">GSK3β</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LCK</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">CDK6</td><td class="colsep0 rowsep0" align="left">>50</td></tr></tbody></table></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Cellular Activities</h3><div class="NLM_p">While adopting a DFG-in mode, we speculated that the large conformational change of ERK2 upon binding to <b>4</b> might disrupt phosphorylation by MEK. To determine if <b>4</b> is capable of inhibiting ERK2 phosphorylation, a cell-based assay was used to measure the level of RSK and ERK1/2 phosphorylation in a melanoma cell line A2058 in the presence of the compound. In this assay, <b>4</b> inhibited the phosphorylation of RSK but also inhibited phosphorylation of ERK1/2 in a dose dependent manner with an EC<sub>50</sub> of ∼800 nM (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). While phosphorylation of ERK can be affected by upstream kinases and growth factors,<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> A2058 is a BRAF mutant cell line, and the up-regulation of the MAP kinase pathway in this cell line is driven by the BRAF mutation. Thus, the inhibition of pERK in this cell line is not likely due to the inhibition of other upstream tyrosine kinase receptors or other growth factors upstream of BRAF. The kinase counterscreen assay results also suggest that <b>4</b> does not inhibit BRAF, and the TdF binding studies confirmed that <b>4</b> does not bind to MEK.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> These results, along with the observation that the compounds bind preferentially to the inactive state of ERK2 in the enzyme and TdF assays, suggest the inhibition of pERK1,2 in the cell based assay is likely to be due to the binding of the compounds to the inactive state of ERK1,2.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/medium/jm-2014-00847m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/large/jm-2014-00847m_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>4</b> suppresses the phosphorylation ERK1,2. A2058 BRAF mutant cell lines were treated for 4 h at 37 °C with 0, 150, 312, 625, 1250, 2500, 5000, or 10000 nM compound <b>4</b>. Cells were harvested after 4 h, and cell lysates containing equal amounts of protein were electrophoresed and immunoblotted for phosphoERK1,2 and total ERK1,2 using appropriate antibodies. Blots were developed using ECL reagent from Amersham Biosciences. Cells treated with MEK inhibitor PD0325901 were used as a positive control for the suppression of phosphorylated ERK1,2 proteins.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/large/jm-2014-00847m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500847m&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although the exact manner in which MEK binds and activates ERK is not known in detail, the interaction between MEK1,2 and ERK1,2 is very specific. MEK1,2 are the only known activators of ERK1,2, and ERK1,2 are the only known substrates of MEK1,2.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> MEK is one of a few kinases that require the full-length protein substrate in order to phosphorylate the activation loop. We postulated that the large conformational change in the glycine-loop of ERK2 may distort the surface and the docking site of ERK2 such that MEK would either not be able to bind to ERK2 or unable to complete the catalytic step of phosphotransfer to the activation loop residues on ERK2. The phosphorylation of ERK1,2 by MEK1,2 requires both the correct orientation of the activation loop residues and the native ERK1,2 tertiary fold for recognition and phosphorylation.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Such stringent requirement for the precise conformation of ERK2 may be disrupted by the large conformational change at the G-loop of ERK2 upon the binding of compound <b>4</b>, and as a result, the ERK2 phosphorylation is blocked.</div><div class="NLM_p last">We have tested <b>4</b> in cell proliferation assays, and it shows inhibition of cell growth in several cell lines with BRAF mutation. The IC<sub>50</sub> values of <b>4</b> were found to be 28.8, 11.5, and 10.8 μM for A2058, A375SM, and Colo-205, respectively. Moreover, <b>4</b> shows no activity (>100 μM) in a cell line (CHL-1) with wild type BRAF.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02063" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02063" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Screening of inactive ERK2 utilizing an affinity-based screening technology has resulted in a series of novel, potent, and selective ERK2 inhibitors. It has been shown that compound <b>4</b> is a dual function inhibitor that is capable of inhibiting not only the kinase activity of ERK but also the phosphorylation of ERK by MEK in cells. The X-ray structure of compound <b>4</b> in complex with inactive ERK protein reveals that the inhibitory function of ERK phosphorylation is likely attained through the large shift of the glycine rich loop upon binding. This is quite different from the DFG-out type inhibitors, which inhibit the kinase activation through conformational changes at the activation loop. If this new active site conformational change is observed in other inhibitor–protein complexes, the poly-glycine loop conformational change and torsional rotation of the Tyr32 side chain could be designated as binding mode type IV. We believe the methodology and observations made in this study can provide a new approach to the discovery and design of a new class of kinase inhibitors for additional targets of interest.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56446" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56446" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All reagents and anhydrous solvents were obtained from commercial sources and were used without further purification unless otherwise specified. Mass spectrometry samples were analyzed on an Agilent 1100 series LC–MS mass spectrometer with electrospray ionization. Samples were introduced into the mass spectrometer using flow injection or chromatography. The mobile phase for all mass analysis consisted of acetonitrile–water mixtures with either 0.1% formic acid or trifluoroacetic acid. FAB HRMS results were recorded on a Micromass QT of Ultima API US mass spectrometer. The following HPLC methods were used to obtain the reported retention times. (i) Method A: Varian XRS 5, 4.6 mm × 30 mm column; linear gradient from 0% to 90% CH<sub>3</sub>CN in H<sub>2</sub>O over 5 min (0.1% trifluoroacetic acid); flow rate 3.0 mL/min; 214 nm/254 nm. (ii) Method B: Varian XRS 5, 4.6 mm × 100 mm column; linear gradient from 10% to 90% CH<sub>3</sub>CN in H<sub>2</sub>O over 10 min (0.1% trifluoroacetic acid); flow rate 3.0 mL/min; detection diode array. The purity of all compounds was determined using method B, and all tested compounds were confirmed to have ≥95% purity. <sup>1</sup>H NMR spectra (δ, ppm) were recorded using a Varian-400 (400 MHz) instrument. Column chromatography was performed using a Biotage instrument. Preparative reversed-phase chromatography was carried out using a Gilson 322 pump coupled to a UV–vis 156 Gilson detector with a Gilson 215 liquid handler, a Varian XRS 10, C18, 21.2 mm × 250 mm, a linear gradient from 10% to 90% acetonitrile in water over 10 min (0.1% trifluoroacetic acid); flow rate 20 mL/min.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Affinity Selection–Mass Spectrometry Methods (AS–MS)</h3><div class="NLM_p">The size exclusion chromatography (SEC) based AS–MS hardware configuration used in this study has been described previously. Briefly, this system uses continuous SEC to isolate protein–ligand complexes from unbound library members. Samples containing a target protein, protein–ligand complexes, and unbound compounds are injected onto an SEC column, where the complexes are separated from nonbinding component by a rapid SEC step. SEC is performed at 4 °C using phosphate-buffered or Tris-buffered saline, typically 50 mM pH 7.5 phosphate buffer containing 200 mM NaCl. SEC columns are prepared in-house by proprietary methods. Operationally comparable columns are available from Regis Technologies, Inc. (Morton Grove, IL).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> An Agilent (Palo Alto, CA) isocratic pump (G1310A) fitted with an Agilent online degasser (G1322A) is used for eluent delivery at 300 μL/min. The eluent from the SEC column is passed through a UV detector (Agilent G1314A using a G1313 microflow cell) where the band containing the protein–ligand complex is identified by its native UV absorbance at 230 nm. After a pause to allow the band to leave the first detector and enter a valving arrangement, the protein–ligand complex peak is automatically transferred to a reverse-phase chromatography column (Higgins Targa-C18, Higgins Analytical Inc., Mountain View, CA). Ligands are dissociated from the complex and trapped at the head of the RPC column, where they are desalted and eluted into the mass spectrometer using a gradient of 0–95% acetonitrile (0.1% formic acid) in water (0.1% formic acid) over 5 min using an Agilent capillary binary pump (G1376A) for eluent delivery at 20 μL/min. To promote dissociation of ligands from the complex, the RPC column is maintained at 60 °C using an Agilent G1316A column compartment. In this study, MS analysis was performed using a Waters LCT “classic” high resolution time-of-flight mass spectrometer (Manchester, U.K.) with positive-mode ionization occurring from a standard nebulized ESI source with the capillary at 3.5 kV, a desolvation temperature of 180 °C, a source temperature of 100 °C, and 30 V “cone” and 3 V extraction lens settings.</div><div class="NLM_p last">AS–MS analyses were conducted by incubating 2500-member libraries at 2.5 μM cumulative compound concentration with 5 μM ERK2 protein in a final volume of 2 μL of pH 7.5 phosphate buffer containing 2.5% DMSO and 200 mM NaCl. As such, 2 pmol of each library component (at 1.0 μM/component) and 10 pmol of protein were used in a single analysis. The use of excess protein relative to each library member minimizes competition between multiple binders in a given library. Typical sample preparation protocol is as follows: to 1 μL of a DMSO solution of 100 mM 2500-member library was added 19 μL of prewarmed (37 °C) pH 7.5 50 mM phosphate buffer containing 200 mM NaCl. The resulting solution was mixed by repeated pipetting and centrifuged at 10000<i>g</i> for 10 min. A 1.0 μL aliquot of the supernatant was added to 1.0 μL of a 5 μM solution of purified ERK2 in pH 7.5 50 mM phosphate buffer containing 200 mM NaCl. Samples were incubated at room temperature for 30 min and then chilled at 4 °C pending AS–MS analysis. Discrete compound screening and competition experiments were prepared identically except that compound stock concentrations in DMSO were adjusted such that the final DMSO concentration in each protein-containing sample was 2.5%.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> <i>tert</i>-Butyl 3-(4-Hydroxyphenylcarbamoyl)pyrrolidine-1-carboxylate (<b>19a</b>)</h3><div class="NLM_p last">To a solution of 1-(<i>tert</i>-butoxycarbonyl)pyrrolidine-3-carboxylic acid (2.15 g, 10 mmol) and diisopropylethylamine (DIEA) (3.9 g, 30 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (DMF) (20 mL) at 0 °C was added 2-(7-aza-1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium (HATU) (4.56 g, 12 mmol). The reaction mixture was stirred for 10 min, and 4-aminophenol (1.09 g, 10 mmol) was added. The reaction mixture was allowed to warm to room temperature and stirred overnight. The crude product was poured onto ice and extracted with ethyl acetate (20 mL × 3). After drying over anhydrous sodium sulfate and removing the solvent under reduced pressure, the crude product was purified by flash chromatography on silica gel, eluting with dichloromethane and methanol (5%). The title compound <b>19a</b> was isolated as a solid (2.8 g, 82%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.802 (d, 2H), 6.75 (d, 2H), 3.70 (m, 1H), 3.55 (m, 1H), 3.30–3.40 (m, 2H), 2.48 (m, 1H), 1.80–1.95 (m, 2H), 1.38 (s, 9H); LC–MS <i>t</i><sub>R</sub> = 1.35 min (method A), 307.1 (M + H<sup>+</sup>).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> <i>tert</i>-Butyl 3-(3-Chloro-4-hydroxyphenylcarbamoyl)pyrrolidine-1-carboxylate (<b>19b</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.88 (br s, 1H), 7.27 (m, 1H), 6.90 (d, 1H), 3.80 (m, 1H), 3.52 (m, 1H), 3.30–3.40 (m, 2H), 2.48 (m, 1H), 1.80–1.95 (m, 2H), 1.38 (s, 9H); LC–MS <i>t</i><sub>R</sub> = 2.16 min (method A), 341.2 (M + H<sup>+</sup>).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> <i>N</i>-(4-Hydroxyphenyl)pyrrolidine-3-carboxamide Trifluoroacetate (<b>20a</b>)</h3><div class="NLM_p last">To a stirring solution of compound <b>19a</b> (1.0 g, 3.26 mmol) in DCM (5 mL) was added TFA (3 mL) at room temperature. The reaction was monitored by LC–MS, and it was completed in about 1 h. After removal of TFA and solvent under reduced pressure, the crude product (0.95 g) was used directly in the next step. LC–MS <i>t</i><sub>R</sub> = 0.25 min (method A), 207.2 (M + H<sup>+</sup>).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> <i>N</i>-(3-Chloro-4-hydroxyphenyl)pyrrolidine-3-carboxamide Trifluoroacetate (<b>20b</b>)</h3><div class="NLM_p last">LC–MS <i>t</i><sub>R</sub> = 0.67 min (method A), 241.1 (M + H<sup>+</sup>).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Ethyl 2-(3-(4-Hydroxyphenylcarbamoyl)pyrrolidin-1-yl)acetate (<b>21a</b>)</h3><div class="NLM_p last">At room temperature, to a stirring solution of <b>20a</b> prepared from previous step in the mixture of DCM and MeOH (1:1 ratio, 10 mL) were added ethyl glyoxylate (2.3 g, 50% in toluene, 11.7 mmol) and acetic acid (100 μL). After the reaction mixture was stirred at room temperature for 1 h, sodium triacetoxyborohydride (2.49 g, 11.7 mmol) was added in several portions and the reaction mixture was stirred at room temperature overnight. After removal of the solvent, ethyl acetate (50 mL) was added, followed by water (20 mL). The organic layer was collected, and the aqueous layer was extracted with ethyl acetate (20 mL). The two extractions were combined and were washed with saturated sodium bicarbonate solution (20 mL), water (30 mL × 3), and brine. After removal of the solvent under vacuum, the residue was purified by flash chromatography (10% methanol in DCM) to give the desired product (0.58 g) in 60% yield for the last two steps. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.75 (d, 2H), 6.75 (d, 2H), 4.18 (q, 2 H), 3.30 (s, 2H), 2.68 (m, 1H), 2.50 (m, 1H), 2.48 (m, 1H), 2.20–2.30 (m, 2H), 1.80–2.05 (m, 2H), 1.32 (t, 3H); LC–MS <i>t</i><sub>R</sub> = 0.53 min (method A), 293.1 (M + H<sup>+</sup>);</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Ethyl 2-(3-(3-Chloro-4-hydroxyphenylcarbamoyl)pyrrolidin-1-yl)acetate (<b>21b</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.85 (br s, 1H), 7.36 (d, 1H), 6.82 (d, 1H), 4.15 (q, 2 H), 3.32 (s, 2H), 2.78 (m, 1H), 2.50 (m, 1H), 2.48 (m, 1H), 2.20–2.30 (m, 2H), 1.80–2.05 (m, 2H), 1.32 (t, 3H); LC–MS <i>t</i><sub>R</sub> = 0.77 min (method A), 327.1 (M + H<sup>+</sup>);</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 2-(3-(4-Hydroxyphenylcarbamoyl)pyrrolidin-1-yl)acetic Acid (<b>22a</b>)</h3><div class="NLM_p last">To a solution of <b>21a</b> (0.52 g, 1.77 mmol) in THF (5 mL) was added LiOH solution (1 M, 3.6 mL, 3.6 mmol). The reaction mixture was stirred at room temperature overnight. After acidification to pH ≈ 5 with 1 N HCl, THF was removed under vacuum and the mixture was extracted with dichloromethane (30 mL × 3). The combined extracts were washed with brine (20 mL) and dried over sodium sulfate. The solution was filtered and the solvent was removed under reduced pressure to afford the desired product as brown solid (0.34 g, 72% yield). LC–MS <i>t</i><sub>R</sub> = 0.25 min (method B), 265.1 (M + H<sup>+</sup>).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 2-(3-(3-Chloro-4-hydroxyphenylcarbamoyl)pyrrolidin-1-yl)acetic Acid (<b>22b</b>)</h3><div class="NLM_p last">LC–MS <i>t</i><sub>R</sub> = 0.64 min (method B), 299.0 (M + H<sup>+</sup>);</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 1-(2-(4-(4-Acetylphenyl)piperazin-1-yl)-2-oxoethyl)-<i>N</i>-(4-hydroxyphenyl)pyrrolidine-3-carboxamide Hydrochloride (<b>1</b>)</h3><div class="NLM_p last">To a solution of <b>22a</b> (40 mg, 0.15 mmol) and DIEA (38 mg, 0.30 mmol) in DMF (1.5 mL) at 0 °C was added HATU (68 mg, 0.18 mmol). After the reaction mixture was stirred for 30 min at 0 °C, 1-(4-(piperazin-1-yl)phenyl)ethanone (31 mg, 0.15 mmol) was added and the reaction mixture was allowed to stir at room temperature for 2 h. Water (10 mL) was added, and the mixture was extracted with ethyl acetate (5 mL × 3). The combined extracts were washed with water (10 mL) and brine (10 mL). The solvent was removed under reduced pressure, and the crude product was purified using preparative HPLC. The resulting product was then converted to hydrochloride salt to afford the title compound (25 mg) in 32% yield as white powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.0 (s, 1H), 7.82 (d, 2H), 7.40 (d, 2H) 7.02 (d, 2H), 6.64 (d, 2H), 4.52 (m, 2H), 3.84 (m, 1H), 3.62 (m, 4H), 3.50 (m, 4H), 3.45–3.02 (m, 4H), 2.45 (s, 3H), 2.12 (m, 1H), 2.02 (m, 1H); LC–MS purity, 97%, <i>t</i><sub>R</sub> = 1.78 min (method B), 451.1 (M + 1); HRMS (ESI) calcd for C<sub>25</sub>H<sub>30</sub>N<sub>4</sub>O<sub>4</sub> (M + H<sup>+</sup>) 451.2345, found 451.2349.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 1-(2-(4-(4-Acetylphenyl)piperazin-1-yl)-2-oxoethyl)-<i>N</i>-(3-chloro-4-hydroxyphenyl)pyrrolidine-3-carboxamide Hydrochloride (<b>2</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.8 (s, 1H), 7.82 (d, 2H), 7.76 (m, 1H) 7.26 (m, 1H), 7.02 (d, 2H), 6.90 (d, 1H), 4.52 (m, 2H), 3.84 (m, 1H), 3.62 (m, 4H), 3.50 (m, 4H), 3.45–3.02 (m, 4H), 2.45 (s, 3H), 2.12 (m, 1H), 2.02 (m, 1H); LC–MS purity, 95%, <i>t</i><sub>R</sub> = 2.67 min (method B), 485.2 (M + 1); HRMS (ESI) calcd for C<sub>25</sub>H<sub>30</sub>ClN<sub>4</sub>O<sub>4</sub> (M + H<sup>+</sup>) 485.1956, found 485.1950.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 1-(2-(4-(3-Chlorophenyl)piperazin-1-yl)-2-oxoethyl)-<i>N</i>-(4-hydroxyphenyl)pyrrolidine-3-carboxamide Hydrochloride (<b>3</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.0 (s, 1H), 7.40 (d, 2H), 7.22 (m, 1H), 7.00 (s, 1H), 6.95 (d, 1H), 6.82 (d, 1H), 6.72 (d, 2H), 4.52 (m, 2H), 3.84 (m, 1H), 3.62 (m, 4H), 3.50 (m, 4H), 3.45–3.02 (m, 4H), 2.22 (m, 1H), 2.10 (m, 1H); LC–MS purity, 95%, <i>t</i><sub>R</sub> = 2.28 min (method B), 443.2 (M + 1); HRMS (ESI) calcd for C<sub>23</sub>H<sub>28</sub>ClN<sub>4</sub>O<sub>3</sub> (M + H<sup>+</sup>) 443.1850, found 443.1844.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (<i>R</i>)-1-(2-(4-(4-Acetylphenyl)piperazin-1-yl)-2-oxoethyl)-<i>N</i>-(3-chloro-4-hydroxyphenyl)pyrrolidine-3-carboxamide Hydrochloride (<b>4</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.8 (s, 1H), 7.82 (d, 2H), 7.76 (m, 1H) 7.26 (m, 1H), 7.02 (d, 2H), 6.90 (d, 1H), 4.52 (m, 2H), 3.84 (m, 1H), 3.62 (m, 4H), 3.50 (m, 4H), 3.45–3.02 (m, 4H), 2.45 (s, 3H), 2.12 (m, 1H), 2.02 (m, 1H); LC–MS purity, 98%, <i>t</i><sub>R</sub> = 2.67 min (method B), 485.2 (M + 1); HRMS (ESI) calcd for C<sub>25</sub>H<sub>30</sub>ClN<sub>4</sub>O<sub>4</sub> (M + H<sup>+</sup>) 485.1956, found 485.1950.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (<i>S</i>)-1-(2-(4-(4-Acetylphenyl)piperazin-1-yl)-2-oxoethyl)-<i>N</i>-(3-chloro-4-hydroxyphenyl)pyrrolidine-3-carboxamide Hydrochloride (<b>5</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.8 (s, 1H), 7.82 (d, 2H), 7.76 (m, 1H) 7.26 (m, 1H), 7.02 (d, 2H), 6.90 (d, 1H), 4.52 (m, 2H), 3.84 (m, 1H), 3.62 (m, 4H), 3.50 (m, 4H), 3.45–3.02 (m, 4H), 2.45 (s, 3H), 2.12 (m, 1H), 2.02 (m, 1H); LC–MS purity, 95%, <i>t</i><sub>R</sub> = 2.67 min (method B), 485.2 (M + 1); HRMS (ESI) calcd for C<sub>25</sub>H<sub>30</sub>ClN<sub>4</sub>O<sub>4</sub> (M + H<sup>+</sup>) 485.1956, found 485.1950.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>N</i>-(3-Chloro-4-hydroxyphenyl)-1-(2-(4-(3-chlorophenyl)piperazin-1-yl)-2-oxoethyl)pyrrolidine-3-carboxamide (<b>6</b>)</h3><div class="NLM_p last">HRMS (ESI) calcd for C<sub>23</sub>H<sub>27</sub>Cl<sup>2</sup>N<sub>4</sub>O<sub>3</sub> (M + H<sup>+</sup>) 477.1460</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (<i>R</i>)-1-(2-(4-(4-Bromophenyl)piperazin-1-yl)-2-oxoethyl)-<i>N</i>-(3-chloro-4-hydroxyphenyl)pyrrolidine-3-carboxamide Hydrochloride (<b>7</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.00 (s, 1H), 7.75 (s, 1H), 7.40 (d, 2H) 7.30 (m, 1H), 6.95 (d, 2H), 6.82 (d, 1H), 4.50 (m, 2H), 3.82 (m, 1H), 3.62 (m, 4H), 3.50 (m, 4H), 3.45–3.02 (m, 4H), 2.22 (m, 1H), 2.10 (m, 1H); LC–MS purity, 95%, <i>t</i><sub>R</sub> = 2.50 min (method B), 521.1 (M + 1); HRMS (ESI) calcd for C<sub>23</sub>H<sub>27</sub>BrClN<sub>4</sub>O<sub>3</sub> (M + H<sup>+</sup>) 521.0950, 523.0935, found 521.0947, 523.0925</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (<i>R</i>)-1-(2-(4-(Biphenyl-4-yl)piperazin-1-yl)-2-oxoethyl)-<i>N</i>-(3-chloro-4-hydroxyphenyl)pyrrolidine-3-carboxamide (<b>8</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.80 (s, 1H), 7.72 (s, 1H), 7.60 (d, 2H) 7.54 (d, 2H), 7.41 (m, 2H), 7.30 (m, 1H), 7.28 (m, 1H), 7.08 (d, 2H), 6.82 (d, 1H), 4.50 (m, 2H), 3.90 (m, 1H), 3.62 (m, 4H), 3.50 (m, 2H), 3.45–3.02 (m, 6H), 2.22 (m, 1H), 2.10 (m, 1H); LC–MS purity, 95%, <i>t</i><sub>R</sub> = 2.69 min (method B), 519.1 (M + 1); HRMS (ESI) calcd for C<sub>29</sub>H<sub>32</sub>ClN<sub>4</sub>O<sub>3</sub> (M + H<sup>+</sup>) 519.2157, found 519.2156.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (<i>R</i>)-<i>N</i>-(3-Chloro-4-hydroxyphenyl)-1-(2-oxo-2-(4-(4-(thiophen-3-yl)phenyl)piperazin-1-yl)ethyl)pyrrolidine-3-carboxamide (<b>9</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.80 (s, 1H), 7.72 (s, 1H), 7.68 (s, 1H), 7.60 (d, 2H), 7.58 (m, 1H), 7.46 (d, 1H), 7.26 (m, 1H), 7.02 (d, 2H), 6.92 (d, 1H), 4.50 (m, 2H), 3.84 (m, 1H), 3.62 (m, 4H), 3.50 (m, 2H), 3.45–3.02 (m, 6H), 2.22 (m, 1H), 2.10 (m, 1H); LC–MS purity, 98%, <i>t</i><sub>R</sub> = 2.60 min (method B), 525.2 (M + 1); HRMS (ESI) calcd for C<sub>27</sub>H<sub>30</sub>ClN<sub>4</sub>O<sub>3</sub>S (M + H<sup>+</sup>) 525.1722, found 525.1721.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (<i>R</i>)-<i>N</i>-(3-Chloro-4-hydroxyphenyl)-1-(2-(4-(4-(furan-3-yl)phenyl)piperazin-1-yl)-2-oxoethyl)pyrrolidine-3-carboxamide (<b>10</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ12.00 (s, 1H), 8.04 (s, 1H), 7.72 (d, 1H), 7.68 (s, 1H), 7.48 (d, 2H), 7.26 (m, 1H), 7.02 (d, 2H), 6.92 (d, 1H), 6.88 (s, 1H), 4.50 (m, 2H), 3.84 (m, 1H), 3.66 (m, 2H), 3.50 (m, 2H), 3.40 (m, 2H), 3.45–3.02 (m, 6H), 2.22 (m, 1H), 2.10 (m, 1H); LC–MS purity, 96%, <i>t</i><sub>R</sub> = 2.42 min (method B), 509.1 (M + 1); HRMS (ESI) calcd for C<sub>27</sub>H<sub>30</sub>ClN<sub>4</sub>O<sub>4</sub> (M + H<sup>+</sup>) 509.1950, found 509.1950.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (<i>R</i>)-1-(2-(4-(Benzo[<i>d</i>]thiazol-2-yl)piperazin-1-yl)-2-oxoethyl)-<i>N</i>-(3-chloro-4-hydroxyphenyl)pyrrolidine-3-carboxamide (<b>11</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.40 (s, 1H), 7.82 (d, 1H), 7.76 (s, 1H), 7.54 (d, 1H), 7.36 (m, 2H), 7.14 (m, 1H), 6.92 (d, 1H), 4.52 (m, 2H), 3.84 (m, 1H), 3.66 (m, 2H), 3.50 (m, 2H), 3.40 (m, 2H), 3.45–3.02 (m, 6H), 2.22 (m, 1H), 2.10 (m, 1H); LC–MS purity, 95%, <i>t</i><sub>R</sub> = 2.10 min (method B), 501.1 (M + 1); HRMS (ESI) calcd for C<sub>24</sub>H<sub>27</sub>ClN<sub>5</sub>O<sub>3</sub>S (M + H<sup>+</sup>) 500.1518, found 500.1518.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (<i>R</i>)-Methyl Pyrrolidine-3-carboxylate (<b>24</b>)</h3><div class="NLM_p last">(<i>R</i>)-1-<i>N</i>-Boc-β-proline (1 g, 4.65 mmol) was dissolved in the mixture of toluene (8 mL) and MeOH (2 mL). The mixture was cooled to 0–5 °C, and TMSCHN<sub>2</sub> (2 M in hexanes) (∼2.5 mL) was added slowly until yellow color was sustained. After stirring for additional half hour, the reaction was quenched with drops of acetic acid and concentrated under reduced pressure. The residue was taken into dichloromethane (10 mL), and 4 N HCl in dioxane (4 mL) was added. The resulting solution was stirred for 1 h and concentrated to provide 0.8 g of crude <b>24</b>.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (<i>R</i>)-Methyl 1-(2-<i>tert</i>-Butoxy-2-oxoethyl)pyrrolidine-3-carboxylate (<b>25</b>)</h3><div class="NLM_p last">To a reaction mixture containing <b>24</b> (750 mg, 4.53 mmol), DIEA (2.4 mL, 13.8 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (1.5 g, 4.6 mmol) in DMF (10 mL) was added <i>tert</i>-butyl bromoacetate (748 μL, 5.06 mmol) slowly, and the reaction mixture was stirred at room temperature for 1 h. The mixture was diluted with EtOAc (70 mL), washed with water (3 × 15 mL), brine, and dried over MgSO<sub>4</sub>. The solvent was evaporated under reduced pressure, and the residue was purified on silica gel. Eluting with hexane/EtOAc (0–50%) provided the desired product (830 mg, 75%) as colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 3.69 (s, 3H), 3.16(m, 2H), 3.11 (m, 2H), 2.93 (m,1H), 2.74 (m,1H), 2.58 (m,1H), 2.11 (m, 2H), 1.48 (s, 9H).</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (<i>R</i>)-2-(3-(Methoxycarbonyl)pyrrolidin-1-yl)acetic Acid (<b>26</b>)</h3><div class="NLM_p last">(<i>R</i>)-Methyl 1-(2-<i>tert</i>-butoxy-2-oxoethyl)pyrrolidine-3-carboxylate (830 mg, 3.41 mmol) was dissolved in dichloromethane (5 mL), and TFA (5 mL) was added. The solution was stirred for 2 h and concentrated to a residue which was exchanged with hydrochloric acid by dissolving in acetonitrile (5 mL) and adding 4 N HCl in dioxane (3 mL) to provide the crude title compound as HCl salt (1.49 g) after concentration.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (<i>R</i>)-Methyl 1-(2-(4-(4-Acetylphenyl)piperazin-1-yl)-2-oxoethyl)pyrrolidine-3-carboxylate (<b>27</b>)</h3><div class="NLM_p last">To a solution of (<i>R</i>)-2-(3-(methoxycarbonyl)pyrrolidin-1-yl)acetic acid (3.2 mmol), 1-(4-(piperazin-1-yl)phenyl)ethanone (650 mg, 3.2 mmol), and HATU (1.2 g, 3.2 mmol) in DMF (4 mL) was added DIEA (1.7 mL, 9.8 mmol). The reaction mixture was stirred for 10 min. 1-(4-(Piperazin-1-yl)phenyl)ethanone (673 mg, 3.3 mmol) was added, and the reaction mixture was allowed to stir at room temperature for 2 h. Water (30 mL) was added, and the mixture was extracted with EtOAc (3 × 30 mL). The organic extracts were combined and washed with water (3 × 20 mL), brine (20 mL) and dried over MgSO<sub>4</sub>. Solvent was evaporated under reduced pressure and the residue was purified on silica gel. Elution with MeOH/EtOAc (0–20%) provided the title compound (728 mg, 59%) as colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.89 (d, 2H), 6.87 (d, 2H), 3.80 (m,3H), 3.66 (s,3H), 3.66 (m,4H), 3.36 (m,6H), 3.06 (m, 2H), 2.90 (m, 2H), 2.71 (m,2H), 2.53 (s, 3H), 2.13 (2H).</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (<i>R</i>)-1-(2-(4-(4-Acetylphenyl)piperazin-1-yl)-2-oxoethyl)pyrrolidine-3-carboxylic Acid (<b>28</b>)</h3><div class="NLM_p last">To a solution of (<i>R</i>)-methyl 1-(2-(4-(4-acetylphenyl)piperazin-1-yl)-2-oxoethyl)pyrrolidine-3-carboxylate (728 mg, 1.95 mmol) in THF/water (3:1, 4 mL) was added LiOH monohydrate (98 mg, 2.33 mmol), and the resulting mixture was stirred at room temperature for 12 h. The reaction mixture was acidified to pH ≈ 3 by adding slowly 4 N HCl and was lyophilized to provide the crude product which was used next step without further purification.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (<i>R</i>)-1-(2-(4-(4-Acetylphenyl)piperazin-1-yl)-2-oxoethyl)-<i>N</i>-(2-chloro-4-hydroxyphenyl)pyrrolidine-3-carboxamide Hydrochloride (<b>12</b>)</h3><div class="NLM_p last">To a solution of (<i>R</i>)-1-(2-(4-(4-acetylphenyl)piperazin-1-yl)-2-oxoethyl)pyrrolidine-3-carboxylic acid (72 mg, 0.2 mmol) in DMF (2 mL) were added HATU (76 mg, 0.2 mmol) and DIEA (104 uL, 0.6 mmol), followed by 4-amino-3-chlorophenol (36 mg, 0.25 mmol). The mixture was allowed to stir at room temperature overnight, and the reaction mixture was directly purified by HPLC to provide the title product. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 10.6 (m, 1H), 7.83 (d, 1H), 7.23 (dd, 1H), 6.96–7.02 (m, 4H), 4.53 (d, 2H), 3.25–3.98 (m, 13H), 2.46 (s, 3H), 2.0–2.34 (m, 2H); LC–MS purity, 98%, <i>t</i><sub>R</sub> = 2.16 min (method B), 485.0 (M + 1). HRMS (ESI) calcd for C<sub>25</sub>H<sub>30</sub>ClN<sub>4</sub>O<sub>4</sub> (M + H<sup>+</sup>) 485.1956, found 485.1950.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (<i>R</i>)-1-(2-(4-(4-Acetylphenyl)piperazin-1-yl)-2-oxoethyl)-<i>N</i>-(3,5-dichloro-4-hydroxyphenyl)pyrrolidine-3-carboxamide (<b>13</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 10.2–10.9 (m, 2H), 7.83 (d, 2H), 7.72 (d, 2H), 7.00 (d, 2 H), 6.75 (s, 1H), 4.53 (m, 2H), 3.25–4.00 (m, 13H), 2.46 (s, 3H), 2.0–2.6 (m, 2H); LC–MS purity, 95%, <i>t</i><sub>R</sub> = 2.18 min (method B), 519.0 (M + 1); HRMS (ESI) calcd for C<sub>25</sub>H<sub>29</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>4</sub> (M + H<sup>+</sup>) 519.1566, found 519.1568.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (<i>R</i>)-1-(2-(4-(4-Acetylphenyl)piperazin-1-yl)-2-oxoethyl)-<i>N</i>-(3-bromo-4-hydroxyphenyl)pyrrolidine-3-carboxamide Hydrochloride (<b>14</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 10.2–10.4 (m, 3H), 7.89 (s,1H), 7.83 (d, 1H, <i>J</i> = 9.2 Hz), 7.30 (m, 1H), 7.0 (d, 1H, <i>J</i> = 8.8 Hz), 6.93 (m, 1H), 4.50 (m, 2H), 3.20–3.90 (m, 13H), 2.46(s, 3H), 2.0–2.4(m,2H); LC–MS purity, 97%, <i>t</i><sub>R</sub> = 2.07 min (method B), 528.9 (M + 1); HRMS (ESI) calcd for C<sub>25</sub>H<sub>30</sub>BrN<sub>4</sub>O<sub>4</sub> (M + H<sup>+</sup>) 529.1450 and 567.1197, found 529.1450 and 567.1197.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (<i>R</i>)-1-(2-(4-(4-Acetylphenyl)piperazin-1-yl)-2-oxoethyl)-<i>N</i>-(3-fluoro-4-hydroxyphenyl)pyrrolidine-3-carboxamide Hydrochloride (<b>15</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 10.2–10.5 (m, 2H), 7.83 (d, 1H, <i>J</i> = 9.2 Hz), 7.57 (dd, <i>J</i> = 14 Hz, <i>J</i> = 2.4 Hz), 6.89–7.16 (m, 3H), 4.50(m, 2H), 3.20–3.90 (m, 13H), 2.46 (s, 3H), 2.0–2.4 (m, 2H); LC–MS purity, 98%, <i>t</i><sub>R</sub> = 1.90 min (method B), 468.9 (M + 1); HRMS (ESI) calcd for C<sub>25</sub>H<sub>31</sub>ClFN<sub>4</sub>O<sub>4</sub> (M + H<sup>+</sup>) 505.2018, found 505.2016.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (<i>R</i>)-1-(2-(4-(4-Acetylphenyl)piperazin-1-yl)-2-oxoethyl)-<i>N</i>-(4-hydroxy-3-methylphenyl)pyrrolidine-3-carboxamide Hydrochloride (<b>16</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 10.1–10.4 (m, 2H), 7.83 (d, 2H, <i>J</i> = 9.2 Hz), 7.30 (d, 2H, <i>J</i> = 2.0 Hz), 7.22 (m, 1H), 7.01 (d, 1H, <i>J</i> = 8.8 Hz), 6.71 (m, 1H), 4.47–4.55 (m, 2H), 3.16–3.99 (m, 13H), 2.46 (s,3H), 2.1–2.44(m, 2H), 2.08 (d, 3H, <i>J</i> = 4 Hz); LC–MS purity, 98%, <i>t</i><sub>R</sub> = 1.94 min (method B), 464.9 (M + 1); HRMS (ESI) calcd for C<sub>26</sub>H<sub>33</sub>N<sub>4</sub>O<sub>4</sub> (M + H<sup>+</sup>) 465.2496, found 465.2493.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Temperature Dependent Fluorescence (TdF) Assay</h3><div class="NLM_p last">The TdF assay was mainly conducted in the 96-well based CHROMO-4 real time fluorescence plate reader (Bio-Rad). The Sypro Orange (Sigma-Aldrich), an environmentally sensitive fluorescence dye, was used to monitor the protein folding–unfolding transition. Protein–ligand binding was gauged by the change (or shift) in the unfolding transition temperature (Δ<i>T</i><sub>m</sub>) acquired at protein alone with respect to protein in the presence of ligand of interest. Compound of interest was first prepared in DMSO stock (typical concentration, 10 mM). Sample of 20 μL was then added into the 96-well PCR plate, where it consisted of 3 μM ERK protein and 15, 50, or 100 μM compound (depending on compound’s solubility) in buffer (25 mM HEPES, 200 mM NaCl, pH 7.5, and 1 mM DTT) incorporated with Sypro Orange dye (5× final concentration). Final percentage of DMSO resided in the sample was 2%. The sample plate was heated from 30 to 90 °C with thermal ramping rate of 1 °C/min. The fluorescence signals were acquired with excitation and emission wavelengths centered at 490 and 560 nm, respectively. The instrument thermal stability was ±0.2 °C. The melting temperatures (<i>T</i><sub>m</sub>) for inactive ERK2 protein and phosphorylated ERK2 under aforementioned conditions occurred at 56.3 ± 0.2 and 58.6 ± 0.2 °C respectively.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Coupled ERK2 Assay</h3><div class="NLM_p last">Activity of compounds against inactive ERK2 was tested in a coupled MEK1/ERK2 IMAP assay as follows: Compounds were diluted to 25× final test concentration in 100% DMSO. Then 14 μL of kinase buffer (10 mM Tris-HCl, pH 7.2, 10 mM MgCl<sub>2</sub>, 0.01% Tween-20, 1 mM DTT) containing 0.4 ng of unphosphorylated mouse ERK2 protein was added to each well of a black 384-well assay plate. An amount of 1 μL of 25× compound was added to each well and incubated at room temperature for 30 min to allow an opportunity for the compound to bind to the inactive enzyme. DMSO concentration during initial incubation is 6.7%. ERK2 activity was determined to be insensitive to DMSO concentrations up to 20%. ERK2 was then activated and its kinase activity measured by the addition of 10 μL of kinase buffer with the following components (final concentration per reaction): 2 ng of active (phosphorylated) human MEK1 protein and 4 μM (total) ERK2 IMAP substrate peptides (3.9 μM unlabeled IPTTPITTTYFFFK-CONH<sub>2</sub> and 100 nM IPTTPITTTYFFFK (5-carboxyfluorescein)-CONH<sub>2</sub>) and 30 μM ATP. DMSO concentration during ERK activation was 4%. After 1 h, reactions were terminated by addition of 60 μL of IMAP detection beads in binding buffer (Molecular Devices). Binding was allowed to equilibrate for 30 min before reading the plate on an LJL Analyst fluorescence polarization plate reader. Compound inhibition was calculated relative to DMSO and fully inhibited standards. Active compounds were reconfirmed in two independent assays (<i>N</i> = 2).</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Active ERK2 Assay</h3><div class="NLM_p last">Activated ERK2 activity was also determined in the IMAP assay format using the procedure outlined above. An amount of 1 μL of 25× compound was added to 14 μL of kinase buffer containing 0.25 ng of fully phosphorylated active mouse ERK2 protein. Following a 30 min incubation, the reactions were initiated by addition of 10 μL of kinase buffer containing 1 μM ERK2 IMAP substrate peptide (0.9 μM unlabeled IPTTPITTTYFFFK-CONH<sub>2</sub> and 100 nM IPTTPITTTYFFFK (5-carboxyfluorescein)-CONH<sub>2</sub>) and 30 μM ATP. Reactions proceeded for 30 min before termination by addition of 60 μL of IMAP detection beads in binding buffer. Plates were read as above after a 30 min binding equilibration. Active compounds were repeated in two independent assays (<i>N</i> = 2).</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Proliferation Assay</h3><div class="NLM_p last">Melanoma (A2058 and A375) and colon cancer (Colo-205) cell lines were grown and maintained in RPMI-1640 medium containing 100 U/mL penicillin–streptomycin and 10% fetal bovine serum. Cells were seeded on the day of treatment in 40 μL of growth medium in white/opaque bottom 384-well collagen-coated Biocoat plates at 2000 cells/well (A2058, Colo-205) or 1500 cells/well (A375SM) and allowed to attach to the plates for 2 h before treatment. Compounds were diluted in 100% DMSO in a Labcyte Echo qualified plate and delivered using an Echo 555 so that the final concentration of DMSO in the assay was 1.0% or 0.1%. Plates were placed in 37 °C, 5% CO<sub>2</sub> for 3 days before they were developed by adding 40 μL of CellTiter-Glo reagent (Promega). Plates were shaken briefly after reagent addition and read on an EnVision 2104 plate reader (PerkinElmer). Data were analyzed in GraphPad Prism.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46"><a href="/doi/suppl/10.1021/jm500847m">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21881" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21881" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Crystallization data table and additional kinase selectivity data for <b>4</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500847m/suppl_file/jm500847m_si_001.pdf">jm500847m_si_001.pdf (198.67 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm500847m" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34878" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34878" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yongqi Deng</span> - <span class="hlFld-Affiliation affiliation">Merck
Research Laboratories, 33 Avenue Louis Pasteur, Boston, Massachusetts 02115, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#94edfbfaf3e5fdbaf0f1faf3d4f9f1e6f7ffbaf7fbf9"><span class="__cf_email__" data-cfemail="a5dccacbc2d4cc8bc1c0cbc2e5c8c0d7c6ce8bc6cac8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gerald W. Shipps</span> - <span class="hlFld-Affiliation affiliation">Merck
Research Laboratories, 33 Avenue Louis Pasteur, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan Cooper</span> - <span class="hlFld-Affiliation affiliation">Merck
Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jessie M. English</span> - <span class="hlFld-Affiliation affiliation">Merck
Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">D. Allen Annis</span> - <span class="hlFld-Affiliation affiliation">Merck
Research Laboratories, 33 Avenue Louis Pasteur, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donna Carr</span> - <span class="hlFld-Affiliation affiliation">Merck
Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yang Nan</span> - <span class="hlFld-Affiliation affiliation">Merck
Research Laboratories, 33 Avenue Louis Pasteur, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tong Wang</span> - <span class="hlFld-Affiliation affiliation">Merck
Research Laboratories, 33 Avenue Louis Pasteur, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hugh Y. Zhu</span> - <span class="hlFld-Affiliation affiliation">Merck
Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheng-Chi Chuang</span> - <span class="hlFld-Affiliation affiliation">Merck
Research Laboratories, 33 Avenue Louis Pasteur, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Priya Dayananth</span> - <span class="hlFld-Affiliation affiliation">Merck
Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan W. Hruza</span> - <span class="hlFld-Affiliation affiliation">Merck
Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li Xiao</span> - <span class="hlFld-Affiliation affiliation">Merck
Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weihong Jin</span> - <span class="hlFld-Affiliation affiliation">Merck
Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Kirschmeier</span> - <span class="hlFld-Affiliation affiliation">Merck
Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William T. Windsor</span> - <span class="hlFld-Affiliation affiliation">Merck
Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ahmed A. Samatar</span> - <span class="hlFld-Affiliation affiliation">Merck
Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1684e2211-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i47">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20233" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20233" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Stuart Black, Kimberly Gray, Tom Hesson, and Catherine Smith for providing ERK and MEK proteins for this study.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i48" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i48"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i49" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i49"> Abbreviations Used</h2><tr><td class="NLM_term">ERK</td><td class="NLM_def"><p class="first last">extracellular regulated kinase</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine 5′-triphosphate</p></td></tr><tr><td class="NLM_term">Ras</td><td class="NLM_def"><p class="first last">renin–angiotensin system</p></td></tr><tr><td class="NLM_term">MAPK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase</p></td></tr><tr><td class="NLM_term">MEK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase kinase</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butoxycarbonyl</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">(1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxide hexafluorophosphate)</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i50">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87464" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87464" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 34 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Cheng, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobb, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baer, R.</span><span> </span><span class="NLM_article-title">Phosphorylation of the TAL1 oncoprotein by the extracellular-signal-regulated protein kinase ERK1</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm500847m&amp;key=8423803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADyaK3sXps12gsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1993&pages=801-8&author=J.+T.+Chengauthor=M.+H.+Cobbauthor=R.+Baer&title=Phosphorylation+of+the+TAL1+oncoprotein+by+the+extracellular-signal-regulated+protein+kinase+ERK1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of the TAL1 oncoprotein by the extracellular-signal-regulated protein kinase ERK1</span></div><div class="casAuthors">Cheng, Jiin Tsuey; Cobb, Melanie H.; Baer, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">801-8</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    </div><div class="casAbstract">Alteration of the TAL1 gene is the most common genetic lesion found in T-cell acute lymphoblastic leukemia.  TAL1 Encodes phosphoproteins, pp42TAL1 and pp22TALq, that represent phosphorylated versions of the full-length (residues 1 to 331) and truncated (residues 176 to 331) TAL1 gene products, resp.  Both proteins contain the basic helix-loop-helix motif, a DNA-binding and protein dimerization motif common to several known transcriptional regulatory factors.  Serine residue 122 (S122) is a major phosphorylation site of pp42TAL1 in leukemic cell lines and transfected COS1 cells.  In vivo phosphorylation of S122 is induced by epidermal growth factor with a rapid time course that parallels activation of the ERK/MAP2 protein kinases.  Moreover, S122 is readily phosphorylated in vitro by the extracellular signal-regulated protein kinase ERK1.  These data suggest that TAL1 residue S122 serves as an in vivo substrate for ERK/MAP2 kinases such as ERK1.  Therefore, S122 phosphorylation may provide a mechanism whereby the properties of TAL1 polypeptides can be modulated by extracellular stimuli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRFp8xKjm7LbVg90H21EOLACvtfcHk0ljSi7v5hUVQag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXps12gsw%253D%253D&md5=9d9f6009f036d35630b57fb086ddbdfb</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DJ.%2BT.%26aulast%3DCobb%26aufirst%3DM.%2BH.%26aulast%3DBaer%26aufirst%3DR.%26atitle%3DPhosphorylation%2520of%2520the%2520TAL1%2520oncoprotein%2520by%2520the%2520extracellular-signal-regulated%2520protein%2520kinase%2520ERK1%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1993%26volume%3D13%26spage%3D801%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. J.</span><span> </span><span class="NLM_article-title">Map Kinase Binds to the NH2-Terminal Activation Domain of C-Myc</span> <span class="citation_source-journal">Febs Letters</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">285</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=1994&pages=281-285&author=S.+Guptaauthor=R.+J.+Davis&title=Map+Kinase+Binds+to+the+NH2-Terminal+Activation+Domain+of+C-Myc"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DR.%2BJ.%26atitle%3DMap%2520Kinase%2520Binds%2520to%2520the%2520NH2-Terminal%2520Activation%2520Domain%2520of%2520C-Myc%26jtitle%3DFebs%2520Letters%26date%3D1994%26volume%3D353%26spage%3D281%26epage%3D285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Robbins, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhen, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobb, M. H.</span><span> </span><span class="NLM_article-title">Map Kinases Erk1 and Erk2—Pleiotropic Enzymes in a Ubiquitous Signaling Network</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1994&pages=93-116&author=D.+J.+Robbinsauthor=E.+H.+Zhenauthor=M.+G.+Chengauthor=S.+C.+Xuauthor=D.+Ebertauthor=M.+H.+Cobb&title=Map+Kinases+Erk1+and+Erk2%E2%80%94Pleiotropic+Enzymes+in+a+Ubiquitous+Signaling+Network"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRobbins%26aufirst%3DD.%2BJ.%26aulast%3DZhen%26aufirst%3DE.%2BH.%26aulast%3DCheng%26aufirst%3DM.%2BG.%26aulast%3DXu%26aufirst%3DS.%2BC.%26aulast%3DEbert%26aufirst%3DD.%26aulast%3DCobb%26aufirst%3DM.%2BH.%26atitle%3DMap%2520Kinases%2520Erk1%2520and%2520Erk2%25E2%2580%2594Pleiotropic%2520Enzymes%2520in%2520a%2520Ubiquitous%2520Signaling%2520Network%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D1994%26volume%3D63%26spage%3D93%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Cobb, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, E. J.</span><span> </span><span class="NLM_article-title">How Map Kinases Are Regulated</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">14843</span><span class="NLM_x">–</span> <span class="NLM_lpage">14846</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=14843-14846&author=M.+H.+Cobbauthor=E.+J.+Goldsmith&title=How+Map+Kinases+Are+Regulated"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCobb%26aufirst%3DM.%2BH.%26aulast%3DGoldsmith%26aufirst%3DE.%2BJ.%26atitle%3DHow%2520Map%2520Kinases%2520Are%2520Regulated%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D14843%26epage%3D14846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Campbell, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krebs, E. G.</span><span> </span><span class="NLM_article-title">The Map Kinase Cascade</span> <span class="citation_source-journal">Recent Prog. Horm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm500847m&amp;key=7740155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADyaK2MXmt1Kjuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1995&pages=131-159&author=J.+S.+Campbellauthor=R.+Segerauthor=J.+D.+Gravesauthor=L.+M.+Gravesauthor=A.+M.+Jensenauthor=E.+G.+Krebs&title=The+Map+Kinase+Cascade"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The MAP kinase cascade</span></div><div class="casAuthors">Campbell, Jean S.; Seger, Rony; Graves, Jonathan D.; Graves, Lee M.; Jensen, Amy M.; Krebs, Edwin G.</div><div class="citationInfo"><span class="NLM_cas:title">Recent Progress in Hormone Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">131-59</span>CODEN:
                <span class="NLM_cas:coden">RPHRA6</span>;
        ISSN:<span class="NLM_cas:issn">0079-9963</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">A review, with 160 refs., of the MAP kinase cascade and its involvement in signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlhvLtbVDGy7Vg90H21EOLACvtfcHk0ljSi7v5hUVQag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmt1Kjuro%253D&md5=3ca608283bacc95feff8c1a5b04a4c75</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DJ.%2BS.%26aulast%3DSeger%26aufirst%3DR.%26aulast%3DGraves%26aufirst%3DJ.%2BD.%26aulast%3DGraves%26aufirst%3DL.%2BM.%26aulast%3DJensen%26aufirst%3DA.%2BM.%26aulast%3DKrebs%26aufirst%3DE.%2BG.%26atitle%3DThe%2520Map%2520Kinase%2520Cascade%26jtitle%3DRecent%2520Prog.%2520Horm.%2520Res.%26date%3D1995%26volume%3D50%26spage%3D131%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Samowitz, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albertsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murtaugh, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slattery, M. L.</span><span> </span><span class="NLM_article-title">Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">6063</span><span class="NLM_x">–</span> <span class="NLM_lpage">6070</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=6063-6070&author=W.+S.+Samowitzauthor=C.+Sweeneyauthor=J.+Herrickauthor=H.+Albertsenauthor=T.+R.+Levinauthor=M.+A.+Murtaughauthor=R.+K.+Wolffauthor=M.+L.+Slattery&title=Poor+survival+associated+with+the+BRAF+V600E+mutation+in+microsatellite-stable+colon+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSamowitz%26aufirst%3DW.%2BS.%26aulast%3DSweeney%26aufirst%3DC.%26aulast%3DHerrick%26aufirst%3DJ.%26aulast%3DAlbertsen%26aufirst%3DH.%26aulast%3DLevin%26aufirst%3DT.%2BR.%26aulast%3DMurtaugh%26aufirst%3DM.%2BA.%26aulast%3DWolff%26aufirst%3DR.%2BK.%26aulast%3DSlattery%26aufirst%3DM.%2BL.%26atitle%3DPoor%2520survival%2520associated%2520with%2520the%2520BRAF%2520V600E%2520mutation%2520in%2520microsatellite-stable%2520colon%2520cancers%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D6063%26epage%3D6070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Shapiro, P.</span><span> </span><span class="NLM_article-title">Ras-MAP kinase signaling pathways and control of cell proliferation: relevance to cancer therapy</span> <span class="citation_source-journal">Crit. Rev. Clin. Lab. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm500847m&amp;key=10.1080%2F10408360290795538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm500847m&amp;key=12385501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtlKit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2002&pages=285-330&author=P.+Shapiro&title=Ras-MAP+kinase+signaling+pathways+and+control+of+cell+proliferation%3A+relevance+to+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Ras-MAP kinase signaling pathways and control of cell proliferation: relevance to cancer therapy</span></div><div class="casAuthors">Shapiro, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Clinical Laboratory Sciences</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4 and 5</span>),
    <span class="NLM_cas:pages">285-330</span>CODEN:
                <span class="NLM_cas:coden">CRCLBH</span>;
        ISSN:<span class="NLM_cas:issn">1040-8363</span>.
    
            (<span class="NLM_cas:orgname">CRC Press LLC</span>)
        </div><div class="casAbstract">A review.  The mitogen-activated protein (MAP) kinase pathways represent several families of signal transduction cascades that mediate information provided by extracellular stimuli.  MAP kinase pathways regulate a wide range of physiol. responses, including cell proliferation, apoptosis, cell differentiation, and tissue development.  Constitutive activation of MAP kinase proteins in exptl. models has been shown to cause cell transformation and is implicated in tumorigenesis.  Of clin. importance, MAP kinase pathways are regulated by Ras G-proteins, which are found to be mutated and constitutively active in ∼30% of all human cancers.  Thus, a major goal in the treatment of cancer is the development of specific compds. that target Ras and crit. downstream signaling proteins responsible for uncontrolled cell growth.  A variety of biochem., mol., and structural approaches have been used to develop drug compds. that target signaling proteins important for MAP kinase pathway activation.  These compds. have been useful tools for identifying the mechanisms of MAP kinase pathway signaling and hold promise for clin. use.  This review will present an overview of the major proteins involved in Ras and MAP kinase signaling pathways and their function in regulating cell cycle events and proliferation.  In addn., some of the relevant compds. that have been developed to inhibit the activities of these proteins and MAP kinase signaling are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVr0dyOfX0jbVg90H21EOLACvtfcHk0lgEALA8zuYUQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtlKit74%253D&md5=4441af89966fb06d2d1c9f84868d1f4b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1080%2F10408360290795538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10408360290795538%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DP.%26atitle%3DRas-MAP%2520kinase%2520signaling%2520pathways%2520and%2520control%2520of%2520cell%2520proliferation%253A%2520relevance%2520to%2520cancer%2520therapy%26jtitle%3DCrit.%2520Rev.%2520Clin.%2520Lab.%2520Sci.%26date%3D2002%26volume%3D39%26spage%3D285%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Brose, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rishi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerrero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einhorn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albelda, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brignell, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futreal, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wooster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratton, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, B. L.</span><span> </span><span class="NLM_article-title">BRAF and RAS mutations in human lung cancer and melanoma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">6997</span><span class="NLM_x">–</span> <span class="NLM_lpage">7000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm500847m&amp;key=12460918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVahsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=6997-7000&author=M.+S.+Broseauthor=P.+Volpeauthor=M.+Feldmanauthor=M.+Kumarauthor=I.+Rishiauthor=R.+Gerreroauthor=E.+Einhornauthor=M.+Herlynauthor=J.+Minnaauthor=A.+Nicholsonauthor=J.+A.+Rothauthor=S.+M.+Albeldaauthor=H.+Daviesauthor=C.+Coxauthor=G.+Brignellauthor=P.+Stephensauthor=P.+A.+Futrealauthor=R.+Woosterauthor=M.+R.+Strattonauthor=B.+L.+Weber&title=BRAF+and+RAS+mutations+in+human+lung+cancer+and+melanoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">BRAF and RAS mutations in human lung cancer and melanoma</span></div><div class="casAuthors">Brose, Marcia S.; Volpe, Patricia; Feldman, Michael; Kumar, Madhu; Rishi, Irum; Gerrero, Renee; Einhorn, Eugene; Herlyn, Meenhard; Minna, John; Nicholson, Andrew; Roth, Jack A.; Albelda, Steven M.; Davies, Helen; Cox, Charles; Brignell, Graham; Stephens, Philip; Futreal, P. Andrew; Wooster, Richard; Stratton, Michael R.; Weber, Barbara L.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6997-7000</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">BRAF encodes a RAS-regulated kinase that mediates cell growth and malignant transformation kinase pathway activation.  Recently, we have identified activating BRAF mutations in 66% of melanomas and a smaller percentage of many other human cancers.  To det. whether BRAF mutations account for the MAP kinase pathway activation common in non-small cell lung carcinomas (NSCLCs) and to extend the initial findings in melanoma, we screened DNA from 179 NSCLCs and 35 melanomas for BRAF mutations (exons 11 and 15).  We identified BRAF mutations in 5 NSCLCs (3%; one V599 and four non-V599) and 22 melanomas (63%; 21 V599 and 1 non-V599).  Three BRAF mutations identified in this study are novel, altering residues important in AKT-mediated BRAF phosphorylation and suggesting that disruption of AKT -induced BRAF inhibition can play a role in malignant transformation.  To our knowledge, this is the first report of mutations documenting this interaction in human cancers.  Although >90% of BRAF mutations in melanoma involve codon 599 (57 of 60), 8 of 9 BRAF mutations reported to date in NSCLC are non-V599 (89%; P < 10-7), strongly suggesting that BRAF mutations in NSCLC are qual. different from those in melanoma; thus, there may be therapeutic differences between lung cancer and melanoma in response to RAF inhibitors.  Although uncommon, BRAF mutations in human lung cancers may identify a subset of tumors sensitive to targeted therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTgYE0tREoTrVg90H21EOLACvtfcHk0lgSvOmV-Gucmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVahsbo%253D&md5=14d00ac58479d0a0f98830abe436dfde</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrose%26aufirst%3DM.%2BS.%26aulast%3DVolpe%26aufirst%3DP.%26aulast%3DFeldman%26aufirst%3DM.%26aulast%3DKumar%26aufirst%3DM.%26aulast%3DRishi%26aufirst%3DI.%26aulast%3DGerrero%26aufirst%3DR.%26aulast%3DEinhorn%26aufirst%3DE.%26aulast%3DHerlyn%26aufirst%3DM.%26aulast%3DMinna%26aufirst%3DJ.%26aulast%3DNicholson%26aufirst%3DA.%26aulast%3DRoth%26aufirst%3DJ.%2BA.%26aulast%3DAlbelda%26aufirst%3DS.%2BM.%26aulast%3DDavies%26aufirst%3DH.%26aulast%3DCox%26aufirst%3DC.%26aulast%3DBrignell%26aufirst%3DG.%26aulast%3DStephens%26aufirst%3DP.%26aulast%3DFutreal%26aufirst%3DP.%2BA.%26aulast%3DWooster%26aufirst%3DR.%26aulast%3DStratton%26aufirst%3DM.%2BR.%26aulast%3DWeber%26aufirst%3DB.%2BL.%26atitle%3DBRAF%2520and%2520RAS%2520mutations%2520in%2520human%2520lung%2520cancer%2520and%2520melanoma%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D6997%26epage%3D7000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Tsai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bremer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillette, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sproesser, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smalley, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marimuthu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settachatgul, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shellooe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantwell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habets, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artis, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollag, G.</span><span> </span><span class="NLM_article-title">Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">3041</span><span class="NLM_x">–</span> <span class="NLM_lpage">3046</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm500847m&amp;key=10.1073%2Fpnas.0711741105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm500847m&amp;key=18287029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtVSitrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=3041-3046&author=J.+Tsaiauthor=J.+T.+Leeauthor=W.+Wangauthor=J.+Zhangauthor=H.+Choauthor=S.+Mamoauthor=R.+Bremerauthor=S.+Gilletteauthor=J.+Kongauthor=N.+K.+Haassauthor=K.+Sproesserauthor=L.+Liauthor=K.+S.+Smalleyauthor=D.+Fongauthor=Y.+L.+Zhuauthor=A.+Marimuthuauthor=H.+Nguyenauthor=B.+Lamauthor=J.+Liuauthor=I.+Cheungauthor=J.+Riceauthor=Y.+Suzukiauthor=C.+Luuauthor=C.+Settachatgulauthor=R.+Shellooeauthor=J.+Cantwellauthor=S.+H.+Kimauthor=J.+Schlessingerauthor=K.+Y.+Zhangauthor=B.+L.+Westauthor=B.+Powellauthor=G.+Habetsauthor=C.+Zhangauthor=P.+N.+Ibrahimauthor=P.+Hirthauthor=D.+R.+Artisauthor=M.+Herlynauthor=G.+Bollag&title=Discovery+of+a+selective+inhibitor+of+oncogenic+B-Raf+kinase+with+potent+antimelanoma+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity</span></div><div class="casAuthors">Tsai, James; Lee, John T.; Wang, Weiru; Zhang, Jiazhong; Cho, Hanna; Mamo, Shumeye; Bremer, Ryan; Gillette, Sam; Kong, Jun; Haass, Nikolas K.; Sproesser, Katrin; Li, Ling; Smalley, Keiran S. M.; Fong, Daniel; Zhu, Yong-Liang; Marimuthu, Adhirai; Nguyen, Hoa; Lam, Billy; Liu, Jennifer; Cheung, Ivana; Rice, Julie; Suzuki, Yoshihisa; Luu, Catherine; Settachatgul, Calvin; Shellooe, Rafe; Cantwell, John; Kim, Sung-Hou; Schlessinger, Joseph; Zhang, Kam Y. J.; West, Brian L.; Powell, Ben; Habets, Gaston; Zhang, Chao; Ibrahim, Prabha N.; Hirth, Peter; Artis, Dean R.; Herlyn, Meenhard; Bollag, Gideon</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3041-3046</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">BRAFV600E is the most frequent oncogenic protein kinase mutation known.  Furthermore, inhibitors targeting "active" protein kinases have demonstrated significant utility in the therapeutic repertoire against cancer.  Therefore, the authors pursued the development of specific kinase inhibitors targeting B-Raf, and the V600E allele in particular.  By using a structure-guided discovery approach, a potent and selective inhibitor of active B-Raf has been discovered.  PLX4720, a 7-azaindole deriv. that inhibits B-RafV600E with an IC50 of 13 nM, defines a class of kinase inhibitor with marked selectivity in both biochem. and cellular assays.  PLX4720 preferentially inhibits the active B-RafV600E kinase compared with a broad spectrum of other kinases, and potent cytotoxic effects are also exclusive to cells bearing the V600E allele.  Consistent with the high degree of selectivity, ERK phosphorylation is potently inhibited by PLX4720 in B-RafV600E-bearing tumor cell lines but not in cells lacking oncogenic B-Raf.  In melanoma models, PLX4720 induces cell cycle arrest and apoptosis exclusively in B-RafV600E-pos. cells.  In B-RafV600E-dependent tumor xenograft models, orally dosed PLX4720 causes significant tumor growth delays, including tumor regressions, without evidence of toxicity.  The work described here represents the entire discovery process, from initial identification through structural and biol. studies in animal models to a promising therapeutic for testing in cancer patients bearing B-RafV600E-driven tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPX53IQCbDJ7Vg90H21EOLACvtfcHk0lgSvOmV-Gucmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtVSitrk%253D&md5=273b94202f99984e6eb24723d0c6141f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0711741105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0711741105%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%2BT.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DMamo%26aufirst%3DS.%26aulast%3DBremer%26aufirst%3DR.%26aulast%3DGillette%26aufirst%3DS.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DHaass%26aufirst%3DN.%2BK.%26aulast%3DSproesser%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DSmalley%26aufirst%3DK.%2BS.%26aulast%3DFong%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DY.%2BL.%26aulast%3DMarimuthu%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DLam%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DCheung%26aufirst%3DI.%26aulast%3DRice%26aufirst%3DJ.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DLuu%26aufirst%3DC.%26aulast%3DSettachatgul%26aufirst%3DC.%26aulast%3DShellooe%26aufirst%3DR.%26aulast%3DCantwell%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DK.%2BY.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DHabets%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DHerlyn%26aufirst%3DM.%26aulast%3DBollag%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520a%2520selective%2520inhibitor%2520of%2520oncogenic%2520B-Raf%2520kinase%2520with%2520potent%2520antimelanoma%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D3041%26epage%3D3046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Barrett, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudley, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltiel, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fergus, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flamme, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LePage, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopold, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przybranowski, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebolt-Leopold, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Becelaere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marston, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, W. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmus, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tecle, H.</span><span> </span><span class="NLM_article-title">The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6501</span><span class="NLM_x">–</span> <span class="NLM_lpage">6504</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm500847m&amp;key=10.1016%2Fj.bmcl.2008.10.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm500847m&amp;key=18952427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWjsL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6501-6504&author=S.+D.+Barrettauthor=A.+J.+Bridgesauthor=D.+T.+Dudleyauthor=A.+R.+Saltielauthor=J.+H.+Fergusauthor=C.+M.+Flammeauthor=A.+M.+Delaneyauthor=M.+Kaufmanauthor=S.+LePageauthor=W.+R.+Leopoldauthor=S.+A.+Przybranowskiauthor=J.+Sebolt-Leopoldauthor=K.+Van+Becelaereauthor=A.+M.+Dohertyauthor=R.+M.+Kennedyauthor=D.+Marstonauthor=W.+A.+Howardauthor=Y.+Smithauthor=J.+S.+Warmusauthor=H.+Tecle&title=The+discovery+of+the+benzhydroxamate+MEK+inhibitors+CI-1040+and+PD+0325901"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901</span></div><div class="casAuthors">Barrett, Stephen D.; Bridges, Alexander J.; Dudley, David T.; Saltiel, Alan R.; Fergus, James H.; Flamme, Cathlin M.; Delaney, Amy M.; Kaufman, Michael; LePage, Sophie; Leopold, Wilbur R.; Przybranowski, Sally A.; Sebolt-Leopold, Judith; Van Becelaere, Keri; Doherty, Annette M.; Kennedy, Robert M.; Marston, Dan; Howard, W. Allen, Jr.; Smith, Yvonne; Warmus, Joseph S.; Tecle, Haile</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6501-6504</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of benzhydroxamate esters derived from their precursor anthranilic acids have been prepd. and have been identified as potent MEK inhibitors.  CI-1040 (I) was the first MEK inhibitor to demonstrate in vivo activity in preclin. animal models and subsequently became the first MEK inhibitor to enter clin. trial.  CI-1040 suffered however from poor exposure due to its poor soly. and rapid clearance, and as a result, development of the compd. was terminated.  Optimization of the diphenylamine core and modification of the hydroxamate side chain for cell potency, soly., and exposure with oral delivery resulted in the discovery of the clin. candidate PD 0325901 (II).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpam9NxZxX93rVg90H21EOLACvtfcHk0lhYHveuY_fE8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWjsL%252FI&md5=e64f7ae6a446c504528621e7d14d67ce</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.10.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.10.054%26sid%3Dliteratum%253Aachs%26aulast%3DBarrett%26aufirst%3DS.%2BD.%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26aulast%3DDudley%26aufirst%3DD.%2BT.%26aulast%3DSaltiel%26aufirst%3DA.%2BR.%26aulast%3DFergus%26aufirst%3DJ.%2BH.%26aulast%3DFlamme%26aufirst%3DC.%2BM.%26aulast%3DDelaney%26aufirst%3DA.%2BM.%26aulast%3DKaufman%26aufirst%3DM.%26aulast%3DLePage%26aufirst%3DS.%26aulast%3DLeopold%26aufirst%3DW.%2BR.%26aulast%3DPrzybranowski%26aufirst%3DS.%2BA.%26aulast%3DSebolt-Leopold%26aufirst%3DJ.%26aulast%3DVan%2BBecelaere%26aufirst%3DK.%26aulast%3DDoherty%26aufirst%3DA.%2BM.%26aulast%3DKennedy%26aufirst%3DR.%2BM.%26aulast%3DMarston%26aufirst%3DD.%26aulast%3DHoward%26aufirst%3DW.%2BA.%26aulast%3DSmith%26aufirst%3DY.%26aulast%3DWarmus%26aufirst%3DJ.%2BS.%26aulast%3DTecle%26aufirst%3DH.%26atitle%3DThe%2520discovery%2520of%2520the%2520benzhydroxamate%2520MEK%2520inhibitors%2520CI-1040%2520and%2520PD%25200325901%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6501%26epage%3D6504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Wong, K. K.</span><span> </span><span class="NLM_article-title">Recent developments in anti-cancer agents targeting the Ras/Raf/ MEK/ERK pathway</span> <span class="citation_source-journal">Recent Pat. Anti-Cancer Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=28-35&author=K.+K.+Wong&title=Recent+developments+in+anti-cancer+agents+targeting+the+Ras%2FRaf%2F+MEK%2FERK+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DK.%2BK.%26atitle%3DRecent%2520developments%2520in%2520anti-cancer%2520agents%2520targeting%2520the%2520Ras%252FRaf%252F%2520MEK%252FERK%2520pathway%26jtitle%3DRecent%2520Pat.%2520Anti-Cancer%2520Drug%2520Discovery%26date%3D2009%26volume%3D4%26spage%3D28%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Aronov, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germann, U. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janetka, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Botella, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namchuk, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straub, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X.</span><span> </span><span class="NLM_article-title">Flipped out: structure-guided design of selective pyrazolylpyrrole ERK inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1280</span><span class="NLM_x">–</span> <span class="NLM_lpage">1287</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061381f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1280-1287&author=A.+M.+Aronovauthor=C.+Bakerauthor=G.+W.+Bemisauthor=J.+Caoauthor=G.+Chenauthor=P.+J.+Fordauthor=U.+A.+Germannauthor=J.+Greenauthor=M.+R.+Haleauthor=M.+Jacobsauthor=J.+W.+Janetkaauthor=F.+Maltaisauthor=G.+Martinez-Botellaauthor=M.+N.+Namchukauthor=J.+Straubauthor=Q.+Tangauthor=X.+Xie&title=Flipped+out%3A+structure-guided+design+of+selective+pyrazolylpyrrole+ERK+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm061381f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061381f%26sid%3Dliteratum%253Aachs%26aulast%3DAronov%26aufirst%3DA.%2BM.%26aulast%3DBaker%26aufirst%3DC.%26aulast%3DBemis%26aufirst%3DG.%2BW.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DFord%26aufirst%3DP.%2BJ.%26aulast%3DGermann%26aufirst%3DU.%2BA.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DHale%26aufirst%3DM.%2BR.%26aulast%3DJacobs%26aufirst%3DM.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DMaltais%26aufirst%3DF.%26aulast%3DMartinez-Botella%26aufirst%3DG.%26aulast%3DNamchuk%26aufirst%3DM.%2BN.%26aulast%3DStraub%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DQ.%26aulast%3DXie%26aufirst%3DX.%26atitle%3DFlipped%2520out%253A%2520structure-guided%2520design%2520of%2520selective%2520pyrazolylpyrrole%2520ERK%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1280%26epage%3D1287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Ohori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinoshita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okubo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arakawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, T.</span><span> </span><span class="NLM_article-title">Identification of a selective ERK inhibitor and structural determination of the inhibitor-ERK2 complex</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">363</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2005&pages=357-363&author=M.+Ohoriauthor=T.+Kinoshitaauthor=M.+Okuboauthor=K.+Satoauthor=A.+Yamazakiauthor=H.+Arakawaauthor=S.+Nishimuraauthor=N.+Inamuraauthor=H.+Nakajimaauthor=M.+Neyaauthor=H.+Miyakeauthor=T.+Fujii&title=Identification+of+a+selective+ERK+inhibitor+and+structural+determination+of+the+inhibitor-ERK2+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhori%26aufirst%3DM.%26aulast%3DKinoshita%26aufirst%3DT.%26aulast%3DOkubo%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DYamazaki%26aufirst%3DA.%26aulast%3DArakawa%26aufirst%3DH.%26aulast%3DNishimura%26aufirst%3DS.%26aulast%3DInamura%26aufirst%3DN.%26aulast%3DNakajima%26aufirst%3DH.%26aulast%3DNeya%26aufirst%3DM.%26aulast%3DMiyake%26aufirst%3DH.%26aulast%3DFujii%26aufirst%3DT.%26atitle%3DIdentification%2520of%2520a%2520selective%2520ERK%2520inhibitor%2520and%2520structural%2520determination%2520of%2520the%2520inhibitor-ERK2%2520complex%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D336%26spage%3D357%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Hancock, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macias, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKerell, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, P.</span><span> </span><span class="NLM_article-title">Identification of novel extracellular signal-regulated kinase docking domain inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4586</span><span class="NLM_x">–</span> <span class="NLM_lpage">4595</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0501174" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4586-4595&author=C.+N.+Hancockauthor=A.+Maciasauthor=E.+K.+Leeauthor=S.+Y.+Yuauthor=A.+D.+MacKerellauthor=P.+Shapiro&title=Identification+of+novel+extracellular+signal-regulated+kinase+docking+domain+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm0501174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0501174%26sid%3Dliteratum%253Aachs%26aulast%3DHancock%26aufirst%3DC.%2BN.%26aulast%3DMacias%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DE.%2BK.%26aulast%3DYu%26aufirst%3DS.%2BY.%26aulast%3DMacKerell%26aufirst%3DA.%2BD.%26aulast%3DShapiro%26aufirst%3DP.%26atitle%3DIdentification%2520of%2520novel%2520extracellular%2520signal-regulated%2520kinase%2520docking%2520domain%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4586%26epage%3D4595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Zimmermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchdunger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mett, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lydon, N. B.</span><span> </span><span class="NLM_article-title">Potent and selective inhibitors of the Abl-kinase: phenylamino-pyrimidine (PAP) derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm500847m&amp;key=10.1016%2FS0960-894X%2896%2900601-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADyaK2sXht1egs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=187-192&author=J.+Zimmermannauthor=E.+Buchdungerauthor=H.+Mettauthor=T.+Meyerauthor=N.+B.+Lydon&title=Potent+and+selective+inhibitors+of+the+Abl-kinase%3A+phenylamino-pyrimidine+%28PAP%29+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective inhibitors of the ABL-kinase: phenylaminopyrimidine (PAP) derivatives</span></div><div class="casAuthors">Zimmermann, Jurg; Buchdunger, Elisabeth; Mett, Helmut; Meyer, Thomas; Lydon, Nicholas B.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-192</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Due to its relatively clear etiol., chronic myelogenous leukemia (CML) represents an ideal disease target for a therapy using a selective inhibitor of the Bcr-Abl tyrosine protein kinase.  Extensive optimization of the class of phenylamino-pyrimidines yielded highly potent and selective Bcr-Abl kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEGaTJgyxfUbVg90H21EOLACvtfcHk0lhNJRzlprIKnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXht1egs7w%253D&md5=35962f1735e8d3a595fdb49d95cdc305</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2896%2900601-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252896%252900601-4%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DJ.%26aulast%3DBuchdunger%26aufirst%3DE.%26aulast%3DMett%26aufirst%3DH.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DLydon%26aufirst%3DN.%2BB.%26atitle%3DPotent%2520and%2520selective%2520inhibitors%2520of%2520the%2520Abl-kinase%253A%2520phenylamino-pyrimidine%2520%2528PAP%2529%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D187%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Manley, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan-Jacob, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mestan, J.</span><span> </span><span class="NLM_article-title">Advances in the structural biology, design and clinical development of Bcr-Abl kinase inhibitors for the treatment of chronic myeloid leukaemia</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Proteins Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1754</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm500847m&amp;key=10.1016%2Fj.bbapap.2005.07.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm500847m&amp;key=16172030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlags7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1754&publication_year=2005&pages=3-13&author=P.+W.+Manleyauthor=S.+W.+Cowan-Jacobauthor=J.+Mestan&title=Advances+in+the+structural+biology%2C+design+and+clinical+development+of+Bcr-Abl+kinase+inhibitors+for+the+treatment+of+chronic+myeloid+leukaemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the structural biology, design and clinical development of Bcr-Abl kinase inhibitors for the treatment of chronic myeloid leukaemia</span></div><div class="casAuthors">Manley, Paul William; Cowan-Jacob, Sandra W.; Mestan, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1754</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">3-13</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The constitutively activated Abl tyrosine kinase domain of the chimeric Bcr-Abl oncoprotein is responsible for the transformation of hematopoietic stem cells and the symptoms of chronic myeloid leukemia (CML).  Imatinib targets the tyrosine kinase activity of Bcr-Abl and is a first-line therapy for this malignancy.  Although highly effective in chronic phase CML, patients who have progressed to the advanced phase of the disease frequently fail to respond to imatinib or develop resistance to therapy and relapse.  This is often due to the emergence of clones expressing mutant forms of Bcr-Abl, which exhibit a decreased sensitivity towards inhibition by imatinib.  Considerable progress has recently been made in understanding the structural biol. of Abl and the mol. basis for resistance, facilitating the discovery and development of second generation drugs designed to combat mutant forms of Bcr-Abl.  The first of these compds. to enter clin. development were BMS-354825 (BristolMyersSquibb) and AMN107 (Novartis Pharma) and, from Phase I results, both of these promise a breakthrough in the treatment of imatinib-resistant CML.  Recent advances with these and other promising classes of new CML drugs are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0fkeC4vxU_bVg90H21EOLACvtfcHk0lhNJRzlprIKnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlags7fI&md5=b9d67d465f61804d2acd78605a4e9a75</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2005.07.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2005.07.040%26sid%3Dliteratum%253Aachs%26aulast%3DManley%26aufirst%3DP.%2BW.%26aulast%3DCowan-Jacob%26aufirst%3DS.%2BW.%26aulast%3DMestan%26aufirst%3DJ.%26atitle%3DAdvances%2520in%2520the%2520structural%2520biology%252C%2520design%2520and%2520clinical%2520development%2520of%2520Bcr-Abl%2520kinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520chronic%2520myeloid%2520leukaemia%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2005%26volume%3D1754%26spage%3D3%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Rusnak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Affleck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stubberfield, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guntrip, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jowett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stables, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brignola, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadwell, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reep, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alligood, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackey, K.</span><span> </span><span class="NLM_article-title">The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">7196</span><span class="NLM_x">–</span> <span class="NLM_lpage">7203</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm500847m&amp;key=11585755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsVeht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=7196-7203&author=D.+W.+Rusnakauthor=K.+Affleckauthor=S.+G.+Cockerillauthor=C.+Stubberfieldauthor=R.+Harrisauthor=M.+Pageauthor=K.+J.+Smithauthor=S.+B.+Guntripauthor=M.+C.+Carterauthor=R.+J.+Shawauthor=A.+Jowettauthor=J.+Stablesauthor=P.+Topleyauthor=E.+R.+Woodauthor=P.+S.+Brignolaauthor=S.+H.+Kadwellauthor=B.+R.+Reepauthor=R.+J.+Mullinauthor=K.+J.+Alligoodauthor=B.+R.+Keithauthor=R.+M.+Crosbyauthor=D.+M.+Murrayauthor=W.+B.+Knightauthor=T.+M.+Gilmerauthor=K.+Lackey&title=The+characterization+of+novel%2C+dual+ErbB-2%2FEGFR%2C+tyrosine+kinase+inhibitors%3A+potential+therapy+for+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer</span></div><div class="casAuthors">Rusnak, David W.; Affleck, Karen; Cockerill, Stuart G.; Stubberfield, Colin; Harris, Robert; Page, Martin; Smith, Kathryn J.; Guntrip, Stephen B.; Carter, Malcolm C.; Shaw, Robert J.; Jowett, Amanda; Stables, Jeremy; Topley, Peter; Wood, Edgar R.; Brignola, Perry S.; Kadwell, Sue H.; Reep, Bryan R.; Mullin, Robert J.; Alligood, Krystal J.; Keith, Barry R.; Crosby, Renae M.; Murray, Doris M.; Knight, W. Blaine; Gilmer, Tona M.; Lackey, Karen</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7196-7203</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The type 1 receptor tyrosine kinases constitute a family of transmembrane proteins involved in various aspects of cell growth and survival and have been implicated in the initiation and progression of several types of human malignancies.  The best characterized of these proteins are the epidermal growth factor receptor (EGFR) and ErbB-2 (HER-2/neu).  We have developed potent quinazoline and pyrido-[3,4-d]-pyrimidine small mols. that are dual inhibitors of ErbB-2 and EGFR.  The compds. demonstrate potent in vitro inhibition of the ErbB-2 and EGFR kinase domains with IC50s <80 nM.  Growth of ErbB-2- and EGFR-expressing tumor cell lines is inhibited at concns. <0.5 μM.  Selectivity for tumor cell growth inhibition vs. normal human fibroblast growth inhibition ranges from 10- to >75-fold.  Tumor growth in mouse s.c. xenograft models of the BT474 and HN5 cell lines is inhibited in a dose-responsive manner using oral doses of 10 and 30 mg/kg twice per day.  In addn., the tested compds. caused a redn. of ErbB-2 and EGFR autophosphorylation in tumor fragments from these xenograft models.  These data indicate that these compds. have potential use as therapy in the broad population of cancer patients overexpressing ErbB-2 and/or EGFR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoifUxgOrEfMLVg90H21EOLACvtfcHk0lhY3oIPzEGwNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsVeht70%253D&md5=374cb1b4451356866a5060c5ff39a1d1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DAffleck%26aufirst%3DK.%26aulast%3DCockerill%26aufirst%3DS.%2BG.%26aulast%3DStubberfield%26aufirst%3DC.%26aulast%3DHarris%26aufirst%3DR.%26aulast%3DPage%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DGuntrip%26aufirst%3DS.%2BB.%26aulast%3DCarter%26aufirst%3DM.%2BC.%26aulast%3DShaw%26aufirst%3DR.%2BJ.%26aulast%3DJowett%26aufirst%3DA.%26aulast%3DStables%26aufirst%3DJ.%26aulast%3DTopley%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DE.%2BR.%26aulast%3DBrignola%26aufirst%3DP.%2BS.%26aulast%3DKadwell%26aufirst%3DS.%2BH.%26aulast%3DReep%26aufirst%3DB.%2BR.%26aulast%3DMullin%26aufirst%3DR.%2BJ.%26aulast%3DAlligood%26aufirst%3DK.%2BJ.%26aulast%3DKeith%26aufirst%3DB.%2BR.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DMurray%26aufirst%3DD.%2BM.%26aulast%3DKnight%26aufirst%3DW.%2BB.%26aulast%3DGilmer%26aufirst%3DT.%2BM.%26aulast%3DLackey%26aufirst%3DK.%26atitle%3DThe%2520characterization%2520of%2520novel%252C%2520dual%2520ErbB-2%252FEGFR%252C%2520tyrosine%2520kinase%2520inhibitors%253A%2520potential%2520therapy%2520for%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D7196%26epage%3D7203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Lowinger, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedl, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. A.</span><span> </span><span class="NLM_article-title">Design and discovery of small molecules targeting Raf-1 kinase</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2269</span><span class="NLM_x">–</span> <span class="NLM_lpage">2278</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm500847m&amp;key=10.2174%2F1381612023393125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm500847m&amp;key=12369855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvVGntrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=2269-2278&author=T.+B.+Lowingerauthor=B.+Riedlauthor=J.+Dumasauthor=R.+A.+Smith&title=Design+and+discovery+of+small+molecules+targeting+Raf-1+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Design and discovery of small molecules targeting raf-1 kinase</span></div><div class="casAuthors">Lowinger, Timothy B.; Riedl, Bernd; Dumas, Jacques; Smith, Roger A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2269-2278</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  Raf kinase, an enzyme which acts downstream in the Ras signaling pathway, is involved in cancerous cell proliferation.  Thus, small mol. inhibitors of Raf kinase activity may be important agents for the treatment of cancer.  A novel class of Raf-1 inhibitors was discovered, using a combination of medicinal and combinatorial chem. approaches.  This effort culminated in the identification of the clin. candidate BAY 43-9006, currently undergoing Phase I clin. trials.  The present review summarizes the medicinal chem. development of ureas as highly potent inhibitors of Raf-1 kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqviNIBK_IYW7Vg90H21EOLACvtfcHk0lhY3oIPzEGwNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvVGntrk%253D&md5=a62445c3fb50083175ee4863ae84f6ce</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F1381612023393125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612023393125%26sid%3Dliteratum%253Aachs%26aulast%3DLowinger%26aufirst%3DT.%2BB.%26aulast%3DRiedl%26aufirst%3DB.%26aulast%3DDumas%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DR.%2BA.%26atitle%3DDesign%2520and%2520discovery%2520of%2520small%2520molecules%2520targeting%2520Raf-1%2520kinase%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2002%26volume%3D8%26spage%3D2269%26epage%3D2278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Jung, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert-van der Brempt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohmann, J. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germain, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Savi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dousson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortlock, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heron, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedge, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odedra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keen, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brightwell, S.</span><span> </span><span class="NLM_article-title">Discovery of novel and potent thiazoloquinazolines as selective Aurora A and B kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">955</span><span class="NLM_x">–</span> <span class="NLM_lpage">970</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050786h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=955-970&author=F.+H.+Jungauthor=G.+Pasquetauthor=C.+Lambert-van+der+Bremptauthor=J.+J.+M.+Lohmannauthor=N.+Warinauthor=F.+Renaudauthor=H.+Germainauthor=C.+De+Saviauthor=N.+Robertsauthor=T.+Johnsonauthor=C.+Doussonauthor=G.+B.+Hillauthor=A.+A.+Mortlockauthor=N.+Heronauthor=R.+W.+Wilkinsonauthor=S.+R.+Wedgeauthor=S.+P.+Heatonauthor=R.+Odedraauthor=N.+J.+Keenauthor=S.+Greenauthor=E.+Brownauthor=K.+Thompsonauthor=S.+Brightwell&title=Discovery+of+novel+and+potent+thiazoloquinazolines+as+selective+Aurora+A+and+B+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm050786h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050786h%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DF.%2BH.%26aulast%3DPasquet%26aufirst%3DG.%26aulast%3DLambert-van%2Bder%2BBrempt%26aufirst%3DC.%26aulast%3DLohmann%26aufirst%3DJ.%2BJ.%2BM.%26aulast%3DWarin%26aufirst%3DN.%26aulast%3DRenaud%26aufirst%3DF.%26aulast%3DGermain%26aufirst%3DH.%26aulast%3DDe%2BSavi%26aufirst%3DC.%26aulast%3DRoberts%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DDousson%26aufirst%3DC.%26aulast%3DHill%26aufirst%3DG.%2BB.%26aulast%3DMortlock%26aufirst%3DA.%2BA.%26aulast%3DHeron%26aufirst%3DN.%26aulast%3DWilkinson%26aufirst%3DR.%2BW.%26aulast%3DWedge%26aufirst%3DS.%2BR.%26aulast%3DHeaton%26aufirst%3DS.%2BP.%26aulast%3DOdedra%26aufirst%3DR.%26aulast%3DKeen%26aufirst%3DN.%2BJ.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DE.%26aulast%3DThompson%26aufirst%3DK.%26aulast%3DBrightwell%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520novel%2520and%2520potent%2520thiazoloquinazolines%2520as%2520selective%2520Aurora%2520A%2520and%2520B%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D955%26epage%3D970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Pargellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchill, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grob, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, J.</span><span> </span><span class="NLM_article-title">Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm500847m&amp;key=10.1038%2Fnsb770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm500847m&amp;key=11896401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Kisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=268-272&author=C.+Pargellisauthor=L.+Tongauthor=L.+Churchillauthor=P.+F.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=P.+M.+Grobauthor=E.+R.+Hickeyauthor=N.+Mossauthor=S.+Pavauthor=J.+Regan&title=Inhibition+of+p38+MAP+kinase+by+utilizing+a+novel+allosteric+binding+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site</span></div><div class="casAuthors">Pargellis, Christopher; Tong, Liang; Churchill, Laurie; Cirillo, Pier F.; Gilmore, Thomas; Graham, Anne G.; Grob, Peter M.; Hickey, Eugene R.; Moss, Neil; Pav, Susan; Regan, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">268-272</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">The p38 MAP kinase plays a crucial role in regulating the prodn. of proinflammatory cytokines, such as tumor necrosis factor and interleukin-1.  Blocking this kinase may offer an effective therapy for treating many inflammatory diseases.  Here we report a new allosteric binding site for a diaryl urea class of highly potent and selective inhibitors against human p38 MAP kinase.  The formation of this binding site requires a large conformational change not obsd. previously for any of the protein Ser/Thr kinases.  This change is in the highly conserved Asp-Phe-Gly motif within the active site of the kinase.  Soln. studies demonstrate that this class of compds. has slow binding kinetics, consistent with the requirement for conformational change.  Improving interactions in this allosteric pocket, as well as establishing binding interactions in the ATP pocket, enhanced the affinity of the inhibitors by 12,000-fold.  One of the most potent compds. in this series, BIRB 796, has picomolar affinity for the kinase and low nanomolar inhibitory activity in cell culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqT8_QT7_pbYrVg90H21EOLACvtfcHk0ljwFJi1qklCcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Kisbk%253D&md5=68850ecdbe08df4285ba38cfa2c93ea4</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnsb770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb770%26sid%3Dliteratum%253Aachs%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DChurchill%26aufirst%3DL.%26aulast%3DCirillo%26aufirst%3DP.%2BF.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DGrob%26aufirst%3DP.%2BM.%26aulast%3DHickey%26aufirst%3DE.%2BR.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DRegan%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520p38%2520MAP%2520kinase%2520by%2520utilizing%2520a%2520novel%2520allosteric%2520binding%2520site%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D268%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Kelly, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLellan, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosner, P. J.</span><span> </span><span class="NLM_article-title">Strategic use of affinity-based mass spectrometry techniques in the drug discovery process</span> <span class="citation_source-journal">Anal. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/doi/10.1021/ac010569y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2002&pages=1-9&author=M.+A.+Kellyauthor=T.+J.+McLellanauthor=P.+J.+Rosner&title=Strategic+use+of+affinity-based+mass+spectrometry+techniques+in+the+drug+discovery+process"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fac010569y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac010569y%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DM.%2BA.%26aulast%3DMcLellan%26aufirst%3DT.%2BJ.%26aulast%3DRosner%26aufirst%3DP.%2BJ.%26atitle%3DStrategic%2520use%2520of%2520affinity-based%2520mass%2520spectrometry%2520techniques%2520in%2520the%2520drug%2520discovery%2520process%26jtitle%3DAnal.%2520Chem.%26date%3D2002%26volume%3D74%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Annis, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Athanasopoulos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felsch, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalghatgi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orminati, J. P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosner, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipps, G. W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thaddupathy, G. R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyler, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenchik, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wintner, E. A.</span> <span class="citation_source-journal">Int. J. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">238</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm500847m&amp;key=10.1016%2Fj.ijms.2003.11.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpslyisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Annis%2C+D.+A.%3B+Athanasopoulos%2C+J.%3B+Curran%2C+P.+J.%3B+Felsch%2C+J.+S.%3B+Kalghatgi%2C+K.%3B+Lee%2C+W.+H.%3B+Nash%2C+H.+M.%3B+Orminati%2C+J.+P.+A.%3B+Rosner%2C+K.+E.%3B+Shipps%2C+G.+W.%2C+Jr.%3B+Thaddupathy%2C+G.+R.+A.%3B+Tyler%2C+A.+N.%3B+Vilenchik%2C+L.%3B+Wagner%2C+C.+R.%3B+Wintner%2C+E.+A.Int.+J.+Mass+Spectrom.+2004%2C+238%2C+77%E2%80%9383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">An affinity selection-mass spectrometry method for the identification of small molecule ligands from self-encoded combinatorial libraries. Discovery of a novel antagonist of E. coli dihydrofolate reductase</span></div><div class="casAuthors">Annis, D. Allen; Athanasopoulos, John; Curran, Patrick J.; Felsch, Jason S.; Kalghatgi, Krishna; Lee, William H.; Nash, Huw M.; Orminati, Jean-Paul A.; Rosner, Kristin E.; Shipps, Gerald W.; Thaddupathy, G. R. A.; Tyler, Andrew N.; Vilenchik, Lev; Wagner, Carston R.; Wintner, Edward A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Mass Spectrometry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">238</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">77-83</span>CODEN:
                <span class="NLM_cas:coden">IMSPF8</span>;
        ISSN:<span class="NLM_cas:issn">1387-3806</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The NeoGenesis Automated Ligand Identification System (ALIS), an affinity selection-mass spectrometry (AS-MS) process consisting of a rapid size-exclusion chromatog. stage integrated with reverse-phase chromatog., electrospray mass spectrometry, and novel data searching algorithms, was used to screen mass-encoded, 2500-member combinatorial libraries, leading to the discovery of a novel, bioactive ligand for the anti-infective target Escherichia coli dihydrofolate reductase (DHFR).  Synthesis of the mass-encoded, ligand-contg. library, discussion of the deconvolution process for verifying the structure of the ligand through independent synthesis and screening in a small mixt. (sub-library) format, and ALIS-MS/MS techniques to assign its regioisomeric connectivity are presented.  ALIS-based competition expts. between the newly discovered ligand and other, known DHFR ligands, and biol. activity assessments with stereo- and regioisomers of the hit compd. confirm its DHFR-specific biol. activity.  The method described requires no foreknowledge of the structure or biochem. of the protein target, consumes less than 1 μg protein to screen >2500 compds. in a single expt., and enables screening of >250,000 compds. per system per day.  These advantages highlight the potential of the ALIS method for drug discovery against genomic targets with unknown biol. function, as well as validated targets for which traditional discovery efforts have failed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF9t0__7HggLVg90H21EOLACvtfcHk0ljUL-mW-2Xwbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpslyisLk%253D&md5=2f0e7e5c2f76f28ef6ac697e76d24092</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ijms.2003.11.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijms.2003.11.022%26sid%3Dliteratum%253Aachs%26aulast%3DAnnis%26aufirst%3DD.%2BA.%26aulast%3DAthanasopoulos%26aufirst%3DJ.%26aulast%3DCurran%26aufirst%3DP.%2BJ.%26aulast%3DFelsch%26aufirst%3DJ.%2BS.%26aulast%3DKalghatgi%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DW.%2BH.%26aulast%3DNash%26aufirst%3DH.%2BM.%26aulast%3DOrminati%26aufirst%3DJ.%2BP.%2BA.%26aulast%3DRosner%26aufirst%3DK.%2BE.%26aulast%3DShipps%26aufirst%3DG.%2BW.%26aulast%3DThaddupathy%26aufirst%3DG.%2BR.%2BA.%26aulast%3DTyler%26aufirst%3DA.%2BN.%26aulast%3DVilenchik%26aufirst%3DL.%26aulast%3DWagner%26aufirst%3DC.%2BR.%26aulast%3DWintner%26aufirst%3DE.%2BA.%26jtitle%3DInt.%2520J.%2520Mass%2520Spectrom.%26date%3D2004%26volume%3D238%26spage%3D77%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Annis, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nazef, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, H. M.</span><span> </span><span class="NLM_article-title">A general technique to rank protein–ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">15495</span><span class="NLM_x">–</span> <span class="NLM_lpage">15503</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja048365x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=15495-15503&author=D.+A.+Annisauthor=N.+Nazefauthor=C.+C.+Chuangauthor=M.+P.+Scottauthor=H.+M.+Nash&title=A+general+technique+to+rank+protein%E2%80%93ligand+binding+affinities+and+determine+allosteric+versus+direct+binding+site+competition+in+compound+mixtures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fja048365x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja048365x%26sid%3Dliteratum%253Aachs%26aulast%3DAnnis%26aufirst%3DD.%2BA.%26aulast%3DNazef%26aufirst%3DN.%26aulast%3DChuang%26aufirst%3DC.%2BC.%26aulast%3DScott%26aufirst%3DM.%2BP.%26aulast%3DNash%26aufirst%3DH.%2BM.%26atitle%3DA%2520general%2520technique%2520to%2520rank%2520protein%25E2%2580%2593ligand%2520binding%2520affinities%2520and%2520determine%2520allosteric%2520versus%2520direct%2520binding%2520site%2520competition%2520in%2520compound%2520mixtures%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D15495%26epage%3D15503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Annis, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipps, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popovici-Muller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windsor, W. T.</span><span> </span><span class="NLM_article-title">Method for quantitative protein–ligand affinity measurements in compound mixtures</span> <span class="citation_source-journal">Anal. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">4538</span><span class="NLM_x">–</span> <span class="NLM_lpage">4542</span></span><div class="citationLinks">[<a href="/doi/10.1021/ac0702701" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2007&pages=4538-4542&author=D.+A.+Annisauthor=G.+W.+Shippsauthor=Y.+Q.+Dengauthor=J.+Popovici-Mullerauthor=M.+A.+Siddiquiauthor=P.+J.+Curranauthor=M.+Gowenauthor=W.+T.+Windsor&title=Method+for+quantitative+protein%E2%80%93ligand+affinity+measurements+in+compound+mixtures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fac0702701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac0702701%26sid%3Dliteratum%253Aachs%26aulast%3DAnnis%26aufirst%3DD.%2BA.%26aulast%3DShipps%26aufirst%3DG.%2BW.%26aulast%3DDeng%26aufirst%3DY.%2BQ.%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DSiddiqui%26aufirst%3DM.%2BA.%26aulast%3DCurran%26aufirst%3DP.%2BJ.%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DWindsor%26aufirst%3DW.%2BT.%26atitle%3DMethod%2520for%2520quantitative%2520protein%25E2%2580%2593ligand%2520affinity%2520measurements%2520in%2520compound%2520mixtures%26jtitle%3DAnal.%2520Chem.%26date%3D2007%26volume%3D79%26spage%3D4538%26epage%3D4542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Brandts, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L. N.</span><span> </span><span class="NLM_article-title">Study of strong to ultratight protein interactions using differential scanning calorimetry</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">6927</span><span class="NLM_x">–</span> <span class="NLM_lpage">6940</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00481a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1990&pages=6927-6940&author=J.+F.+Brandtsauthor=L.+N.+Lin&title=Study+of+strong+to+ultratight+protein+interactions+using+differential+scanning+calorimetry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fbi00481a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00481a024%26sid%3Dliteratum%253Aachs%26aulast%3DBrandts%26aufirst%3DJ.%2BF.%26aulast%3DLin%26aufirst%3DL.%2BN.%26atitle%3DStudy%2520of%2520strong%2520to%2520ultratight%2520protein%2520interactions%2520using%2520differential%2520scanning%2520calorimetry%26jtitle%3DBiochemistry%26date%3D1990%26volume%3D29%26spage%3D6927%26epage%3D6940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Mayhood, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windsor, W. T.</span><span> </span><span class="NLM_article-title">Ligand binding affinity determined by temperature-dependent circular dichroism: cyclin-dependent kinase 2 inhibitors</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">345</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2005&pages=187-197&author=T.+W.+Mayhoodauthor=W.+T.+Windsor&title=Ligand+binding+affinity+determined+by+temperature-dependent+circular+dichroism%3A+cyclin-dependent+kinase+2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMayhood%26aufirst%3DT.%2BW.%26aulast%3DWindsor%26aufirst%3DW.%2BT.%26atitle%3DLigand%2520binding%2520affinity%2520determined%2520by%2520temperature-dependent%2520circular%2520dichroism%253A%2520cyclin-dependent%2520kinase%25202%2520inhibitors%26jtitle%3DAnal.%2520Biochem.%26date%3D2005%26volume%3D345%26spage%3D187%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Deng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipps, G. W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popovici-Muller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosner, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duca, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cable, M.</span><span> </span><span class="NLM_article-title">Discovery of 4<i>H</i>-pyrazolo[1,5-<i>a</i>]pyrimidin-7-ones as potent inhibitors of hepatitis C virus polymerase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5363</span><span class="NLM_x">–</span> <span class="NLM_lpage">5367</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5363-5367&author=Y.+Dengauthor=G.+W.+Shippsauthor=T.+Wangauthor=J.+Popovici-Mullerauthor=K.+E.+Rosnerauthor=M.+A.+Siddiquiauthor=J.+Ducaauthor=A.+B.+Cooperauthor=M.+Cable&title=Discovery+of+4H-pyrazolo%5B1%2C5-a%5Dpyrimidin-7-ones+as+potent+inhibitors+of+hepatitis+C+virus+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DShipps%26aufirst%3DG.%2BW.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DRosner%26aufirst%3DK.%2BE.%26aulast%3DSiddiqui%26aufirst%3DM.%2BA.%26aulast%3DDuca%26aufirst%3DJ.%26aulast%3DCooper%26aufirst%3DA.%2BB.%26aulast%3DCable%26aufirst%3DM.%26atitle%3DDiscovery%2520of%25204H-pyrazolo%255B1%252C5-a%255Dpyrimidin-7-ones%2520as%2520potent%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520polymerase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5363%26epage%3D5367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="note"><p class="first last">More kinases were counterscreened at 1.0 μM concentration, and the % inhibition results are listed in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><div class="note"><p class="first last">For MEK1 assay, an enzymatically inactive, full length murine ERK2 in which catalytic lysine 52 had been mutated to arginine was used as the phosphate acceptor substrate. For reference, see the following:</p></div><span class="NLM_contrib-group">Smith, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayhood, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windsor, W. T.</span><span> </span><span class="NLM_article-title">Expression and purification of phosphorylated and non-phosphorylated human MEK1</span> <span class="citation_source-journal">Protein Expression Purif.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">446</span><span class="NLM_x">–</span> <span class="NLM_lpage">456</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm500847m&amp;key=10.1016%2Fj.pep.2006.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm500847m&amp;key=17175166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVCrtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2007&pages=446-456&author=C.+K.+Smithauthor=D.+Carrauthor=T.+W.+Mayhoodauthor=W.+Jinauthor=K.+Grayauthor=W.+T.+Windsor&title=Expression+and+purification+of+phosphorylated+and+non-phosphorylated+human+MEK1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and purification of phosphorylated and non-phosphorylated human MEK1</span></div><div class="casAuthors">Smith, Catherine K.; Carr, Donna; Mayhood, Todd W.; Jin, Weihong; Gray, Kimberly; Windsor, William T.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression and Purification</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">446-456</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Kinases exist in either a high or low activity form depending on the phosphorylation state of the activating lip.  These two different forms of the same kinase may adopt different conformations that affect not only activity but also inhibitor binding and the ability to crystallize the protein.  Therefore, isolation of homogenous prepns. of the phosphorylated and non-phosphorylated versions of a kinase is crit. for accurate biophys. measurements of activity, stability and ligand binding as well as for protein crystn.  The aim of the present study is the expression, purifn. and characterization of recombinant human MEK1 protein in both the activated and low-activity states.  A baculovirus co-expression system was developed for obtaining high levels of activated, phosphorylated human MEK1 kinase.  High-Five cells were co-infected with human MEK1 virus and Raf-BXB, an untagged constitutively active version of Raf which is the activating kinase for MEK1.  Unphosphorylated MEK1 was generated by treating MEK1 isolated from High-Five baculovirus expression with λ-phosphatase.  The proteins were characterized by SDS-PAGE, LC-MS, Western blotting, enzymic activity, and CD.  Previous reports of MEK1 expression and purifn. yielded lower levels of protein and purity.  The yield using High-Five cells was 5 mg/L for phosphorylated MEK1 and 10 mg/L for unphosphorylated MEK1.  For phosphorylated MEK1, the specific activity was 3530 U/mg, the IC50 values for the non-specific kinase inhibitors K252a and K252b were 8 and 47 nM, resp., and the IC50 for the MEK1 non-ATP competitive inhibitor, PD0325901, was 43 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGq_UwvPp4ObVg90H21EOLACvtfcHk0lhR8CuHQ9mbbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVCrtbg%253D&md5=eb771da10755e45786bcb0393f38878d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.pep.2006.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pep.2006.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DC.%2BK.%26aulast%3DCarr%26aufirst%3DD.%26aulast%3DMayhood%26aufirst%3DT.%2BW.%26aulast%3DJin%26aufirst%3DW.%26aulast%3DGray%26aufirst%3DK.%26aulast%3DWindsor%26aufirst%3DW.%2BT.%26atitle%3DExpression%2520and%2520purification%2520of%2520phosphorylated%2520and%2520non-phosphorylated%2520human%2520MEK1%26jtitle%3DProtein%2520Expression%2520Purif.%26date%3D2007%26volume%3D52%26spage%3D446%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Peyssonnaux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eychene, A.</span><span> </span><span class="NLM_article-title">The Raf/MEK/ERK pathway: new concepts of activation</span> <span class="citation_source-journal">Biol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm500847m&amp;key=10.1016%2FS0248-4900%2801%2901125-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm500847m&amp;key=11730323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptVOju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2001&pages=53-62&author=C.+Peyssonnauxauthor=A.+Eychene&title=The+Raf%2FMEK%2FERK+pathway%3A+new+concepts+of+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The Raf/MEK/ERK pathway: New concepts of activation</span></div><div class="casAuthors">Peyssonnaux, Carole; Eychene, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Biology of the Cell</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">53-62</span>CODEN:
                <span class="NLM_cas:coden">BCELDF</span>;
        ISSN:<span class="NLM_cas:issn">0248-4900</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">A review.  The Raf/MEK/ERK signaling was the first MAP kinase cascade to be characterized.  It is probably one of the most well known signal transduction pathways among biologists because of its implication in a wide variety of cellular functions as diverse -and occasionally contradictory- as cell proliferation, cell-cycle arrest, terminal differentiation and apoptosis.  Discovery and understanding of this pathway have benefited from the combination of both genetic studies in worms and flies and biochem. studies in mammalian cells.  However, ten years after, this field is still under debate and new mol. partners in the cascade continue to increase the complexity of its regulation.  This review deals with the emergence of new concepts in the activation and regulation of the Raf/MEK/ERK module.  In particular, the preponderant role of B-Raf is underlined, and the role of novel regulators such as KSR is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyjiXSFlBQ6rVg90H21EOLACvtfcHk0lhR8CuHQ9mbbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptVOju7s%253D&md5=cde3db5b205a1305dc2e6262deea65ec</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0248-4900%2801%2901125-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0248-4900%252801%252901125-X%26sid%3Dliteratum%253Aachs%26aulast%3DPeyssonnaux%26aufirst%3DC.%26aulast%3DEychene%26aufirst%3DA.%26atitle%3DThe%2520Raf%252FMEK%252FERK%2520pathway%253A%2520new%2520concepts%2520of%2520activation%26jtitle%3DBiol.%2520Cell%26date%3D2001%26volume%3D93%26spage%3D53%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Ramos, J. W.</span><span> </span><span class="NLM_article-title">The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2707</span><span class="NLM_x">–</span> <span class="NLM_lpage">2719</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm500847m&amp;key=10.1016%2Fj.biocel.2008.04.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm500847m&amp;key=18562239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFaisb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2008&pages=2707-2719&author=J.+W.+Ramos&title=The+regulation+of+extracellular+signal-regulated+kinase+%28ERK%29+in+mammalian+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells</span></div><div class="casAuthors">Ramos, Joe W.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2707-2719</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Extracellular signal-regulated kinases 1 and 2 (ERK1/2) are activated by diverse mechanisms.  These include ligation of receptor tyrosine kinases such as epidermal growth factor (EGF) and cell adhesion receptors such as the integrins.  In general, ligand binding of these receptors leads to GTP loading and activation of the small GTPase Ras, which recruits Raf to the membrane where it is activated.  Raf subsequently phosphorylates the dual specificity MAP/ERK kinase (MEK1/2) which in turn phosphorylates and thereby activates ERK1/2.  ERK1/2 is a promiscuous kinase and can phosphorylate >100 different substrates.  Therefore activation of ERK1/2 can affect a broad array of cellular functions including proliferation, survival, apoptosis, motility, transcription, metab., and differentiation.  ERK1/2 activity is controlled by many distinct mechanisms.  Scaffold proteins control when and where ERK1/2 is activated, whereas anchoring proteins can restrain ERK1/2 localization to specific subcellular compartments.  Meanwhile, phosphatases dephosphorylate and inactivate ERK1/2 thereby shutting off the pathway.  Finally, several feedback mechanisms have been identified downstream of ERK1/2 activation.  Here, the authors focus on the diverse mechanisms of ERK1/2 regulation in mammalian cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvF9jKf5C9t7Vg90H21EOLACvtfcHk0lhR8CuHQ9mbbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFaisb7E&md5=dafebb7ddabcf5288d96a45b016b5112</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2008.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2008.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DRamos%26aufirst%3DJ.%2BW.%26atitle%3DThe%2520regulation%2520of%2520extracellular%2520signal-regulated%2520kinase%2520%2528ERK%2529%2520in%2520mammalian%2520cells%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2008%26volume%3D40%26spage%3D2707%26epage%3D2719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="note"><p class="first last">Compounds <b>1</b>–<b>16</b> were found not binding to either phorsphorylated MEK or unphosphorylated MEK in the TdF study.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Seger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munar, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobb, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krebs, E. G.</span><span> </span><span class="NLM_article-title">Purification and characterization of mitogen-activated protein kinase activator(s) from epidermal growth factor-stimulated A431 cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">14373</span><span class="NLM_x">–</span> <span class="NLM_lpage">14381</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=14373-14381&author=R.+Segerauthor=N.+G.+Ahnauthor=J.+Posadaauthor=E.+S.+Munarauthor=A.+M.+Jensenauthor=J.+A.+Cooperauthor=M.+H.+Cobbauthor=E.+G.+Krebs&title=Purification+and+characterization+of+mitogen-activated+protein+kinase+activator%28s%29+from+epidermal+growth+factor-stimulated+A431+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeger%26aufirst%3DR.%26aulast%3DAhn%26aufirst%3DN.%2BG.%26aulast%3DPosada%26aufirst%3DJ.%26aulast%3DMunar%26aufirst%3DE.%2BS.%26aulast%3DJensen%26aufirst%3DA.%2BM.%26aulast%3DCooper%26aufirst%3DJ.%2BA.%26aulast%3DCobb%26aufirst%3DM.%2BH.%26aulast%3DKrebs%26aufirst%3DE.%2BG.%26atitle%3DPurification%2520and%2520characterization%2520of%2520mitogen-activated%2520protein%2520kinase%2520activator%2528s%2529%2520from%2520epidermal%2520growth%2520factor-stimulated%2520A431%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D14373%26epage%3D14381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">English, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobb, M. H.</span><span> </span><span class="NLM_article-title">Pharmacological inhibitors of MAPK pathways</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=40-45&author=J.+M.+Englishauthor=M.+H.+Cobb&title=Pharmacological+inhibitors+of+MAPK+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEnglish%26aufirst%3DJ.%2BM.%26aulast%3DCobb%26aufirst%3DM.%2BH.%26atitle%3DPharmacological%2520inhibitors%2520of%2520MAPK%2520pathways%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2002%26volume%3D23%26spage%3D40%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':[],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':[],'ref33':['cit33'],'ref34':['cit34']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 35 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Bingjie Zhang, Simeng Zhao, Dehua Yang, Yiran Wu, Ye Xin, Haijie Cao, Xi-Ping Huang, Xiaoqing Cai, Wen Sun, Na Ye, Yueming Xu, Yao Peng, Suwen Zhao, Zhi-Jie Liu, Guisheng Zhong, Ming-Wei Wang, <span class="NLM_string-name hlFld-ContribAuthor">Wenqing Shui</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel G Protein-Biased and Subtype-Selective Agonist for a G Protein-Coupled Receptor Discovered from Screening Herbal Extracts. </span><span class="cited-content_cbyCitation_journal-name">ACS Central Science</span><span> <strong>2020,</strong> <em>6 </em>
                                    (2)
                                     , 213-225. <a href="https://doi.org/10.1021/acscentsci.9b01125" title="DOI URL">https://doi.org/10.1021/acscentsci.9b01125</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscentsci.9b01125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscentsci.9b01125%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Central%2520Science%26atitle%3DA%252BNovel%252BG%252BProtein-Biased%252Band%252BSubtype-Selective%252BAgonist%252Bfor%252Ba%252BG%252BProtein-Coupled%252BReceptor%252BDiscovered%252Bfrom%252BScreening%252BHerbal%252BExtracts%26aulast%3DZhang%26aufirst%3DBingjie%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D03112019%26date%3D23012020%26volume%3D6%26issue%3D2%26spage%3D213%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yan Lu, Shanshan Qin, Bingjie Zhang, Antao Dai, Xiaoqing Cai, Mengna Ma, Zhan-Guo Gao, Dehua Yang, Raymond C. Stevens, Kenneth A. Jacobson, Ming-Wei Wang, <span class="NLM_string-name hlFld-ContribAuthor">Wenqing Shui</span>. </span><span class="cited-content_cbyCitation_article-title">Accelerating the Throughput of Affinity Mass Spectrometry-Based Ligand Screening toward a G Protein-Coupled Receptor. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2019,</strong> <em>91 </em>
                                    (13)
                                     , 8162-8169. <a href="https://doi.org/10.1021/acs.analchem.9b00477" title="DOI URL">https://doi.org/10.1021/acs.analchem.9b00477</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.analchem.9b00477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.analchem.9b00477%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DAccelerating%252Bthe%252BThroughput%252Bof%252BAffinity%252BMass%252BSpectrometry-Based%252BLigand%252BScreening%252Btoward%252Ba%252BG%252BProtein-Coupled%252BReceptor%26aulast%3DLu%26aufirst%3DYan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D26012019%26date%3D16052019%26date%3D12062019%26date%3D16052019%26volume%3D91%26issue%3D13%26spage%3D8162%26epage%3D8169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sobhana Babu Boga, Yongqi Deng, Liang Zhu, Yang Nan, Alan B. Cooper, Gerald W. Shipps, Jr., Ronald Doll, Neng-Yang Shih, Hugh Zhu, Robert Sun, Tong Wang, Sunil Paliwal, Hon-Chung Tsui, Xiaolei Gao, Xin Yao, Jagdish Desai, James Wang, Abdul Basit Alhassan, Joseph Kelly, Mehul Patel, Kiran Muppalla, Subrahmanyam Gudipati, Li-Kang Zhang, Alexei Buevich, David Hesk, Donna Carr, Priya Dayananth, Stuart Black, Hong Mei, Kathleen Cox, Bradley Sherborne, Alan W. Hruza, Li Xiao, Weihong Jin, Brian Long, Gongjie Liu, Stacey A. Taylor, Paul Kirschmeier, William T. Windsor, Robert Bishop, <span class="NLM_string-name hlFld-ContribAuthor">Ahmed A. Samatar</span>. </span><span class="cited-content_cbyCitation_article-title">MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (7)
                                     , 761-767. <a href="https://doi.org/10.1021/acsmedchemlett.8b00220" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00220</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00220%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DMK-8353%25253A%252BDiscovery%252Bof%252Ban%252BOrally%252BBioavailable%252BDual%252BMechanism%252BERK%252BInhibitor%252Bfor%252BOncology%26aulast%3DBoga%26aufirst%3DSobhana%2BBabu%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D11052018%26date%3D14062018%26date%3D02072018%26date%3D14062018%26volume%3D9%26issue%3D7%26spage%3D761%26epage%3D767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tom D. Heightman, Valerio Berdini, Hannah Braithwaite, Ildiko M. Buck, Megan Cassidy, Juan Castro, Aurélie Courtin, James E. H. Day, Charlotte East, Lynsey Fazal, Brent Graham, Charlotte M. Griffiths-Jones, John F. Lyons, Vanessa Martins, Sandra Muench, Joanne M. Munck, David Norton, Marc O’Reilly, Nick Palmer, Puja Pathuri, Michael Reader, David C. Rees, Sharna J. Rich, Caroline Richardson, Harpreet Saini, Neil T. Thompson, Nicola G. Wallis, Hugh Walton, Nicola E. Wilsher, Alison J.-A. Woolford, Michael Cooke, David Cousin, Stuart Onions, Jonathan Shannon, John Watts, <span class="NLM_string-name hlFld-ContribAuthor">Christopher W. Murray</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Discovery of a Potent, Orally Bioavailable Inhibitor That Modulates the Phosphorylation and Catalytic Activity of ERK1/2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (11)
                                     , 4978-4992. <a href="https://doi.org/10.1021/acs.jmedchem.8b00421" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00421</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00421%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-Based%252BDiscovery%252Bof%252Ba%252BPotent%25252C%252BOrally%252BBioavailable%252BInhibitor%252BThat%252BModulates%252Bthe%252BPhosphorylation%252Band%252BCatalytic%252BActivity%252Bof%252BERK1%25252F2%26aulast%3DHeightman%26aufirst%3DTom%2BD.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D14032018%26date%3D31052018%26date%3D18052018%26volume%3D61%26issue%3D11%26spage%3D4978%26epage%3D4992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Caterina Musetti, Mark F. Bean, Geoffrey T. Quinque, Christopher Kwiatkowski, Lawrence M. Szewczuk, John Baldoni, <span class="NLM_string-name hlFld-ContribAuthor">Matthew A. Zajac</span>. </span><span class="cited-content_cbyCitation_article-title">High-Throughput Assessment of Structural Continuity in Biologics. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2018,</strong> <em>90 </em>
                                    (4)
                                     , 2970-2975. <a href="https://doi.org/10.1021/acs.analchem.8b00180" title="DOI URL">https://doi.org/10.1021/acs.analchem.8b00180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.analchem.8b00180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.analchem.8b00180%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DHigh-Throughput%252BAssessment%252Bof%252BStructural%252BContinuity%252Bin%252BBiologics%26aulast%3DMusetti%26aufirst%3DCaterina%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D12012018%26date%3D25012018%26date%3D08022018%26date%3D25012018%26volume%3D90%26issue%3D4%26spage%3D2970%26epage%3D2975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Linghu</span>, <span class="hlFld-ContribAuthor ">Nicholas  Wong</span>, <span class="hlFld-ContribAuthor ">Hans  Iding</span>, <span class="hlFld-ContribAuthor ">Vera  Jost</span>, <span class="hlFld-ContribAuthor ">Haiming  Zhang</span>, <span class="hlFld-ContribAuthor ">Stefan G.  Koenig</span>, <span class="hlFld-ContribAuthor ">C. Gregory  Sowell</span>, and <span class="hlFld-ContribAuthor ">Francis  Gosselin</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of a Practical Synthesis of ERK Inhibitor GDC-0994. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2017,</strong> <em>21 </em>
                                    (3)
                                     , 387-398. <a href="https://doi.org/10.1021/acs.oprd.7b00006" title="DOI URL">https://doi.org/10.1021/acs.oprd.7b00006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.7b00006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.7b00006%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DDevelopment%252Bof%252Ba%252BPractical%252BSynthesis%252Bof%252BERK%252BInhibitor%252BGDC-0994%26aulast%3DLinghu%26aufirst%3DXin%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D09012017%26date%3D08032017%26date%3D17032017%26date%3D23022017%26volume%3D21%26issue%3D3%26spage%3D387%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Honorine  Lebraud</span>, <span class="hlFld-ContribAuthor ">David J.  Wright</span>, <span class="hlFld-ContribAuthor ">Christopher N.  Johnson</span>, and <span class="hlFld-ContribAuthor ">Tom D.  Heightman</span>  . </span><span class="cited-content_cbyCitation_article-title">Protein Degradation by In-Cell Self-Assembly of Proteolysis Targeting Chimeras. </span><span class="cited-content_cbyCitation_journal-name">ACS Central Science</span><span> <strong>2016,</strong> <em>2 </em>
                                    (12)
                                     , 927-934. <a href="https://doi.org/10.1021/acscentsci.6b00280" title="DOI URL">https://doi.org/10.1021/acscentsci.6b00280</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscentsci.6b00280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscentsci.6b00280%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Central%2520Science%26atitle%3DProtein%252BDegradation%252Bby%252BIn-Cell%252BSelf-Assembly%252Bof%252BProteolysis%252BTargeting%252BChimeras%26aulast%3DLebraud%26aufirst%3DHonorine%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D19092016%26date%3D05122016%26date%3D28122016%26volume%3D2%26issue%3D12%26spage%3D927%26epage%3D934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jongwon  Lim</span>, <span class="hlFld-ContribAuthor ">Elizabeth H.  Kelley</span>, <span class="hlFld-ContribAuthor ">Joey L.  Methot</span>, <span class="hlFld-ContribAuthor ">Hua  Zhou</span>, <span class="hlFld-ContribAuthor ">Alessia  Petrocchi</span>, <span class="hlFld-ContribAuthor ">Hongmin  Chen</span>, <span class="hlFld-ContribAuthor ">Susan E.  Hill</span>, <span class="hlFld-ContribAuthor ">Marlene C.  Hinton</span>, <span class="hlFld-ContribAuthor ">Alan  Hruza</span>, <span class="hlFld-ContribAuthor ">Joon O.  Jung</span>, <span class="hlFld-ContribAuthor ">John K. F.  Maclean</span>, <span class="hlFld-ContribAuthor ">My  Mansueto</span>, <span class="hlFld-ContribAuthor ">George N.  Naumov</span>, <span class="hlFld-ContribAuthor ">Ulrike  Philippar</span>, <span class="hlFld-ContribAuthor ">Shruti  Raut</span>, <span class="hlFld-ContribAuthor ">Peter  Spacciapoli</span>, <span class="hlFld-ContribAuthor ">Dongyu  Sun</span>, and <span class="hlFld-ContribAuthor ">Phieng  Siliphaivanh</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 1-(1H-Pyrazolo[4,3-c]pyridin-6-yl)urea Inhibitors of Extracellular Signal-Regulated Kinase (ERK) for the Treatment of Cancers. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (13)
                                     , 6501-6511. <a href="https://doi.org/10.1021/acs.jmedchem.6b00708" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00708</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00708%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B1-%2525281H-Pyrazolo%25255B4%25252C3-c%25255Dpyridin-6-yl%252529urea%252BInhibitors%252Bof%252BExtracellular%252BSignal-Regulated%252BKinase%252B%252528ERK%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BCancers%26aulast%3DLim%26aufirst%3DJongwon%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D09052016%26date%3D01072016%26date%3D14072016%26date%3D22062016%26volume%3D59%26issue%3D13%26spage%3D6501%26epage%3D6511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ting  Zhang</span>, <span class="hlFld-ContribAuthor ">Yong  Liu</span>, <span class="hlFld-ContribAuthor ">Xianshu  Yang</span>, <span class="hlFld-ContribAuthor ">Gary E.  Martin</span>, <span class="hlFld-ContribAuthor ">Huifang  Yao</span>, <span class="hlFld-ContribAuthor ">Jackie  Shang</span>, <span class="hlFld-ContribAuthor ">Randal M.  Bugianesi</span>, <span class="hlFld-ContribAuthor ">Kenneth P.  Ellsworth</span>, <span class="hlFld-ContribAuthor ">Lisa M.  Sonatore</span>, <span class="hlFld-ContribAuthor ">Peter  Nizner</span>, <span class="hlFld-ContribAuthor ">Edward C.  Sherer</span>, <span class="hlFld-ContribAuthor ">Susan E.  Hill</span>, <span class="hlFld-ContribAuthor ">Ian W.  Knemeyer</span>, <span class="hlFld-ContribAuthor ">Wayne M.  Geissler</span>, <span class="hlFld-ContribAuthor ">Peter J.  Dandliker</span>, <span class="hlFld-ContribAuthor ">Roy  Helmy</span>, and <span class="hlFld-ContribAuthor ">Harold B.  Wood</span>  . </span><span class="cited-content_cbyCitation_article-title">Definitive Metabolite Identification Coupled with Automated Ligand Identification System (ALIS) Technology: A Novel Approach to Uncover Structure–Activity Relationships and Guide Drug Design in a Factor IXa Inhibitor Program. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (5)
                                     , 1818-1829. <a href="https://doi.org/10.1021/acs.jmedchem.5b01293" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01293</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01293%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDefinitive%252BMetabolite%252BIdentification%252BCoupled%252Bwith%252BAutomated%252BLigand%252BIdentification%252BSystem%252B%252528ALIS%252529%252BTechnology%25253A%252BA%252BNovel%252BApproach%252Bto%252BUncover%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Band%252BGuide%252BDrug%252BDesign%252Bin%252Ba%252BFactor%252BIXa%252BInhibitor%252BProgram%26aulast%3DZhang%26aufirst%3DTing%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D20082015%26date%3D22022016%26date%3D10032016%26date%3D12022016%26volume%3D59%26issue%3D5%26spage%3D1818%26epage%3D1829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clare E.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Noelia  Martinez-Muñoz</span>, and <span class="hlFld-ContribAuthor ">David J.  Gorin</span>  . </span><span class="cited-content_cbyCitation_article-title">Aerobic Copper-Catalyzed O-Methylation with Methylboronic Acid. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>80 </em>
                                    (14)
                                     , 7305-7310. <a href="https://doi.org/10.1021/acs.joc.5b01077" title="DOI URL">https://doi.org/10.1021/acs.joc.5b01077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.5b01077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.5b01077%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAerobic%252BCopper-Catalyzed%252BO-Methylation%252Bwith%252BMethylboronic%252BAcid%26aulast%3DJacobson%26aufirst%3DClare%2BE.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D13052015%26date%3D07072015%26date%3D17072015%26date%3D26062015%26volume%3D80%26issue%3D14%26spage%3D7305%26epage%3D7310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard A.  Ward</span>, <span class="hlFld-ContribAuthor ">Nicola  Colclough</span>, <span class="hlFld-ContribAuthor ">Mairi  Challinor</span>, <span class="hlFld-ContribAuthor ">Judit E.  Debreczeni</span>, <span class="hlFld-ContribAuthor ">Kay  Eckersley</span>, <span class="hlFld-ContribAuthor ">Gary  Fairley</span>, <span class="hlFld-ContribAuthor ">Lyman  Feron</span>, <span class="hlFld-ContribAuthor ">Vikki  Flemington</span>, <span class="hlFld-ContribAuthor ">Mark A.  Graham</span>, <span class="hlFld-ContribAuthor ">Ryan  Greenwood</span>, <span class="hlFld-ContribAuthor ">Philip  Hopcroft</span>, <span class="hlFld-ContribAuthor ">Tina D.  Howard</span>, <span class="hlFld-ContribAuthor ">Michael  James</span>, <span class="hlFld-ContribAuthor ">Clifford D.  Jones</span>, <span class="hlFld-ContribAuthor ">Christopher R.  Jones</span>, <span class="hlFld-ContribAuthor ">Jonathan  Renshaw</span>, <span class="hlFld-ContribAuthor ">Karen  Roberts</span>, <span class="hlFld-ContribAuthor ">Lindsay  Snow</span>, <span class="hlFld-ContribAuthor ">Michael  Tonge</span>, and <span class="hlFld-ContribAuthor ">Kay  Yeung</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Guided Design of Highly Selective and Potent Covalent Inhibitors of ERK1/2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (11)
                                     , 4790-4801. <a href="https://doi.org/10.1021/acs.jmedchem.5b00466" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00466</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00466%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Guided%252BDesign%252Bof%252BHighly%252BSelective%252Band%252BPotent%252BCovalent%252BInhibitors%252Bof%252BERK1%25252F2%26aulast%3DWard%26aufirst%3DRichard%2BA.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D22032015%26date%3D28052015%26date%3D11062015%26date%3D15052015%26volume%3D58%26issue%3D11%26spage%3D4790%26epage%3D4801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dehua  Yang</span>, <span class="hlFld-ContribAuthor ">Qingtong  Zhou</span>, <span class="hlFld-ContribAuthor ">Viktorija  Labroska</span>, <span class="hlFld-ContribAuthor ">Shanshan  Qin</span>, <span class="hlFld-ContribAuthor ">Sanaz  Darbalaei</span>, <span class="hlFld-ContribAuthor ">Yiran  Wu</span>, <span class="hlFld-ContribAuthor ">Elita  Yuliantie</span>, <span class="hlFld-ContribAuthor ">Linshan  Xie</span>, <span class="hlFld-ContribAuthor ">Houchao  Tao</span>, <span class="hlFld-ContribAuthor ">Jianjun  Cheng</span>, <span class="hlFld-ContribAuthor ">Qing  Liu</span>, <span class="hlFld-ContribAuthor ">Suwen  Zhao</span>, <span class="hlFld-ContribAuthor ">Wenqing  Shui</span>, <span class="hlFld-ContribAuthor ">Yi  Jiang</span>, <span class="hlFld-ContribAuthor ">Ming-Wei  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">G protein-coupled receptors: structure- and function-based drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Signal Transduction and Targeted Therapy</span><span> <strong>2021,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41392-020-00435-w" title="DOI URL">https://doi.org/10.1038/s41392-020-00435-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41392-020-00435-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41392-020-00435-w%26sid%3Dliteratum%253Aachs%26jtitle%3DSignal%2520Transduction%2520and%2520Targeted%2520Therapy%26atitle%3DG%252Bprotein-coupled%252Breceptors%25253A%252Bstructure-%252Band%252Bfunction-based%252Bdrug%252Bdiscovery%26aulast%3DYang%26aufirst%3DDehua%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Renee  Barbosa</span>, <span class="hlFld-ContribAuthor ">Lucila A.  Acevedo</span>, <span class="hlFld-ContribAuthor ">Ronen  Marmorstein</span>. </span><span class="cited-content_cbyCitation_article-title">The MEK/ERK Network as a Therapeutic Target in Human Cancer. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Research</span><span> <strong>2021,</strong> <em>19 </em>
                                    (3)
                                     , 361-374. <a href="https://doi.org/10.1158/1541-7786.MCR-20-0687" title="DOI URL">https://doi.org/10.1158/1541-7786.MCR-20-0687</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1541-7786.MCR-20-0687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1541-7786.MCR-20-0687%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Research%26atitle%3DThe%252BMEK%25252FERK%252BNetwork%252Bas%252Ba%252BTherapeutic%252BTarget%252Bin%252BHuman%252BCancer%26aulast%3DBarbosa%26aufirst%3DRenee%26date%3D2021%26date%3D2020%26volume%3D19%26issue%3D3%26spage%3D361%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi  Tao</span>, <span class="hlFld-ContribAuthor ">Jizhong  Yan</span>, <span class="hlFld-ContribAuthor ">Baochang  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">LABEL‐FREE BIO‐AFFINITY MASS SPECTROMETRY FOR SCREENING AND LOCATING BIOACTIVE MOLECULES. </span><span class="cited-content_cbyCitation_journal-name">Mass Spectrometry Reviews</span><span> <strong>2021,</strong> <em>40 </em>
                                    (1)
                                     , 53-71. <a href="https://doi.org/10.1002/mas.21613" title="DOI URL">https://doi.org/10.1002/mas.21613</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/mas.21613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmas.21613%26sid%3Dliteratum%253Aachs%26jtitle%3DMass%2520Spectrometry%2520Reviews%26atitle%3DLABEL%2525E2%252580%252590FREE%252BBIO%2525E2%252580%252590AFFINITY%252BMASS%252BSPECTROMETRY%252BFOR%252BSCREENING%252BAND%252BLOCATING%252BBIOACTIVE%252BMOLECULES%26aulast%3DTao%26aufirst%3DYi%26date%3D2021%26date%3D2019%26volume%3D40%26issue%3D1%26spage%3D53%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shanshan  Li</span>, <span class="hlFld-ContribAuthor ">Wenqing  Shui</span>. </span><span class="cited-content_cbyCitation_article-title">Systematic mapping of protein–metabolite interactions with mass spectrometry-based techniques. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Biotechnology</span><span> <strong>2020,</strong> <em>64 </em>, 24-31. <a href="https://doi.org/10.1016/j.copbio.2019.09.002" title="DOI URL">https://doi.org/10.1016/j.copbio.2019.09.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.copbio.2019.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.copbio.2019.09.002%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Biotechnology%26atitle%3DSystematic%252Bmapping%252Bof%252Bprotein%2525E2%252580%252593metabolite%252Binteractions%252Bwith%252Bmass%252Bspectrometry-based%252Btechniques%26aulast%3DLi%26aufirst%3DShanshan%26date%3D2020%26volume%3D64%26spage%3D24%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Longfei  Miao</span>, <span class="hlFld-ContribAuthor ">Hongqi  Tian</span>. </span><span class="cited-content_cbyCitation_article-title">Development of ERK1/2 inhibitors as a therapeutic strategy for tumour with MAPK upstream target mutations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Drug Targeting</span><span> <strong>2020,</strong> <em>28 </em>
                                    (2)
                                     , 154-165. <a href="https://doi.org/10.1080/1061186X.2019.1648477" title="DOI URL">https://doi.org/10.1080/1061186X.2019.1648477</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1061186X.2019.1648477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1061186X.2019.1648477%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Drug%2520Targeting%26atitle%3DDevelopment%252Bof%252BERK1%25252F2%252Binhibitors%252Bas%252Ba%252Btherapeutic%252Bstrategy%252Bfor%252Btumour%252Bwith%252BMAPK%252Bupstream%252Btarget%252Bmutations%26aulast%3DMiao%26aufirst%3DLongfei%26date%3D2020%26date%3D2019%26volume%3D28%26issue%3D2%26spage%3D154%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noreen F.  Rizvi</span>, <span class="hlFld-ContribAuthor ">Elliott B.  Nickbarg</span>. </span><span class="cited-content_cbyCitation_article-title">RNA-ALIS: Methodology for screening soluble RNAs as small molecule targets using ALIS affinity-selection mass spectrometry. </span><span class="cited-content_cbyCitation_journal-name">Methods</span><span> <strong>2019,</strong> <em>167 </em>, 28-38. <a href="https://doi.org/10.1016/j.ymeth.2019.04.024" title="DOI URL">https://doi.org/10.1016/j.ymeth.2019.04.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ymeth.2019.04.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ymeth.2019.04.024%26sid%3Dliteratum%253Aachs%26jtitle%3DMethods%26atitle%3DRNA-ALIS%25253A%252BMethodology%252Bfor%252Bscreening%252Bsoluble%252BRNAs%252Bas%252Bsmall%252Bmolecule%252Btargets%252Busing%252BALIS%252Baffinity-selection%252Bmass%252Bspectrometry%26aulast%3DRizvi%26aufirst%3DNoreen%2BF.%26date%3D2019%26volume%3D167%26spage%3D28%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuzhen  Niu</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Yao</span>, <span class="hlFld-ContribAuthor ">Hongfang  Ji</span>. </span><span class="cited-content_cbyCitation_article-title">Importance of protein flexibility in ranking ERK2 Type I
              1/2
              inhibitor affinities: a computational study. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2019,</strong> <em>9 </em>
                                    (22)
                                     , 12441-12454. <a href="https://doi.org/10.1039/C9RA01657K" title="DOI URL">https://doi.org/10.1039/C9RA01657K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9RA01657K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9RA01657K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DImportance%252Bof%252Bprotein%252Bflexibility%252Bin%252Branking%252BERK2%252BType%252BI%252B1%25252F2%252Binhibitor%252Baffinities%25253A%252Ba%252Bcomputational%252Bstudy%26aulast%3DNiu%26aufirst%3DYuzhen%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D22%26spage%3D12441%26epage%3D12454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shu-Kee  Eng</span>, <span class="hlFld-ContribAuthor ">Teng Hern Tan  Loh</span>, <span class="hlFld-ContribAuthor ">Bey-Hing  Goh</span>, <span class="hlFld-ContribAuthor ">Wai-Leng  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">KRAS as Potential Target in Colorectal Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 389-424. <a href="https://doi.org/10.1007/978-981-13-7154-7_12" title="DOI URL">https://doi.org/10.1007/978-981-13-7154-7_12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-13-7154-7_12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-13-7154-7_12%26sid%3Dliteratum%253Aachs%26atitle%3DKRAS%252Bas%252BPotential%252BTarget%252Bin%252BColorectal%252BCancer%252BTherapy%26aulast%3DEng%26aufirst%3DShu-Kee%26date%3D2019%26date%3D2019%26spage%3D389%26epage%3D424%26pub%3DSpringer%2520Singapore%26atitle%3DNatural%252BBio-active%252BCompounds%26aulast%3DAkhtar%26aufirst%3DMohd%2BSayeed%26date%3D2019%26volume%3D595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew M.  Kidger</span>, <span class="hlFld-ContribAuthor ">James  Sipthorp</span>, <span class="hlFld-ContribAuthor ">Simon J.  Cook</span>. </span><span class="cited-content_cbyCitation_article-title">ERK1/2 inhibitors: New weapons to inhibit the RAS-regulated RAF-MEK1/2-ERK1/2 pathway. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2018,</strong> <em>187 </em>, 45-60. <a href="https://doi.org/10.1016/j.pharmthera.2018.02.007" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2018.02.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2018.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2018.02.007%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DERK1%25252F2%252Binhibitors%25253A%252BNew%252Bweapons%252Bto%252Binhibit%252Bthe%252BRAS-regulated%252BRAF-MEK1%25252F2-ERK1%25252F2%252Bpathway%26aulast%3DKidger%26aufirst%3DAndrew%2BM.%26date%3D2018%26volume%3D187%26spage%3D45%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sobhana Babu  Boga</span>, <span class="hlFld-ContribAuthor ">Abdul-Basit  Alhassan</span>, <span class="hlFld-ContribAuthor ">Alan B.  Cooper</span>, <span class="hlFld-ContribAuthor ">Ronald  Doll</span>, <span class="hlFld-ContribAuthor ">Neng-Yang  Shih</span>, <span class="hlFld-ContribAuthor ">Gerald  Shipps</span>, <span class="hlFld-ContribAuthor ">Yongqi  Deng</span>, <span class="hlFld-ContribAuthor ">Hugh  Zhu</span>, <span class="hlFld-ContribAuthor ">Yang  Nan</span>, <span class="hlFld-ContribAuthor ">Robert  Sun</span>, <span class="hlFld-ContribAuthor ">Liang  Zhu</span>, <span class="hlFld-ContribAuthor ">Jagdish  Desai</span>, <span class="hlFld-ContribAuthor ">Mehul  Patel</span>, <span class="hlFld-ContribAuthor ">Kiran  Muppalla</span>, <span class="hlFld-ContribAuthor ">Xiaolei  Gao</span>, <span class="hlFld-ContribAuthor ">James  Wang</span>, <span class="hlFld-ContribAuthor ">Xin  Yao</span>, <span class="hlFld-ContribAuthor ">Joseph  Kelly</span>, <span class="hlFld-ContribAuthor ">Subrahmanyam  Gudipati</span>, <span class="hlFld-ContribAuthor ">Sunil  Paliwal</span>, <span class="hlFld-ContribAuthor ">Hon-Chung  Tsui</span>, <span class="hlFld-ContribAuthor ">Tong  Wang</span>, <span class="hlFld-ContribAuthor ">Bradley  Sherborne</span>, <span class="hlFld-ContribAuthor ">Li  Xiao</span>, <span class="hlFld-ContribAuthor ">Alan  Hruza</span>, <span class="hlFld-ContribAuthor ">Alexei  Buevich</span>, <span class="hlFld-ContribAuthor ">Li-Kang  Zhang</span>, <span class="hlFld-ContribAuthor ">David  Hesk</span>, <span class="hlFld-ContribAuthor ">Ahmed A.  Samatar</span>, <span class="hlFld-ContribAuthor ">Donna  Carr</span>, <span class="hlFld-ContribAuthor ">Brian  Long</span>, <span class="hlFld-ContribAuthor ">Stuart  Black</span>, <span class="hlFld-ContribAuthor ">Priya  Dayananth</span>, <span class="hlFld-ContribAuthor ">William  Windsor</span>, <span class="hlFld-ContribAuthor ">Paul  Kirschmeier</span>, <span class="hlFld-ContribAuthor ">Robert  Bishop</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3( S )-thiomethyl pyrrolidine ERK inhibitors for oncology. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (11)
                                     , 2029-2034. <a href="https://doi.org/10.1016/j.bmcl.2018.04.063" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.04.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.04.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.04.063%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B3%252528%252BS%252B%252529-thiomethyl%252Bpyrrolidine%252BERK%252Binhibitors%252Bfor%252Boncology%26aulast%3DBoga%26aufirst%3DSobhana%2BBabu%26date%3D2018%26volume%3D28%26issue%3D11%26spage%3D2029%26epage%3D2034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shanshan  Qin</span>, <span class="hlFld-ContribAuthor ">Mengmeng  Meng</span>, <span class="hlFld-ContribAuthor ">Dehua  Yang</span>, <span class="hlFld-ContribAuthor ">Wenwen  Bai</span>, <span class="hlFld-ContribAuthor ">Yan  Lu</span>, <span class="hlFld-ContribAuthor ">Yao  Peng</span>, <span class="hlFld-ContribAuthor ">Gaojie  Song</span>, <span class="hlFld-ContribAuthor ">Yiran  Wu</span>, <span class="hlFld-ContribAuthor ">Qingtong  Zhou</span>, <span class="hlFld-ContribAuthor ">Suwen  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiping  Huang</span>, <span class="hlFld-ContribAuthor ">John D.  McCorvy</span>, <span class="hlFld-ContribAuthor ">Xiaoqing  Cai</span>, <span class="hlFld-ContribAuthor ">Antao  Dai</span>, <span class="hlFld-ContribAuthor ">Bryan L.  Roth</span>, <span class="hlFld-ContribAuthor ">Michael A.  Hanson</span>, <span class="hlFld-ContribAuthor ">Zhi-Jie  Liu</span>, <span class="hlFld-ContribAuthor ">Ming-Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Raymond C.  Stevens</span>, <span class="hlFld-ContribAuthor ">Wenqing  Shui</span>. </span><span class="cited-content_cbyCitation_article-title">High-throughput identification of G protein-coupled receptor modulators through affinity mass spectrometry screening. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2018,</strong> <em>9 </em>
                                    (12)
                                     , 3192-3199. <a href="https://doi.org/10.1039/C7SC04698G" title="DOI URL">https://doi.org/10.1039/C7SC04698G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7SC04698G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7SC04698G%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DHigh-throughput%252Bidentification%252Bof%252BG%252Bprotein-coupled%252Breceptor%252Bmodulators%252Bthrough%252Baffinity%252Bmass%252Bspectrometry%252Bscreening%26aulast%3DQin%26aufirst%3DShanshan%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D12%26spage%3D3192%26epage%3D3199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chad J.  Miller</span>, <span class="hlFld-ContribAuthor ">Yagmur  Muftuoglu</span>, <span class="hlFld-ContribAuthor ">Benjamin E.  Turk</span>. </span><span class="cited-content_cbyCitation_article-title">A high throughput assay to identify substrate-selective inhibitors of the ERK protein kinases. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2017,</strong> <em>142 </em>, 39-45. <a href="https://doi.org/10.1016/j.bcp.2017.06.127" title="DOI URL">https://doi.org/10.1016/j.bcp.2017.06.127</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2017.06.127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2017.06.127%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DA%252Bhigh%252Bthroughput%252Bassay%252Bto%252Bidentify%252Bsubstrate-selective%252Binhibitors%252Bof%252Bthe%252BERK%252Bprotein%252Bkinases%26aulast%3DMiller%26aufirst%3DChad%2BJ.%26date%3D2017%26volume%3D142%26spage%3D39%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.A.  Samatar</span>. </span><span class="cited-content_cbyCitation_article-title">Extracellular Signal-Regulated Kinase (ERK1 and ERK2) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 233-249. <a href="https://doi.org/10.1016/B978-0-12-803505-4.00013-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-803505-4.00013-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-803505-4.00013-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-803505-4.00013-8%26sid%3Dliteratum%253Aachs%26atitle%3DExtracellular%252BSignal-Regulated%252BKinase%252B%252528ERK1%252Band%252BERK2%252529%252BInhibitors%26aulast%3DSamatar%26aufirst%3DA.A.%26date%3D2017%26spage%3D233%26epage%3D249%26pub%3DElsevier%26atitle%3DConquering%252BRAS%26date%3D2017%26volume%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feng  Yin</span>, <span class="hlFld-ContribAuthor ">Ainash  Garifullina</span>, <span class="hlFld-ContribAuthor ">Fujie  Tanaka</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of pyrrolidine-3-carboxylic acid derivatives
              via
              asymmetric Michael addition reactions of carboxylate-substituted enones. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2017,</strong> <em>15 </em>
                                    (29)
                                     , 6089-6092. <a href="https://doi.org/10.1039/C7OB01484H" title="DOI URL">https://doi.org/10.1039/C7OB01484H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB01484H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB01484H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bpyrrolidine-3-carboxylic%252Bacid%252Bderivatives%252Bvia%252Basymmetric%252BMichael%252Baddition%252Breactions%252Bof%252Bcarboxylate-substituted%252Benones%26aulast%3DYin%26aufirst%3DFeng%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D29%26spage%3D6089%26epage%3D6092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antoine  Millet</span>, <span class="hlFld-ContribAuthor ">Anthony R.  Martin</span>, <span class="hlFld-ContribAuthor ">Cyril  Ronco</span>, <span class="hlFld-ContribAuthor ">Stéphane  Rocchi</span>, <span class="hlFld-ContribAuthor ">Rachid  Benhida</span>. </span><span class="cited-content_cbyCitation_article-title">Metastatic Melanoma: Insights Into the Evolution of the Treatments and Future Challenges. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2017,</strong> <em>37 </em>
                                    (1)
                                     , 98-148. <a href="https://doi.org/10.1002/med.21404" title="DOI URL">https://doi.org/10.1002/med.21404</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21404%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DMetastatic%252BMelanoma%25253A%252BInsights%252BInto%252Bthe%252BEvolution%252Bof%252Bthe%252BTreatments%252Band%252BFuture%252BChallenges%26aulast%3DMillet%26aufirst%3DAntoine%26date%3D2017%26date%3D2016%26volume%3D37%26issue%3D1%26spage%3D98%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Linzhen  Hu</span>, <span class="hlFld-ContribAuthor ">Hucheng  Zhu</span>, <span class="hlFld-ContribAuthor ">Lei  Li</span>, <span class="hlFld-ContribAuthor ">Jinfeng  Huang</span>, <span class="hlFld-ContribAuthor ">Weiguang  Sun</span>, <span class="hlFld-ContribAuthor ">Junjun  Liu</span>, <span class="hlFld-ContribAuthor ">Hua  Li</span>, <span class="hlFld-ContribAuthor ">Zengwei  Luo</span>, <span class="hlFld-ContribAuthor ">Jianping  Wang</span>, <span class="hlFld-ContribAuthor ">Yongbo  Xue</span>, <span class="hlFld-ContribAuthor ">Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Yonghui  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">(±)-Japonones A and B, two pairs of new enantiomers with anti-KSHV activities from Hypericum japonicum. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep27588" title="DOI URL">https://doi.org/10.1038/srep27588</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep27588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep27588%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3D%252528%2525C2%2525B1%252529-Japonones%252BA%252Band%252BB%25252C%252Btwo%252Bpairs%252Bof%252Bnew%252Benantiomers%252Bwith%252Banti-KSHV%252Bactivities%252Bfrom%252BHypericum%252Bjaponicum%26aulast%3DHu%26aufirst%3DLinzhen%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Victoria D.  Kutilek</span>, <span class="hlFld-ContribAuthor ">Christine L.  Andrews</span>, <span class="hlFld-ContribAuthor ">Matthew P.  Richards</span>, <span class="hlFld-ContribAuthor ">Zangwei  Xu</span>, <span class="hlFld-ContribAuthor ">Tianxiao  Sun</span>, <span class="hlFld-ContribAuthor ">Yiping  Chen</span>, <span class="hlFld-ContribAuthor ">Andrew  Hashke</span>, <span class="hlFld-ContribAuthor ">Nadya  Smotrov</span>, <span class="hlFld-ContribAuthor ">Rafael  Fernandez</span>, <span class="hlFld-ContribAuthor ">Elliott B.  Nickbarg</span>, <span class="hlFld-ContribAuthor ">Chad  Chamberlin</span>, <span class="hlFld-ContribAuthor ">Berengere  Sauvagnat</span>, <span class="hlFld-ContribAuthor ">Patrick J.  Curran</span>, <span class="hlFld-ContribAuthor ">Ryan  Boinay</span>, <span class="hlFld-ContribAuthor ">Peter  Saradjian</span>, <span class="hlFld-ContribAuthor ">Samantha J.  Allen</span>, <span class="hlFld-ContribAuthor ">Noel  Byrne</span>, <span class="hlFld-ContribAuthor ">Nathaniel L.  Elsen</span>, <span class="hlFld-ContribAuthor ">Rachael E.  Ford</span>, <span class="hlFld-ContribAuthor ">Dawn L.  Hall</span>, <span class="hlFld-ContribAuthor ">Maria  Kornienko</span>, <span class="hlFld-ContribAuthor ">Keith W.  Rickert</span>, <span class="hlFld-ContribAuthor ">Sujata  Sharma</span>, <span class="hlFld-ContribAuthor ">Jennifer M.  Shipman</span>, <span class="hlFld-ContribAuthor ">Kevin J.  Lumb</span>, <span class="hlFld-ContribAuthor ">Kevin  Coleman</span>, <span class="hlFld-ContribAuthor ">Peter J.  Dandliker</span>, <span class="hlFld-ContribAuthor ">Ilona  Kariv</span>, <span class="hlFld-ContribAuthor ">Bruce  Beutel</span>. </span><span class="cited-content_cbyCitation_article-title">Integration of Affinity Selection–Mass Spectrometry and Functional Cell-Based Assays to Rapidly Triage Druggable Target Space within the NF-κB Pathway. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Screening</span><span> <strong>2016,</strong> <em>21 </em>
                                    (6)
                                     , 608-619. <a href="https://doi.org/10.1177/1087057116637353" title="DOI URL">https://doi.org/10.1177/1087057116637353</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1087057116637353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1087057116637353%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Screening%26atitle%3DIntegration%252Bof%252BAffinity%252BSelection%2525E2%252580%252593Mass%252BSpectrometry%252Band%252BFunctional%252BCell-Based%252BAssays%252Bto%252BRapidly%252BTriage%252BDruggable%252BTarget%252BSpace%252Bwithin%252Bthe%252BNF-%2525CE%2525BAB%252BPathway%26aulast%3DKutilek%26aufirst%3DVictoria%2BD.%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D6%26spage%3D608%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Klumpp</span>. </span><span class="cited-content_cbyCitation_article-title">Non-stoichiometric inhibition in integrated lead finding – a literature review. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2016,</strong> <em>11 </em>
                                    (2)
                                     , 149-162. <a href="https://doi.org/10.1517/17460441.2016.1128892" title="DOI URL">https://doi.org/10.1517/17460441.2016.1128892</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2016.1128892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2016.1128892%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DNon-stoichiometric%252Binhibition%252Bin%252Bintegrated%252Blead%252Bfinding%252B%2525E2%252580%252593%252Ba%252Bliterature%252Breview%26aulast%3DKlumpp%26aufirst%3DMartin%26date%3D2016%26date%3D2015%26volume%3D11%26issue%3D2%26spage%3D149%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Honorine  Lebraud</span>, <span class="hlFld-ContribAuthor ">David J.  Wright</span>, <span class="hlFld-ContribAuthor ">Charlotte E.  East</span>, <span class="hlFld-ContribAuthor ">Finn P.  Holding</span>, <span class="hlFld-ContribAuthor ">Marc  O'Reilly</span>, <span class="hlFld-ContribAuthor ">Tom D.  Heightman</span>. </span><span class="cited-content_cbyCitation_article-title">In-gel activity-based protein profiling of a clickable covalent ERK1/2 inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Molecular BioSystems</span><span> <strong>2016,</strong> <em>12 </em>
                                    (9)
                                     , 2867-2874. <a href="https://doi.org/10.1039/C6MB00367B" title="DOI URL">https://doi.org/10.1039/C6MB00367B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MB00367B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MB00367B%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520BioSystems%26atitle%3DIn-gel%252Bactivity-based%252Bprotein%252Bprofiling%252Bof%252Ba%252Bclickable%252Bcovalent%252BERK1%25252F2%252Binhibitor%26aulast%3DLebraud%26aufirst%3DHonorine%26date%3D2016%26date%3D2016%26volume%3D12%26issue%3D9%26spage%3D2867%26epage%3D2874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeffrey T.  Bagdanoff</span>, <span class="hlFld-ContribAuthor ">Rama  Jain</span>, <span class="hlFld-ContribAuthor ">Wooseok  Han</span>, <span class="hlFld-ContribAuthor ">Daniel  Poon</span>, <span class="hlFld-ContribAuthor ">Patrick S.  Lee</span>, <span class="hlFld-ContribAuthor ">Cornelia  Bellamacina</span>, <span class="hlFld-ContribAuthor ">Mika  Lindvall</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand efficient tetrahydro-pyrazolopyridines as inhibitors of ERK2 kinase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (17)
                                     , 3626-3629. <a href="https://doi.org/10.1016/j.bmcl.2015.06.063" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.06.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.06.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.06.063%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DLigand%252Befficient%252Btetrahydro-pyrazolopyridines%252Bas%252Binhibitors%252Bof%252BERK2%252Bkinase%26aulast%3DBagdanoff%26aufirst%3DJeffrey%2BT.%26date%3D2015%26volume%3D25%26issue%3D17%26spage%3D3626%26epage%3D3629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeffrey T.  Bagdanoff</span>, <span class="hlFld-ContribAuthor ">Rama  Jain</span>, <span class="hlFld-ContribAuthor ">Wooseok  Han</span>, <span class="hlFld-ContribAuthor ">Shejin  Zhu</span>, <span class="hlFld-ContribAuthor ">Ann-Marie  Madiera</span>, <span class="hlFld-ContribAuthor ">Patrick S.  Lee</span>, <span class="hlFld-ContribAuthor ">Xiaolei  Ma</span>, <span class="hlFld-ContribAuthor ">Daniel  Poon</span>. </span><span class="cited-content_cbyCitation_article-title">Tetrahydropyrrolo-diazepenones as inhibitors of ERK2 kinase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (18)
                                     , 3788-3792. <a href="https://doi.org/10.1016/j.bmcl.2015.07.091" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.07.091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.07.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.07.091%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DTetrahydropyrrolo-diazepenones%252Bas%252Binhibitors%252Bof%252BERK2%252Bkinase%26aulast%3DBagdanoff%26aufirst%3DJeffrey%2BT.%26date%3D2015%26volume%3D25%26issue%3D18%26spage%3D3788%26epage%3D3792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi  Tao</span>, <span class="hlFld-ContribAuthor ">Hao  Cai</span>, <span class="hlFld-ContribAuthor ">Weidong  Li</span>, <span class="hlFld-ContribAuthor ">Baochang  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Ultrafiltration coupled with high-performance liquid chromatography and quadrupole-time-of-flight mass spectrometry for screening lipase binders from different extracts of Dendrobium officinale. </span><span class="cited-content_cbyCitation_journal-name">Analytical and Bioanalytical Chemistry</span><span> <strong>2015,</strong> <em>407 </em>
                                    (20)
                                     , 6081-6093. <a href="https://doi.org/10.1007/s00216-015-8781-4" title="DOI URL">https://doi.org/10.1007/s00216-015-8781-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00216-015-8781-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00216-015-8781-4%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520and%2520Bioanalytical%2520Chemistry%26atitle%3DUltrafiltration%252Bcoupled%252Bwith%252Bhigh-performance%252Bliquid%252Bchromatography%252Band%252Bquadrupole-time-of-flight%252Bmass%252Bspectrometry%252Bfor%252Bscreening%252Blipase%252Bbinders%252Bfrom%252Bdifferent%252Bextracts%252Bof%252BDendrobium%252Bofficinale%26aulast%3DTao%26aufirst%3DYi%26date%3D2015%26date%3D2015%26volume%3D407%26issue%3D20%26spage%3D6081%26epage%3D6093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hugh Y.  Zhu</span>, <span class="hlFld-ContribAuthor ">Jagdish  Desai</span>, <span class="hlFld-ContribAuthor ">Yongqi  Deng</span>, <span class="hlFld-ContribAuthor ">Alan  Cooper</span>, <span class="hlFld-ContribAuthor ">James  Wang</span>, <span class="hlFld-ContribAuthor ">Jerry  Shipps</span>, <span class="hlFld-ContribAuthor ">Ahmed  Samatar</span>, <span class="hlFld-ContribAuthor ">Donna  Carr</span>, <span class="hlFld-ContribAuthor ">William  Windsor</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of hydroxyaniline amides as selective Extracellular Regulated Kinase (Erk) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (7)
                                     , 1627-1629. <a href="https://doi.org/10.1016/j.bmcl.2015.01.049" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.01.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.01.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.01.049%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bhydroxyaniline%252Bamides%252Bas%252Bselective%252BExtracellular%252BRegulated%252BKinase%252B%252528Erk%252529%252Binhibitors%26aulast%3DZhu%26aufirst%3DHugh%2BY.%26date%3D2015%26volume%3D25%26issue%3D7%26spage%3D1627%26epage%3D1629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed A.  Samatar</span>, <span class="hlFld-ContribAuthor ">Poulikos I.  Poulikakos</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting RAS–ERK signalling in cancer: promises and challenges. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2014,</strong> <em>13 </em>
                                    (12)
                                     , 928-942. <a href="https://doi.org/10.1038/nrd4281" title="DOI URL">https://doi.org/10.1038/nrd4281</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd4281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd4281%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DTargeting%252BRAS%2525E2%252580%252593ERK%252Bsignalling%252Bin%252Bcancer%25253A%252Bpromises%252Band%252Bchallenges%26aulast%3DSamatar%26aufirst%3DAhmed%2BA.%26date%3D2014%26date%3D2014%26volume%3D13%26issue%3D12%26spage%3D928%26epage%3D942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/medium/jm-2014-00847m_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/large/jm-2014-00847m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500847m&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/medium/jm-2014-00847m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/large/jm-2014-00847m_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Initial ALIS screening hit <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/large/jm-2014-00847m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500847m&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/medium/jm-2014-00847m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/large/jm-2014-00847m_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/large/jm-2014-00847m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500847m&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) HATU, DIEA, DMF, rt, overnight; (ii) TFA, rt, 1 h; (iii) HOAc, ethyl glyoxylate, rt, 1 h; then sodium borohydride triacetoxy, rt, overnight; (iv) LiOH, THF, rt, overnight; (v) arylpiperazine, HATU, DIEA, DMF, rt, 2 h.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/medium/jm-2014-00847m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/large/jm-2014-00847m_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/large/jm-2014-00847m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500847m&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) TMSCHN<sub>2</sub>, toluene/MeOH, 0–5 °C, 30 min; (ii) TFA, rt, 1 h; (iii) <i>tert</i>-butyl chloroacetate, DIEA, rt, 1 h; (iv) arylpiperidine, HATU, DIEA, DMF, rt, 2 h; (v) LiOH, THF, rt, 12 h; (vi) aminophenol, HATU, DIEA, DMF, rt, overnight.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/medium/jm-2014-00847m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/large/jm-2014-00847m_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal structure of ERK2 with bound inhibitor <b>4</b>: inhibitor <b>4</b>, carbon atoms, cyan; ERK2 carbon, gray; nitrogen, blue; oxygen, red; chloride, green; sulfur, yellow. The water molecule oxygen atom involved in the hydrogen bond network is in CPK representation. The hydrogen bonds are labeled with dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/large/jm-2014-00847m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500847m&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/medium/jm-2014-00847m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/large/jm-2014-00847m_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Superposition of the X-ray crystal structures of apo ERK2 and inhibitor <b>4</b> bound ERK2 complex: apo ERK2, carbon, green; inhibitor <b>4</b> bound ERK2 complex, carbon, gray; inhibitor <b>4</b>, carbon, cyan. Tyr34 in ERK2/<b>4</b> complex is highlighted with carbon atoms in yellow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/large/jm-2014-00847m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500847m&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/medium/jm-2014-00847m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/large/jm-2014-00847m_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>4</b> suppresses the phosphorylation ERK1,2. A2058 BRAF mutant cell lines were treated for 4 h at 37 °C with 0, 150, 312, 625, 1250, 2500, 5000, or 10000 nM compound <b>4</b>. Cells were harvested after 4 h, and cell lysates containing equal amounts of protein were electrophoresed and immunoblotted for phosphoERK1,2 and total ERK1,2 using appropriate antibodies. Blots were developed using ECL reagent from Amersham Biosciences. Cells treated with MEK inhibitor PD0325901 were used as a positive control for the suppression of phosphorylated ERK1,2 proteins.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500847m/20141107/images/large/jm-2014-00847m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500847m&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i50">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23105" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23105" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 34 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Cheng, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobb, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baer, R.</span><span> </span><span class="NLM_article-title">Phosphorylation of the TAL1 oncoprotein by the extracellular-signal-regulated protein kinase ERK1</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm500847m&amp;key=8423803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADyaK3sXps12gsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1993&pages=801-8&author=J.+T.+Chengauthor=M.+H.+Cobbauthor=R.+Baer&title=Phosphorylation+of+the+TAL1+oncoprotein+by+the+extracellular-signal-regulated+protein+kinase+ERK1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of the TAL1 oncoprotein by the extracellular-signal-regulated protein kinase ERK1</span></div><div class="casAuthors">Cheng, Jiin Tsuey; Cobb, Melanie H.; Baer, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">801-8</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    </div><div class="casAbstract">Alteration of the TAL1 gene is the most common genetic lesion found in T-cell acute lymphoblastic leukemia.  TAL1 Encodes phosphoproteins, pp42TAL1 and pp22TALq, that represent phosphorylated versions of the full-length (residues 1 to 331) and truncated (residues 176 to 331) TAL1 gene products, resp.  Both proteins contain the basic helix-loop-helix motif, a DNA-binding and protein dimerization motif common to several known transcriptional regulatory factors.  Serine residue 122 (S122) is a major phosphorylation site of pp42TAL1 in leukemic cell lines and transfected COS1 cells.  In vivo phosphorylation of S122 is induced by epidermal growth factor with a rapid time course that parallels activation of the ERK/MAP2 protein kinases.  Moreover, S122 is readily phosphorylated in vitro by the extracellular signal-regulated protein kinase ERK1.  These data suggest that TAL1 residue S122 serves as an in vivo substrate for ERK/MAP2 kinases such as ERK1.  Therefore, S122 phosphorylation may provide a mechanism whereby the properties of TAL1 polypeptides can be modulated by extracellular stimuli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRFp8xKjm7LbVg90H21EOLACvtfcHk0lgv7QIzDhncsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXps12gsw%253D%253D&md5=9d9f6009f036d35630b57fb086ddbdfb</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DJ.%2BT.%26aulast%3DCobb%26aufirst%3DM.%2BH.%26aulast%3DBaer%26aufirst%3DR.%26atitle%3DPhosphorylation%2520of%2520the%2520TAL1%2520oncoprotein%2520by%2520the%2520extracellular-signal-regulated%2520protein%2520kinase%2520ERK1%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1993%26volume%3D13%26spage%3D801%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. J.</span><span> </span><span class="NLM_article-title">Map Kinase Binds to the NH2-Terminal Activation Domain of C-Myc</span> <span class="citation_source-journal">Febs Letters</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">285</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=1994&pages=281-285&author=S.+Guptaauthor=R.+J.+Davis&title=Map+Kinase+Binds+to+the+NH2-Terminal+Activation+Domain+of+C-Myc"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DR.%2BJ.%26atitle%3DMap%2520Kinase%2520Binds%2520to%2520the%2520NH2-Terminal%2520Activation%2520Domain%2520of%2520C-Myc%26jtitle%3DFebs%2520Letters%26date%3D1994%26volume%3D353%26spage%3D281%26epage%3D285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Robbins, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhen, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobb, M. H.</span><span> </span><span class="NLM_article-title">Map Kinases Erk1 and Erk2—Pleiotropic Enzymes in a Ubiquitous Signaling Network</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1994&pages=93-116&author=D.+J.+Robbinsauthor=E.+H.+Zhenauthor=M.+G.+Chengauthor=S.+C.+Xuauthor=D.+Ebertauthor=M.+H.+Cobb&title=Map+Kinases+Erk1+and+Erk2%E2%80%94Pleiotropic+Enzymes+in+a+Ubiquitous+Signaling+Network"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRobbins%26aufirst%3DD.%2BJ.%26aulast%3DZhen%26aufirst%3DE.%2BH.%26aulast%3DCheng%26aufirst%3DM.%2BG.%26aulast%3DXu%26aufirst%3DS.%2BC.%26aulast%3DEbert%26aufirst%3DD.%26aulast%3DCobb%26aufirst%3DM.%2BH.%26atitle%3DMap%2520Kinases%2520Erk1%2520and%2520Erk2%25E2%2580%2594Pleiotropic%2520Enzymes%2520in%2520a%2520Ubiquitous%2520Signaling%2520Network%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D1994%26volume%3D63%26spage%3D93%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Cobb, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, E. J.</span><span> </span><span class="NLM_article-title">How Map Kinases Are Regulated</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">14843</span><span class="NLM_x">–</span> <span class="NLM_lpage">14846</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=14843-14846&author=M.+H.+Cobbauthor=E.+J.+Goldsmith&title=How+Map+Kinases+Are+Regulated"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCobb%26aufirst%3DM.%2BH.%26aulast%3DGoldsmith%26aufirst%3DE.%2BJ.%26atitle%3DHow%2520Map%2520Kinases%2520Are%2520Regulated%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D14843%26epage%3D14846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Campbell, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krebs, E. G.</span><span> </span><span class="NLM_article-title">The Map Kinase Cascade</span> <span class="citation_source-journal">Recent Prog. Horm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm500847m&amp;key=7740155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADyaK2MXmt1Kjuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1995&pages=131-159&author=J.+S.+Campbellauthor=R.+Segerauthor=J.+D.+Gravesauthor=L.+M.+Gravesauthor=A.+M.+Jensenauthor=E.+G.+Krebs&title=The+Map+Kinase+Cascade"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The MAP kinase cascade</span></div><div class="casAuthors">Campbell, Jean S.; Seger, Rony; Graves, Jonathan D.; Graves, Lee M.; Jensen, Amy M.; Krebs, Edwin G.</div><div class="citationInfo"><span class="NLM_cas:title">Recent Progress in Hormone Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">131-59</span>CODEN:
                <span class="NLM_cas:coden">RPHRA6</span>;
        ISSN:<span class="NLM_cas:issn">0079-9963</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">A review, with 160 refs., of the MAP kinase cascade and its involvement in signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlhvLtbVDGy7Vg90H21EOLACvtfcHk0ljJ3EtcVJW6Zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmt1Kjuro%253D&md5=3ca608283bacc95feff8c1a5b04a4c75</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DJ.%2BS.%26aulast%3DSeger%26aufirst%3DR.%26aulast%3DGraves%26aufirst%3DJ.%2BD.%26aulast%3DGraves%26aufirst%3DL.%2BM.%26aulast%3DJensen%26aufirst%3DA.%2BM.%26aulast%3DKrebs%26aufirst%3DE.%2BG.%26atitle%3DThe%2520Map%2520Kinase%2520Cascade%26jtitle%3DRecent%2520Prog.%2520Horm.%2520Res.%26date%3D1995%26volume%3D50%26spage%3D131%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Samowitz, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albertsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murtaugh, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slattery, M. L.</span><span> </span><span class="NLM_article-title">Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">6063</span><span class="NLM_x">–</span> <span class="NLM_lpage">6070</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=6063-6070&author=W.+S.+Samowitzauthor=C.+Sweeneyauthor=J.+Herrickauthor=H.+Albertsenauthor=T.+R.+Levinauthor=M.+A.+Murtaughauthor=R.+K.+Wolffauthor=M.+L.+Slattery&title=Poor+survival+associated+with+the+BRAF+V600E+mutation+in+microsatellite-stable+colon+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSamowitz%26aufirst%3DW.%2BS.%26aulast%3DSweeney%26aufirst%3DC.%26aulast%3DHerrick%26aufirst%3DJ.%26aulast%3DAlbertsen%26aufirst%3DH.%26aulast%3DLevin%26aufirst%3DT.%2BR.%26aulast%3DMurtaugh%26aufirst%3DM.%2BA.%26aulast%3DWolff%26aufirst%3DR.%2BK.%26aulast%3DSlattery%26aufirst%3DM.%2BL.%26atitle%3DPoor%2520survival%2520associated%2520with%2520the%2520BRAF%2520V600E%2520mutation%2520in%2520microsatellite-stable%2520colon%2520cancers%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D6063%26epage%3D6070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Shapiro, P.</span><span> </span><span class="NLM_article-title">Ras-MAP kinase signaling pathways and control of cell proliferation: relevance to cancer therapy</span> <span class="citation_source-journal">Crit. Rev. Clin. Lab. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm500847m&amp;key=10.1080%2F10408360290795538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm500847m&amp;key=12385501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtlKit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2002&pages=285-330&author=P.+Shapiro&title=Ras-MAP+kinase+signaling+pathways+and+control+of+cell+proliferation%3A+relevance+to+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Ras-MAP kinase signaling pathways and control of cell proliferation: relevance to cancer therapy</span></div><div class="casAuthors">Shapiro, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Clinical Laboratory Sciences</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4 and 5</span>),
    <span class="NLM_cas:pages">285-330</span>CODEN:
                <span class="NLM_cas:coden">CRCLBH</span>;
        ISSN:<span class="NLM_cas:issn">1040-8363</span>.
    
            (<span class="NLM_cas:orgname">CRC Press LLC</span>)
        </div><div class="casAbstract">A review.  The mitogen-activated protein (MAP) kinase pathways represent several families of signal transduction cascades that mediate information provided by extracellular stimuli.  MAP kinase pathways regulate a wide range of physiol. responses, including cell proliferation, apoptosis, cell differentiation, and tissue development.  Constitutive activation of MAP kinase proteins in exptl. models has been shown to cause cell transformation and is implicated in tumorigenesis.  Of clin. importance, MAP kinase pathways are regulated by Ras G-proteins, which are found to be mutated and constitutively active in ∼30% of all human cancers.  Thus, a major goal in the treatment of cancer is the development of specific compds. that target Ras and crit. downstream signaling proteins responsible for uncontrolled cell growth.  A variety of biochem., mol., and structural approaches have been used to develop drug compds. that target signaling proteins important for MAP kinase pathway activation.  These compds. have been useful tools for identifying the mechanisms of MAP kinase pathway signaling and hold promise for clin. use.  This review will present an overview of the major proteins involved in Ras and MAP kinase signaling pathways and their function in regulating cell cycle events and proliferation.  In addn., some of the relevant compds. that have been developed to inhibit the activities of these proteins and MAP kinase signaling are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVr0dyOfX0jbVg90H21EOLACvtfcHk0ljJ3EtcVJW6Zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtlKit74%253D&md5=4441af89966fb06d2d1c9f84868d1f4b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1080%2F10408360290795538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10408360290795538%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DP.%26atitle%3DRas-MAP%2520kinase%2520signaling%2520pathways%2520and%2520control%2520of%2520cell%2520proliferation%253A%2520relevance%2520to%2520cancer%2520therapy%26jtitle%3DCrit.%2520Rev.%2520Clin.%2520Lab.%2520Sci.%26date%3D2002%26volume%3D39%26spage%3D285%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Brose, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rishi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerrero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einhorn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albelda, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brignell, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futreal, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wooster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratton, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, B. L.</span><span> </span><span class="NLM_article-title">BRAF and RAS mutations in human lung cancer and melanoma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">6997</span><span class="NLM_x">–</span> <span class="NLM_lpage">7000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm500847m&amp;key=12460918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVahsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=6997-7000&author=M.+S.+Broseauthor=P.+Volpeauthor=M.+Feldmanauthor=M.+Kumarauthor=I.+Rishiauthor=R.+Gerreroauthor=E.+Einhornauthor=M.+Herlynauthor=J.+Minnaauthor=A.+Nicholsonauthor=J.+A.+Rothauthor=S.+M.+Albeldaauthor=H.+Daviesauthor=C.+Coxauthor=G.+Brignellauthor=P.+Stephensauthor=P.+A.+Futrealauthor=R.+Woosterauthor=M.+R.+Strattonauthor=B.+L.+Weber&title=BRAF+and+RAS+mutations+in+human+lung+cancer+and+melanoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">BRAF and RAS mutations in human lung cancer and melanoma</span></div><div class="casAuthors">Brose, Marcia S.; Volpe, Patricia; Feldman, Michael; Kumar, Madhu; Rishi, Irum; Gerrero, Renee; Einhorn, Eugene; Herlyn, Meenhard; Minna, John; Nicholson, Andrew; Roth, Jack A.; Albelda, Steven M.; Davies, Helen; Cox, Charles; Brignell, Graham; Stephens, Philip; Futreal, P. Andrew; Wooster, Richard; Stratton, Michael R.; Weber, Barbara L.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6997-7000</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">BRAF encodes a RAS-regulated kinase that mediates cell growth and malignant transformation kinase pathway activation.  Recently, we have identified activating BRAF mutations in 66% of melanomas and a smaller percentage of many other human cancers.  To det. whether BRAF mutations account for the MAP kinase pathway activation common in non-small cell lung carcinomas (NSCLCs) and to extend the initial findings in melanoma, we screened DNA from 179 NSCLCs and 35 melanomas for BRAF mutations (exons 11 and 15).  We identified BRAF mutations in 5 NSCLCs (3%; one V599 and four non-V599) and 22 melanomas (63%; 21 V599 and 1 non-V599).  Three BRAF mutations identified in this study are novel, altering residues important in AKT-mediated BRAF phosphorylation and suggesting that disruption of AKT -induced BRAF inhibition can play a role in malignant transformation.  To our knowledge, this is the first report of mutations documenting this interaction in human cancers.  Although >90% of BRAF mutations in melanoma involve codon 599 (57 of 60), 8 of 9 BRAF mutations reported to date in NSCLC are non-V599 (89%; P < 10-7), strongly suggesting that BRAF mutations in NSCLC are qual. different from those in melanoma; thus, there may be therapeutic differences between lung cancer and melanoma in response to RAF inhibitors.  Although uncommon, BRAF mutations in human lung cancers may identify a subset of tumors sensitive to targeted therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTgYE0tREoTrVg90H21EOLACvtfcHk0limI1Bnr22hHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVahsbo%253D&md5=14d00ac58479d0a0f98830abe436dfde</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrose%26aufirst%3DM.%2BS.%26aulast%3DVolpe%26aufirst%3DP.%26aulast%3DFeldman%26aufirst%3DM.%26aulast%3DKumar%26aufirst%3DM.%26aulast%3DRishi%26aufirst%3DI.%26aulast%3DGerrero%26aufirst%3DR.%26aulast%3DEinhorn%26aufirst%3DE.%26aulast%3DHerlyn%26aufirst%3DM.%26aulast%3DMinna%26aufirst%3DJ.%26aulast%3DNicholson%26aufirst%3DA.%26aulast%3DRoth%26aufirst%3DJ.%2BA.%26aulast%3DAlbelda%26aufirst%3DS.%2BM.%26aulast%3DDavies%26aufirst%3DH.%26aulast%3DCox%26aufirst%3DC.%26aulast%3DBrignell%26aufirst%3DG.%26aulast%3DStephens%26aufirst%3DP.%26aulast%3DFutreal%26aufirst%3DP.%2BA.%26aulast%3DWooster%26aufirst%3DR.%26aulast%3DStratton%26aufirst%3DM.%2BR.%26aulast%3DWeber%26aufirst%3DB.%2BL.%26atitle%3DBRAF%2520and%2520RAS%2520mutations%2520in%2520human%2520lung%2520cancer%2520and%2520melanoma%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D6997%26epage%3D7000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Tsai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bremer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillette, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sproesser, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smalley, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marimuthu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settachatgul, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shellooe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantwell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habets, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artis, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollag, G.</span><span> </span><span class="NLM_article-title">Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">3041</span><span class="NLM_x">–</span> <span class="NLM_lpage">3046</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm500847m&amp;key=10.1073%2Fpnas.0711741105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm500847m&amp;key=18287029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtVSitrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=3041-3046&author=J.+Tsaiauthor=J.+T.+Leeauthor=W.+Wangauthor=J.+Zhangauthor=H.+Choauthor=S.+Mamoauthor=R.+Bremerauthor=S.+Gilletteauthor=J.+Kongauthor=N.+K.+Haassauthor=K.+Sproesserauthor=L.+Liauthor=K.+S.+Smalleyauthor=D.+Fongauthor=Y.+L.+Zhuauthor=A.+Marimuthuauthor=H.+Nguyenauthor=B.+Lamauthor=J.+Liuauthor=I.+Cheungauthor=J.+Riceauthor=Y.+Suzukiauthor=C.+Luuauthor=C.+Settachatgulauthor=R.+Shellooeauthor=J.+Cantwellauthor=S.+H.+Kimauthor=J.+Schlessingerauthor=K.+Y.+Zhangauthor=B.+L.+Westauthor=B.+Powellauthor=G.+Habetsauthor=C.+Zhangauthor=P.+N.+Ibrahimauthor=P.+Hirthauthor=D.+R.+Artisauthor=M.+Herlynauthor=G.+Bollag&title=Discovery+of+a+selective+inhibitor+of+oncogenic+B-Raf+kinase+with+potent+antimelanoma+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity</span></div><div class="casAuthors">Tsai, James; Lee, John T.; Wang, Weiru; Zhang, Jiazhong; Cho, Hanna; Mamo, Shumeye; Bremer, Ryan; Gillette, Sam; Kong, Jun; Haass, Nikolas K.; Sproesser, Katrin; Li, Ling; Smalley, Keiran S. M.; Fong, Daniel; Zhu, Yong-Liang; Marimuthu, Adhirai; Nguyen, Hoa; Lam, Billy; Liu, Jennifer; Cheung, Ivana; Rice, Julie; Suzuki, Yoshihisa; Luu, Catherine; Settachatgul, Calvin; Shellooe, Rafe; Cantwell, John; Kim, Sung-Hou; Schlessinger, Joseph; Zhang, Kam Y. J.; West, Brian L.; Powell, Ben; Habets, Gaston; Zhang, Chao; Ibrahim, Prabha N.; Hirth, Peter; Artis, Dean R.; Herlyn, Meenhard; Bollag, Gideon</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3041-3046</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">BRAFV600E is the most frequent oncogenic protein kinase mutation known.  Furthermore, inhibitors targeting "active" protein kinases have demonstrated significant utility in the therapeutic repertoire against cancer.  Therefore, the authors pursued the development of specific kinase inhibitors targeting B-Raf, and the V600E allele in particular.  By using a structure-guided discovery approach, a potent and selective inhibitor of active B-Raf has been discovered.  PLX4720, a 7-azaindole deriv. that inhibits B-RafV600E with an IC50 of 13 nM, defines a class of kinase inhibitor with marked selectivity in both biochem. and cellular assays.  PLX4720 preferentially inhibits the active B-RafV600E kinase compared with a broad spectrum of other kinases, and potent cytotoxic effects are also exclusive to cells bearing the V600E allele.  Consistent with the high degree of selectivity, ERK phosphorylation is potently inhibited by PLX4720 in B-RafV600E-bearing tumor cell lines but not in cells lacking oncogenic B-Raf.  In melanoma models, PLX4720 induces cell cycle arrest and apoptosis exclusively in B-RafV600E-pos. cells.  In B-RafV600E-dependent tumor xenograft models, orally dosed PLX4720 causes significant tumor growth delays, including tumor regressions, without evidence of toxicity.  The work described here represents the entire discovery process, from initial identification through structural and biol. studies in animal models to a promising therapeutic for testing in cancer patients bearing B-RafV600E-driven tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPX53IQCbDJ7Vg90H21EOLACvtfcHk0limI1Bnr22hHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtVSitrk%253D&md5=273b94202f99984e6eb24723d0c6141f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0711741105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0711741105%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%2BT.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DMamo%26aufirst%3DS.%26aulast%3DBremer%26aufirst%3DR.%26aulast%3DGillette%26aufirst%3DS.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DHaass%26aufirst%3DN.%2BK.%26aulast%3DSproesser%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DSmalley%26aufirst%3DK.%2BS.%26aulast%3DFong%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DY.%2BL.%26aulast%3DMarimuthu%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DLam%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DCheung%26aufirst%3DI.%26aulast%3DRice%26aufirst%3DJ.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DLuu%26aufirst%3DC.%26aulast%3DSettachatgul%26aufirst%3DC.%26aulast%3DShellooe%26aufirst%3DR.%26aulast%3DCantwell%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DK.%2BY.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DHabets%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DHerlyn%26aufirst%3DM.%26aulast%3DBollag%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520a%2520selective%2520inhibitor%2520of%2520oncogenic%2520B-Raf%2520kinase%2520with%2520potent%2520antimelanoma%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D3041%26epage%3D3046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Barrett, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudley, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltiel, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fergus, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flamme, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LePage, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopold, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przybranowski, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebolt-Leopold, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Becelaere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marston, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, W. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmus, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tecle, H.</span><span> </span><span class="NLM_article-title">The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6501</span><span class="NLM_x">–</span> <span class="NLM_lpage">6504</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm500847m&amp;key=10.1016%2Fj.bmcl.2008.10.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm500847m&amp;key=18952427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWjsL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6501-6504&author=S.+D.+Barrettauthor=A.+J.+Bridgesauthor=D.+T.+Dudleyauthor=A.+R.+Saltielauthor=J.+H.+Fergusauthor=C.+M.+Flammeauthor=A.+M.+Delaneyauthor=M.+Kaufmanauthor=S.+LePageauthor=W.+R.+Leopoldauthor=S.+A.+Przybranowskiauthor=J.+Sebolt-Leopoldauthor=K.+Van+Becelaereauthor=A.+M.+Dohertyauthor=R.+M.+Kennedyauthor=D.+Marstonauthor=W.+A.+Howardauthor=Y.+Smithauthor=J.+S.+Warmusauthor=H.+Tecle&title=The+discovery+of+the+benzhydroxamate+MEK+inhibitors+CI-1040+and+PD+0325901"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901</span></div><div class="casAuthors">Barrett, Stephen D.; Bridges, Alexander J.; Dudley, David T.; Saltiel, Alan R.; Fergus, James H.; Flamme, Cathlin M.; Delaney, Amy M.; Kaufman, Michael; LePage, Sophie; Leopold, Wilbur R.; Przybranowski, Sally A.; Sebolt-Leopold, Judith; Van Becelaere, Keri; Doherty, Annette M.; Kennedy, Robert M.; Marston, Dan; Howard, W. Allen, Jr.; Smith, Yvonne; Warmus, Joseph S.; Tecle, Haile</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6501-6504</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of benzhydroxamate esters derived from their precursor anthranilic acids have been prepd. and have been identified as potent MEK inhibitors.  CI-1040 (I) was the first MEK inhibitor to demonstrate in vivo activity in preclin. animal models and subsequently became the first MEK inhibitor to enter clin. trial.  CI-1040 suffered however from poor exposure due to its poor soly. and rapid clearance, and as a result, development of the compd. was terminated.  Optimization of the diphenylamine core and modification of the hydroxamate side chain for cell potency, soly., and exposure with oral delivery resulted in the discovery of the clin. candidate PD 0325901 (II).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpam9NxZxX93rVg90H21EOLACvtfcHk0liDPKly_Bp5Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWjsL%252FI&md5=e64f7ae6a446c504528621e7d14d67ce</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.10.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.10.054%26sid%3Dliteratum%253Aachs%26aulast%3DBarrett%26aufirst%3DS.%2BD.%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26aulast%3DDudley%26aufirst%3DD.%2BT.%26aulast%3DSaltiel%26aufirst%3DA.%2BR.%26aulast%3DFergus%26aufirst%3DJ.%2BH.%26aulast%3DFlamme%26aufirst%3DC.%2BM.%26aulast%3DDelaney%26aufirst%3DA.%2BM.%26aulast%3DKaufman%26aufirst%3DM.%26aulast%3DLePage%26aufirst%3DS.%26aulast%3DLeopold%26aufirst%3DW.%2BR.%26aulast%3DPrzybranowski%26aufirst%3DS.%2BA.%26aulast%3DSebolt-Leopold%26aufirst%3DJ.%26aulast%3DVan%2BBecelaere%26aufirst%3DK.%26aulast%3DDoherty%26aufirst%3DA.%2BM.%26aulast%3DKennedy%26aufirst%3DR.%2BM.%26aulast%3DMarston%26aufirst%3DD.%26aulast%3DHoward%26aufirst%3DW.%2BA.%26aulast%3DSmith%26aufirst%3DY.%26aulast%3DWarmus%26aufirst%3DJ.%2BS.%26aulast%3DTecle%26aufirst%3DH.%26atitle%3DThe%2520discovery%2520of%2520the%2520benzhydroxamate%2520MEK%2520inhibitors%2520CI-1040%2520and%2520PD%25200325901%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6501%26epage%3D6504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Wong, K. K.</span><span> </span><span class="NLM_article-title">Recent developments in anti-cancer agents targeting the Ras/Raf/ MEK/ERK pathway</span> <span class="citation_source-journal">Recent Pat. Anti-Cancer Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=28-35&author=K.+K.+Wong&title=Recent+developments+in+anti-cancer+agents+targeting+the+Ras%2FRaf%2F+MEK%2FERK+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DK.%2BK.%26atitle%3DRecent%2520developments%2520in%2520anti-cancer%2520agents%2520targeting%2520the%2520Ras%252FRaf%252F%2520MEK%252FERK%2520pathway%26jtitle%3DRecent%2520Pat.%2520Anti-Cancer%2520Drug%2520Discovery%26date%3D2009%26volume%3D4%26spage%3D28%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Aronov, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germann, U. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janetka, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Botella, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namchuk, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straub, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X.</span><span> </span><span class="NLM_article-title">Flipped out: structure-guided design of selective pyrazolylpyrrole ERK inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1280</span><span class="NLM_x">–</span> <span class="NLM_lpage">1287</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061381f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1280-1287&author=A.+M.+Aronovauthor=C.+Bakerauthor=G.+W.+Bemisauthor=J.+Caoauthor=G.+Chenauthor=P.+J.+Fordauthor=U.+A.+Germannauthor=J.+Greenauthor=M.+R.+Haleauthor=M.+Jacobsauthor=J.+W.+Janetkaauthor=F.+Maltaisauthor=G.+Martinez-Botellaauthor=M.+N.+Namchukauthor=J.+Straubauthor=Q.+Tangauthor=X.+Xie&title=Flipped+out%3A+structure-guided+design+of+selective+pyrazolylpyrrole+ERK+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm061381f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061381f%26sid%3Dliteratum%253Aachs%26aulast%3DAronov%26aufirst%3DA.%2BM.%26aulast%3DBaker%26aufirst%3DC.%26aulast%3DBemis%26aufirst%3DG.%2BW.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DFord%26aufirst%3DP.%2BJ.%26aulast%3DGermann%26aufirst%3DU.%2BA.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DHale%26aufirst%3DM.%2BR.%26aulast%3DJacobs%26aufirst%3DM.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DMaltais%26aufirst%3DF.%26aulast%3DMartinez-Botella%26aufirst%3DG.%26aulast%3DNamchuk%26aufirst%3DM.%2BN.%26aulast%3DStraub%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DQ.%26aulast%3DXie%26aufirst%3DX.%26atitle%3DFlipped%2520out%253A%2520structure-guided%2520design%2520of%2520selective%2520pyrazolylpyrrole%2520ERK%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1280%26epage%3D1287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Ohori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinoshita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okubo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arakawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, T.</span><span> </span><span class="NLM_article-title">Identification of a selective ERK inhibitor and structural determination of the inhibitor-ERK2 complex</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">363</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2005&pages=357-363&author=M.+Ohoriauthor=T.+Kinoshitaauthor=M.+Okuboauthor=K.+Satoauthor=A.+Yamazakiauthor=H.+Arakawaauthor=S.+Nishimuraauthor=N.+Inamuraauthor=H.+Nakajimaauthor=M.+Neyaauthor=H.+Miyakeauthor=T.+Fujii&title=Identification+of+a+selective+ERK+inhibitor+and+structural+determination+of+the+inhibitor-ERK2+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhori%26aufirst%3DM.%26aulast%3DKinoshita%26aufirst%3DT.%26aulast%3DOkubo%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DYamazaki%26aufirst%3DA.%26aulast%3DArakawa%26aufirst%3DH.%26aulast%3DNishimura%26aufirst%3DS.%26aulast%3DInamura%26aufirst%3DN.%26aulast%3DNakajima%26aufirst%3DH.%26aulast%3DNeya%26aufirst%3DM.%26aulast%3DMiyake%26aufirst%3DH.%26aulast%3DFujii%26aufirst%3DT.%26atitle%3DIdentification%2520of%2520a%2520selective%2520ERK%2520inhibitor%2520and%2520structural%2520determination%2520of%2520the%2520inhibitor-ERK2%2520complex%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D336%26spage%3D357%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Hancock, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macias, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKerell, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, P.</span><span> </span><span class="NLM_article-title">Identification of novel extracellular signal-regulated kinase docking domain inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4586</span><span class="NLM_x">–</span> <span class="NLM_lpage">4595</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0501174" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4586-4595&author=C.+N.+Hancockauthor=A.+Maciasauthor=E.+K.+Leeauthor=S.+Y.+Yuauthor=A.+D.+MacKerellauthor=P.+Shapiro&title=Identification+of+novel+extracellular+signal-regulated+kinase+docking+domain+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm0501174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0501174%26sid%3Dliteratum%253Aachs%26aulast%3DHancock%26aufirst%3DC.%2BN.%26aulast%3DMacias%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DE.%2BK.%26aulast%3DYu%26aufirst%3DS.%2BY.%26aulast%3DMacKerell%26aufirst%3DA.%2BD.%26aulast%3DShapiro%26aufirst%3DP.%26atitle%3DIdentification%2520of%2520novel%2520extracellular%2520signal-regulated%2520kinase%2520docking%2520domain%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4586%26epage%3D4595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Zimmermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchdunger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mett, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lydon, N. B.</span><span> </span><span class="NLM_article-title">Potent and selective inhibitors of the Abl-kinase: phenylamino-pyrimidine (PAP) derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm500847m&amp;key=10.1016%2FS0960-894X%2896%2900601-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADyaK2sXht1egs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=187-192&author=J.+Zimmermannauthor=E.+Buchdungerauthor=H.+Mettauthor=T.+Meyerauthor=N.+B.+Lydon&title=Potent+and+selective+inhibitors+of+the+Abl-kinase%3A+phenylamino-pyrimidine+%28PAP%29+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective inhibitors of the ABL-kinase: phenylaminopyrimidine (PAP) derivatives</span></div><div class="casAuthors">Zimmermann, Jurg; Buchdunger, Elisabeth; Mett, Helmut; Meyer, Thomas; Lydon, Nicholas B.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-192</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Due to its relatively clear etiol., chronic myelogenous leukemia (CML) represents an ideal disease target for a therapy using a selective inhibitor of the Bcr-Abl tyrosine protein kinase.  Extensive optimization of the class of phenylamino-pyrimidines yielded highly potent and selective Bcr-Abl kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEGaTJgyxfUbVg90H21EOLACvtfcHk0lgSn9ZGsuhmow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXht1egs7w%253D&md5=35962f1735e8d3a595fdb49d95cdc305</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2896%2900601-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252896%252900601-4%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DJ.%26aulast%3DBuchdunger%26aufirst%3DE.%26aulast%3DMett%26aufirst%3DH.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DLydon%26aufirst%3DN.%2BB.%26atitle%3DPotent%2520and%2520selective%2520inhibitors%2520of%2520the%2520Abl-kinase%253A%2520phenylamino-pyrimidine%2520%2528PAP%2529%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D187%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Manley, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan-Jacob, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mestan, J.</span><span> </span><span class="NLM_article-title">Advances in the structural biology, design and clinical development of Bcr-Abl kinase inhibitors for the treatment of chronic myeloid leukaemia</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Proteins Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1754</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm500847m&amp;key=10.1016%2Fj.bbapap.2005.07.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm500847m&amp;key=16172030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlags7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1754&publication_year=2005&pages=3-13&author=P.+W.+Manleyauthor=S.+W.+Cowan-Jacobauthor=J.+Mestan&title=Advances+in+the+structural+biology%2C+design+and+clinical+development+of+Bcr-Abl+kinase+inhibitors+for+the+treatment+of+chronic+myeloid+leukaemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the structural biology, design and clinical development of Bcr-Abl kinase inhibitors for the treatment of chronic myeloid leukaemia</span></div><div class="casAuthors">Manley, Paul William; Cowan-Jacob, Sandra W.; Mestan, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1754</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">3-13</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The constitutively activated Abl tyrosine kinase domain of the chimeric Bcr-Abl oncoprotein is responsible for the transformation of hematopoietic stem cells and the symptoms of chronic myeloid leukemia (CML).  Imatinib targets the tyrosine kinase activity of Bcr-Abl and is a first-line therapy for this malignancy.  Although highly effective in chronic phase CML, patients who have progressed to the advanced phase of the disease frequently fail to respond to imatinib or develop resistance to therapy and relapse.  This is often due to the emergence of clones expressing mutant forms of Bcr-Abl, which exhibit a decreased sensitivity towards inhibition by imatinib.  Considerable progress has recently been made in understanding the structural biol. of Abl and the mol. basis for resistance, facilitating the discovery and development of second generation drugs designed to combat mutant forms of Bcr-Abl.  The first of these compds. to enter clin. development were BMS-354825 (BristolMyersSquibb) and AMN107 (Novartis Pharma) and, from Phase I results, both of these promise a breakthrough in the treatment of imatinib-resistant CML.  Recent advances with these and other promising classes of new CML drugs are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0fkeC4vxU_bVg90H21EOLACvtfcHk0lgSn9ZGsuhmow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlags7fI&md5=b9d67d465f61804d2acd78605a4e9a75</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2005.07.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2005.07.040%26sid%3Dliteratum%253Aachs%26aulast%3DManley%26aufirst%3DP.%2BW.%26aulast%3DCowan-Jacob%26aufirst%3DS.%2BW.%26aulast%3DMestan%26aufirst%3DJ.%26atitle%3DAdvances%2520in%2520the%2520structural%2520biology%252C%2520design%2520and%2520clinical%2520development%2520of%2520Bcr-Abl%2520kinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520chronic%2520myeloid%2520leukaemia%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2005%26volume%3D1754%26spage%3D3%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Rusnak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Affleck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stubberfield, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guntrip, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jowett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stables, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brignola, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadwell, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reep, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alligood, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackey, K.</span><span> </span><span class="NLM_article-title">The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">7196</span><span class="NLM_x">–</span> <span class="NLM_lpage">7203</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm500847m&amp;key=11585755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsVeht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=7196-7203&author=D.+W.+Rusnakauthor=K.+Affleckauthor=S.+G.+Cockerillauthor=C.+Stubberfieldauthor=R.+Harrisauthor=M.+Pageauthor=K.+J.+Smithauthor=S.+B.+Guntripauthor=M.+C.+Carterauthor=R.+J.+Shawauthor=A.+Jowettauthor=J.+Stablesauthor=P.+Topleyauthor=E.+R.+Woodauthor=P.+S.+Brignolaauthor=S.+H.+Kadwellauthor=B.+R.+Reepauthor=R.+J.+Mullinauthor=K.+J.+Alligoodauthor=B.+R.+Keithauthor=R.+M.+Crosbyauthor=D.+M.+Murrayauthor=W.+B.+Knightauthor=T.+M.+Gilmerauthor=K.+Lackey&title=The+characterization+of+novel%2C+dual+ErbB-2%2FEGFR%2C+tyrosine+kinase+inhibitors%3A+potential+therapy+for+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer</span></div><div class="casAuthors">Rusnak, David W.; Affleck, Karen; Cockerill, Stuart G.; Stubberfield, Colin; Harris, Robert; Page, Martin; Smith, Kathryn J.; Guntrip, Stephen B.; Carter, Malcolm C.; Shaw, Robert J.; Jowett, Amanda; Stables, Jeremy; Topley, Peter; Wood, Edgar R.; Brignola, Perry S.; Kadwell, Sue H.; Reep, Bryan R.; Mullin, Robert J.; Alligood, Krystal J.; Keith, Barry R.; Crosby, Renae M.; Murray, Doris M.; Knight, W. Blaine; Gilmer, Tona M.; Lackey, Karen</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7196-7203</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The type 1 receptor tyrosine kinases constitute a family of transmembrane proteins involved in various aspects of cell growth and survival and have been implicated in the initiation and progression of several types of human malignancies.  The best characterized of these proteins are the epidermal growth factor receptor (EGFR) and ErbB-2 (HER-2/neu).  We have developed potent quinazoline and pyrido-[3,4-d]-pyrimidine small mols. that are dual inhibitors of ErbB-2 and EGFR.  The compds. demonstrate potent in vitro inhibition of the ErbB-2 and EGFR kinase domains with IC50s <80 nM.  Growth of ErbB-2- and EGFR-expressing tumor cell lines is inhibited at concns. <0.5 μM.  Selectivity for tumor cell growth inhibition vs. normal human fibroblast growth inhibition ranges from 10- to >75-fold.  Tumor growth in mouse s.c. xenograft models of the BT474 and HN5 cell lines is inhibited in a dose-responsive manner using oral doses of 10 and 30 mg/kg twice per day.  In addn., the tested compds. caused a redn. of ErbB-2 and EGFR autophosphorylation in tumor fragments from these xenograft models.  These data indicate that these compds. have potential use as therapy in the broad population of cancer patients overexpressing ErbB-2 and/or EGFR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoifUxgOrEfMLVg90H21EOLACvtfcHk0lgSn9ZGsuhmow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsVeht70%253D&md5=374cb1b4451356866a5060c5ff39a1d1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DAffleck%26aufirst%3DK.%26aulast%3DCockerill%26aufirst%3DS.%2BG.%26aulast%3DStubberfield%26aufirst%3DC.%26aulast%3DHarris%26aufirst%3DR.%26aulast%3DPage%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DGuntrip%26aufirst%3DS.%2BB.%26aulast%3DCarter%26aufirst%3DM.%2BC.%26aulast%3DShaw%26aufirst%3DR.%2BJ.%26aulast%3DJowett%26aufirst%3DA.%26aulast%3DStables%26aufirst%3DJ.%26aulast%3DTopley%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DE.%2BR.%26aulast%3DBrignola%26aufirst%3DP.%2BS.%26aulast%3DKadwell%26aufirst%3DS.%2BH.%26aulast%3DReep%26aufirst%3DB.%2BR.%26aulast%3DMullin%26aufirst%3DR.%2BJ.%26aulast%3DAlligood%26aufirst%3DK.%2BJ.%26aulast%3DKeith%26aufirst%3DB.%2BR.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DMurray%26aufirst%3DD.%2BM.%26aulast%3DKnight%26aufirst%3DW.%2BB.%26aulast%3DGilmer%26aufirst%3DT.%2BM.%26aulast%3DLackey%26aufirst%3DK.%26atitle%3DThe%2520characterization%2520of%2520novel%252C%2520dual%2520ErbB-2%252FEGFR%252C%2520tyrosine%2520kinase%2520inhibitors%253A%2520potential%2520therapy%2520for%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D7196%26epage%3D7203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Lowinger, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedl, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. A.</span><span> </span><span class="NLM_article-title">Design and discovery of small molecules targeting Raf-1 kinase</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2269</span><span class="NLM_x">–</span> <span class="NLM_lpage">2278</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm500847m&amp;key=10.2174%2F1381612023393125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm500847m&amp;key=12369855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvVGntrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=2269-2278&author=T.+B.+Lowingerauthor=B.+Riedlauthor=J.+Dumasauthor=R.+A.+Smith&title=Design+and+discovery+of+small+molecules+targeting+Raf-1+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Design and discovery of small molecules targeting raf-1 kinase</span></div><div class="casAuthors">Lowinger, Timothy B.; Riedl, Bernd; Dumas, Jacques; Smith, Roger A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2269-2278</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  Raf kinase, an enzyme which acts downstream in the Ras signaling pathway, is involved in cancerous cell proliferation.  Thus, small mol. inhibitors of Raf kinase activity may be important agents for the treatment of cancer.  A novel class of Raf-1 inhibitors was discovered, using a combination of medicinal and combinatorial chem. approaches.  This effort culminated in the identification of the clin. candidate BAY 43-9006, currently undergoing Phase I clin. trials.  The present review summarizes the medicinal chem. development of ureas as highly potent inhibitors of Raf-1 kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqviNIBK_IYW7Vg90H21EOLACvtfcHk0ljsbDs1BzBSIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvVGntrk%253D&md5=a62445c3fb50083175ee4863ae84f6ce</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F1381612023393125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612023393125%26sid%3Dliteratum%253Aachs%26aulast%3DLowinger%26aufirst%3DT.%2BB.%26aulast%3DRiedl%26aufirst%3DB.%26aulast%3DDumas%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DR.%2BA.%26atitle%3DDesign%2520and%2520discovery%2520of%2520small%2520molecules%2520targeting%2520Raf-1%2520kinase%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2002%26volume%3D8%26spage%3D2269%26epage%3D2278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Jung, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert-van der Brempt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohmann, J. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germain, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Savi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dousson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortlock, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heron, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedge, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odedra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keen, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brightwell, S.</span><span> </span><span class="NLM_article-title">Discovery of novel and potent thiazoloquinazolines as selective Aurora A and B kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">955</span><span class="NLM_x">–</span> <span class="NLM_lpage">970</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050786h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=955-970&author=F.+H.+Jungauthor=G.+Pasquetauthor=C.+Lambert-van+der+Bremptauthor=J.+J.+M.+Lohmannauthor=N.+Warinauthor=F.+Renaudauthor=H.+Germainauthor=C.+De+Saviauthor=N.+Robertsauthor=T.+Johnsonauthor=C.+Doussonauthor=G.+B.+Hillauthor=A.+A.+Mortlockauthor=N.+Heronauthor=R.+W.+Wilkinsonauthor=S.+R.+Wedgeauthor=S.+P.+Heatonauthor=R.+Odedraauthor=N.+J.+Keenauthor=S.+Greenauthor=E.+Brownauthor=K.+Thompsonauthor=S.+Brightwell&title=Discovery+of+novel+and+potent+thiazoloquinazolines+as+selective+Aurora+A+and+B+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm050786h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050786h%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DF.%2BH.%26aulast%3DPasquet%26aufirst%3DG.%26aulast%3DLambert-van%2Bder%2BBrempt%26aufirst%3DC.%26aulast%3DLohmann%26aufirst%3DJ.%2BJ.%2BM.%26aulast%3DWarin%26aufirst%3DN.%26aulast%3DRenaud%26aufirst%3DF.%26aulast%3DGermain%26aufirst%3DH.%26aulast%3DDe%2BSavi%26aufirst%3DC.%26aulast%3DRoberts%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DDousson%26aufirst%3DC.%26aulast%3DHill%26aufirst%3DG.%2BB.%26aulast%3DMortlock%26aufirst%3DA.%2BA.%26aulast%3DHeron%26aufirst%3DN.%26aulast%3DWilkinson%26aufirst%3DR.%2BW.%26aulast%3DWedge%26aufirst%3DS.%2BR.%26aulast%3DHeaton%26aufirst%3DS.%2BP.%26aulast%3DOdedra%26aufirst%3DR.%26aulast%3DKeen%26aufirst%3DN.%2BJ.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DE.%26aulast%3DThompson%26aufirst%3DK.%26aulast%3DBrightwell%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520novel%2520and%2520potent%2520thiazoloquinazolines%2520as%2520selective%2520Aurora%2520A%2520and%2520B%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D955%26epage%3D970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Pargellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchill, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grob, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, J.</span><span> </span><span class="NLM_article-title">Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm500847m&amp;key=10.1038%2Fnsb770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm500847m&amp;key=11896401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Kisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=268-272&author=C.+Pargellisauthor=L.+Tongauthor=L.+Churchillauthor=P.+F.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=P.+M.+Grobauthor=E.+R.+Hickeyauthor=N.+Mossauthor=S.+Pavauthor=J.+Regan&title=Inhibition+of+p38+MAP+kinase+by+utilizing+a+novel+allosteric+binding+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site</span></div><div class="casAuthors">Pargellis, Christopher; Tong, Liang; Churchill, Laurie; Cirillo, Pier F.; Gilmore, Thomas; Graham, Anne G.; Grob, Peter M.; Hickey, Eugene R.; Moss, Neil; Pav, Susan; Regan, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">268-272</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">The p38 MAP kinase plays a crucial role in regulating the prodn. of proinflammatory cytokines, such as tumor necrosis factor and interleukin-1.  Blocking this kinase may offer an effective therapy for treating many inflammatory diseases.  Here we report a new allosteric binding site for a diaryl urea class of highly potent and selective inhibitors against human p38 MAP kinase.  The formation of this binding site requires a large conformational change not obsd. previously for any of the protein Ser/Thr kinases.  This change is in the highly conserved Asp-Phe-Gly motif within the active site of the kinase.  Soln. studies demonstrate that this class of compds. has slow binding kinetics, consistent with the requirement for conformational change.  Improving interactions in this allosteric pocket, as well as establishing binding interactions in the ATP pocket, enhanced the affinity of the inhibitors by 12,000-fold.  One of the most potent compds. in this series, BIRB 796, has picomolar affinity for the kinase and low nanomolar inhibitory activity in cell culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqT8_QT7_pbYrVg90H21EOLACvtfcHk0ljsbDs1BzBSIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Kisbk%253D&md5=68850ecdbe08df4285ba38cfa2c93ea4</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnsb770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb770%26sid%3Dliteratum%253Aachs%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DChurchill%26aufirst%3DL.%26aulast%3DCirillo%26aufirst%3DP.%2BF.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DGrob%26aufirst%3DP.%2BM.%26aulast%3DHickey%26aufirst%3DE.%2BR.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DRegan%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520p38%2520MAP%2520kinase%2520by%2520utilizing%2520a%2520novel%2520allosteric%2520binding%2520site%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D268%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Kelly, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLellan, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosner, P. J.</span><span> </span><span class="NLM_article-title">Strategic use of affinity-based mass spectrometry techniques in the drug discovery process</span> <span class="citation_source-journal">Anal. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/doi/10.1021/ac010569y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2002&pages=1-9&author=M.+A.+Kellyauthor=T.+J.+McLellanauthor=P.+J.+Rosner&title=Strategic+use+of+affinity-based+mass+spectrometry+techniques+in+the+drug+discovery+process"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fac010569y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac010569y%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DM.%2BA.%26aulast%3DMcLellan%26aufirst%3DT.%2BJ.%26aulast%3DRosner%26aufirst%3DP.%2BJ.%26atitle%3DStrategic%2520use%2520of%2520affinity-based%2520mass%2520spectrometry%2520techniques%2520in%2520the%2520drug%2520discovery%2520process%26jtitle%3DAnal.%2520Chem.%26date%3D2002%26volume%3D74%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Annis, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Athanasopoulos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felsch, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalghatgi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orminati, J. P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosner, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipps, G. W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thaddupathy, G. R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyler, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenchik, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wintner, E. A.</span> <span class="citation_source-journal">Int. J. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">238</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm500847m&amp;key=10.1016%2Fj.ijms.2003.11.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpslyisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Annis%2C+D.+A.%3B+Athanasopoulos%2C+J.%3B+Curran%2C+P.+J.%3B+Felsch%2C+J.+S.%3B+Kalghatgi%2C+K.%3B+Lee%2C+W.+H.%3B+Nash%2C+H.+M.%3B+Orminati%2C+J.+P.+A.%3B+Rosner%2C+K.+E.%3B+Shipps%2C+G.+W.%2C+Jr.%3B+Thaddupathy%2C+G.+R.+A.%3B+Tyler%2C+A.+N.%3B+Vilenchik%2C+L.%3B+Wagner%2C+C.+R.%3B+Wintner%2C+E.+A.Int.+J.+Mass+Spectrom.+2004%2C+238%2C+77%E2%80%9383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">An affinity selection-mass spectrometry method for the identification of small molecule ligands from self-encoded combinatorial libraries. Discovery of a novel antagonist of E. coli dihydrofolate reductase</span></div><div class="casAuthors">Annis, D. Allen; Athanasopoulos, John; Curran, Patrick J.; Felsch, Jason S.; Kalghatgi, Krishna; Lee, William H.; Nash, Huw M.; Orminati, Jean-Paul A.; Rosner, Kristin E.; Shipps, Gerald W.; Thaddupathy, G. R. A.; Tyler, Andrew N.; Vilenchik, Lev; Wagner, Carston R.; Wintner, Edward A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Mass Spectrometry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">238</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">77-83</span>CODEN:
                <span class="NLM_cas:coden">IMSPF8</span>;
        ISSN:<span class="NLM_cas:issn">1387-3806</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The NeoGenesis Automated Ligand Identification System (ALIS), an affinity selection-mass spectrometry (AS-MS) process consisting of a rapid size-exclusion chromatog. stage integrated with reverse-phase chromatog., electrospray mass spectrometry, and novel data searching algorithms, was used to screen mass-encoded, 2500-member combinatorial libraries, leading to the discovery of a novel, bioactive ligand for the anti-infective target Escherichia coli dihydrofolate reductase (DHFR).  Synthesis of the mass-encoded, ligand-contg. library, discussion of the deconvolution process for verifying the structure of the ligand through independent synthesis and screening in a small mixt. (sub-library) format, and ALIS-MS/MS techniques to assign its regioisomeric connectivity are presented.  ALIS-based competition expts. between the newly discovered ligand and other, known DHFR ligands, and biol. activity assessments with stereo- and regioisomers of the hit compd. confirm its DHFR-specific biol. activity.  The method described requires no foreknowledge of the structure or biochem. of the protein target, consumes less than 1 μg protein to screen >2500 compds. in a single expt., and enables screening of >250,000 compds. per system per day.  These advantages highlight the potential of the ALIS method for drug discovery against genomic targets with unknown biol. function, as well as validated targets for which traditional discovery efforts have failed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF9t0__7HggLVg90H21EOLACvtfcHk0lhUyb78QlVJtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpslyisLk%253D&md5=2f0e7e5c2f76f28ef6ac697e76d24092</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ijms.2003.11.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijms.2003.11.022%26sid%3Dliteratum%253Aachs%26aulast%3DAnnis%26aufirst%3DD.%2BA.%26aulast%3DAthanasopoulos%26aufirst%3DJ.%26aulast%3DCurran%26aufirst%3DP.%2BJ.%26aulast%3DFelsch%26aufirst%3DJ.%2BS.%26aulast%3DKalghatgi%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DW.%2BH.%26aulast%3DNash%26aufirst%3DH.%2BM.%26aulast%3DOrminati%26aufirst%3DJ.%2BP.%2BA.%26aulast%3DRosner%26aufirst%3DK.%2BE.%26aulast%3DShipps%26aufirst%3DG.%2BW.%26aulast%3DThaddupathy%26aufirst%3DG.%2BR.%2BA.%26aulast%3DTyler%26aufirst%3DA.%2BN.%26aulast%3DVilenchik%26aufirst%3DL.%26aulast%3DWagner%26aufirst%3DC.%2BR.%26aulast%3DWintner%26aufirst%3DE.%2BA.%26jtitle%3DInt.%2520J.%2520Mass%2520Spectrom.%26date%3D2004%26volume%3D238%26spage%3D77%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Annis, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nazef, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, H. M.</span><span> </span><span class="NLM_article-title">A general technique to rank protein–ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">15495</span><span class="NLM_x">–</span> <span class="NLM_lpage">15503</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja048365x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=15495-15503&author=D.+A.+Annisauthor=N.+Nazefauthor=C.+C.+Chuangauthor=M.+P.+Scottauthor=H.+M.+Nash&title=A+general+technique+to+rank+protein%E2%80%93ligand+binding+affinities+and+determine+allosteric+versus+direct+binding+site+competition+in+compound+mixtures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fja048365x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja048365x%26sid%3Dliteratum%253Aachs%26aulast%3DAnnis%26aufirst%3DD.%2BA.%26aulast%3DNazef%26aufirst%3DN.%26aulast%3DChuang%26aufirst%3DC.%2BC.%26aulast%3DScott%26aufirst%3DM.%2BP.%26aulast%3DNash%26aufirst%3DH.%2BM.%26atitle%3DA%2520general%2520technique%2520to%2520rank%2520protein%25E2%2580%2593ligand%2520binding%2520affinities%2520and%2520determine%2520allosteric%2520versus%2520direct%2520binding%2520site%2520competition%2520in%2520compound%2520mixtures%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D15495%26epage%3D15503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Annis, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipps, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popovici-Muller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windsor, W. T.</span><span> </span><span class="NLM_article-title">Method for quantitative protein–ligand affinity measurements in compound mixtures</span> <span class="citation_source-journal">Anal. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">4538</span><span class="NLM_x">–</span> <span class="NLM_lpage">4542</span></span><div class="citationLinks">[<a href="/doi/10.1021/ac0702701" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2007&pages=4538-4542&author=D.+A.+Annisauthor=G.+W.+Shippsauthor=Y.+Q.+Dengauthor=J.+Popovici-Mullerauthor=M.+A.+Siddiquiauthor=P.+J.+Curranauthor=M.+Gowenauthor=W.+T.+Windsor&title=Method+for+quantitative+protein%E2%80%93ligand+affinity+measurements+in+compound+mixtures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fac0702701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac0702701%26sid%3Dliteratum%253Aachs%26aulast%3DAnnis%26aufirst%3DD.%2BA.%26aulast%3DShipps%26aufirst%3DG.%2BW.%26aulast%3DDeng%26aufirst%3DY.%2BQ.%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DSiddiqui%26aufirst%3DM.%2BA.%26aulast%3DCurran%26aufirst%3DP.%2BJ.%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DWindsor%26aufirst%3DW.%2BT.%26atitle%3DMethod%2520for%2520quantitative%2520protein%25E2%2580%2593ligand%2520affinity%2520measurements%2520in%2520compound%2520mixtures%26jtitle%3DAnal.%2520Chem.%26date%3D2007%26volume%3D79%26spage%3D4538%26epage%3D4542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Brandts, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L. N.</span><span> </span><span class="NLM_article-title">Study of strong to ultratight protein interactions using differential scanning calorimetry</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">6927</span><span class="NLM_x">–</span> <span class="NLM_lpage">6940</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00481a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1990&pages=6927-6940&author=J.+F.+Brandtsauthor=L.+N.+Lin&title=Study+of+strong+to+ultratight+protein+interactions+using+differential+scanning+calorimetry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fbi00481a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00481a024%26sid%3Dliteratum%253Aachs%26aulast%3DBrandts%26aufirst%3DJ.%2BF.%26aulast%3DLin%26aufirst%3DL.%2BN.%26atitle%3DStudy%2520of%2520strong%2520to%2520ultratight%2520protein%2520interactions%2520using%2520differential%2520scanning%2520calorimetry%26jtitle%3DBiochemistry%26date%3D1990%26volume%3D29%26spage%3D6927%26epage%3D6940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Mayhood, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windsor, W. T.</span><span> </span><span class="NLM_article-title">Ligand binding affinity determined by temperature-dependent circular dichroism: cyclin-dependent kinase 2 inhibitors</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">345</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2005&pages=187-197&author=T.+W.+Mayhoodauthor=W.+T.+Windsor&title=Ligand+binding+affinity+determined+by+temperature-dependent+circular+dichroism%3A+cyclin-dependent+kinase+2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMayhood%26aufirst%3DT.%2BW.%26aulast%3DWindsor%26aufirst%3DW.%2BT.%26atitle%3DLigand%2520binding%2520affinity%2520determined%2520by%2520temperature-dependent%2520circular%2520dichroism%253A%2520cyclin-dependent%2520kinase%25202%2520inhibitors%26jtitle%3DAnal.%2520Biochem.%26date%3D2005%26volume%3D345%26spage%3D187%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Deng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipps, G. W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popovici-Muller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosner, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duca, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cable, M.</span><span> </span><span class="NLM_article-title">Discovery of 4<i>H</i>-pyrazolo[1,5-<i>a</i>]pyrimidin-7-ones as potent inhibitors of hepatitis C virus polymerase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5363</span><span class="NLM_x">–</span> <span class="NLM_lpage">5367</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5363-5367&author=Y.+Dengauthor=G.+W.+Shippsauthor=T.+Wangauthor=J.+Popovici-Mullerauthor=K.+E.+Rosnerauthor=M.+A.+Siddiquiauthor=J.+Ducaauthor=A.+B.+Cooperauthor=M.+Cable&title=Discovery+of+4H-pyrazolo%5B1%2C5-a%5Dpyrimidin-7-ones+as+potent+inhibitors+of+hepatitis+C+virus+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DShipps%26aufirst%3DG.%2BW.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DRosner%26aufirst%3DK.%2BE.%26aulast%3DSiddiqui%26aufirst%3DM.%2BA.%26aulast%3DDuca%26aufirst%3DJ.%26aulast%3DCooper%26aufirst%3DA.%2BB.%26aulast%3DCable%26aufirst%3DM.%26atitle%3DDiscovery%2520of%25204H-pyrazolo%255B1%252C5-a%255Dpyrimidin-7-ones%2520as%2520potent%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520polymerase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5363%26epage%3D5367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="note"><p class="first last">More kinases were counterscreened at 1.0 μM concentration, and the % inhibition results are listed in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><div class="note"><p class="first last">For MEK1 assay, an enzymatically inactive, full length murine ERK2 in which catalytic lysine 52 had been mutated to arginine was used as the phosphate acceptor substrate. For reference, see the following:</p></div><span class="NLM_contrib-group">Smith, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayhood, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windsor, W. T.</span><span> </span><span class="NLM_article-title">Expression and purification of phosphorylated and non-phosphorylated human MEK1</span> <span class="citation_source-journal">Protein Expression Purif.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">446</span><span class="NLM_x">–</span> <span class="NLM_lpage">456</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm500847m&amp;key=10.1016%2Fj.pep.2006.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm500847m&amp;key=17175166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVCrtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2007&pages=446-456&author=C.+K.+Smithauthor=D.+Carrauthor=T.+W.+Mayhoodauthor=W.+Jinauthor=K.+Grayauthor=W.+T.+Windsor&title=Expression+and+purification+of+phosphorylated+and+non-phosphorylated+human+MEK1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and purification of phosphorylated and non-phosphorylated human MEK1</span></div><div class="casAuthors">Smith, Catherine K.; Carr, Donna; Mayhood, Todd W.; Jin, Weihong; Gray, Kimberly; Windsor, William T.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression and Purification</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">446-456</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Kinases exist in either a high or low activity form depending on the phosphorylation state of the activating lip.  These two different forms of the same kinase may adopt different conformations that affect not only activity but also inhibitor binding and the ability to crystallize the protein.  Therefore, isolation of homogenous prepns. of the phosphorylated and non-phosphorylated versions of a kinase is crit. for accurate biophys. measurements of activity, stability and ligand binding as well as for protein crystn.  The aim of the present study is the expression, purifn. and characterization of recombinant human MEK1 protein in both the activated and low-activity states.  A baculovirus co-expression system was developed for obtaining high levels of activated, phosphorylated human MEK1 kinase.  High-Five cells were co-infected with human MEK1 virus and Raf-BXB, an untagged constitutively active version of Raf which is the activating kinase for MEK1.  Unphosphorylated MEK1 was generated by treating MEK1 isolated from High-Five baculovirus expression with λ-phosphatase.  The proteins were characterized by SDS-PAGE, LC-MS, Western blotting, enzymic activity, and CD.  Previous reports of MEK1 expression and purifn. yielded lower levels of protein and purity.  The yield using High-Five cells was 5 mg/L for phosphorylated MEK1 and 10 mg/L for unphosphorylated MEK1.  For phosphorylated MEK1, the specific activity was 3530 U/mg, the IC50 values for the non-specific kinase inhibitors K252a and K252b were 8 and 47 nM, resp., and the IC50 for the MEK1 non-ATP competitive inhibitor, PD0325901, was 43 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGq_UwvPp4ObVg90H21EOLACvtfcHk0ljlTZ17Q9QLpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVCrtbg%253D&md5=eb771da10755e45786bcb0393f38878d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.pep.2006.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pep.2006.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DC.%2BK.%26aulast%3DCarr%26aufirst%3DD.%26aulast%3DMayhood%26aufirst%3DT.%2BW.%26aulast%3DJin%26aufirst%3DW.%26aulast%3DGray%26aufirst%3DK.%26aulast%3DWindsor%26aufirst%3DW.%2BT.%26atitle%3DExpression%2520and%2520purification%2520of%2520phosphorylated%2520and%2520non-phosphorylated%2520human%2520MEK1%26jtitle%3DProtein%2520Expression%2520Purif.%26date%3D2007%26volume%3D52%26spage%3D446%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Peyssonnaux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eychene, A.</span><span> </span><span class="NLM_article-title">The Raf/MEK/ERK pathway: new concepts of activation</span> <span class="citation_source-journal">Biol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm500847m&amp;key=10.1016%2FS0248-4900%2801%2901125-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm500847m&amp;key=11730323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptVOju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2001&pages=53-62&author=C.+Peyssonnauxauthor=A.+Eychene&title=The+Raf%2FMEK%2FERK+pathway%3A+new+concepts+of+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The Raf/MEK/ERK pathway: New concepts of activation</span></div><div class="casAuthors">Peyssonnaux, Carole; Eychene, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Biology of the Cell</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">53-62</span>CODEN:
                <span class="NLM_cas:coden">BCELDF</span>;
        ISSN:<span class="NLM_cas:issn">0248-4900</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">A review.  The Raf/MEK/ERK signaling was the first MAP kinase cascade to be characterized.  It is probably one of the most well known signal transduction pathways among biologists because of its implication in a wide variety of cellular functions as diverse -and occasionally contradictory- as cell proliferation, cell-cycle arrest, terminal differentiation and apoptosis.  Discovery and understanding of this pathway have benefited from the combination of both genetic studies in worms and flies and biochem. studies in mammalian cells.  However, ten years after, this field is still under debate and new mol. partners in the cascade continue to increase the complexity of its regulation.  This review deals with the emergence of new concepts in the activation and regulation of the Raf/MEK/ERK module.  In particular, the preponderant role of B-Raf is underlined, and the role of novel regulators such as KSR is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyjiXSFlBQ6rVg90H21EOLACvtfcHk0ljlTZ17Q9QLpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptVOju7s%253D&md5=cde3db5b205a1305dc2e6262deea65ec</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0248-4900%2801%2901125-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0248-4900%252801%252901125-X%26sid%3Dliteratum%253Aachs%26aulast%3DPeyssonnaux%26aufirst%3DC.%26aulast%3DEychene%26aufirst%3DA.%26atitle%3DThe%2520Raf%252FMEK%252FERK%2520pathway%253A%2520new%2520concepts%2520of%2520activation%26jtitle%3DBiol.%2520Cell%26date%3D2001%26volume%3D93%26spage%3D53%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Ramos, J. W.</span><span> </span><span class="NLM_article-title">The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2707</span><span class="NLM_x">–</span> <span class="NLM_lpage">2719</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm500847m&amp;key=10.1016%2Fj.biocel.2008.04.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm500847m&amp;key=18562239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm500847m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFaisb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2008&pages=2707-2719&author=J.+W.+Ramos&title=The+regulation+of+extracellular+signal-regulated+kinase+%28ERK%29+in+mammalian+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells</span></div><div class="casAuthors">Ramos, Joe W.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2707-2719</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Extracellular signal-regulated kinases 1 and 2 (ERK1/2) are activated by diverse mechanisms.  These include ligation of receptor tyrosine kinases such as epidermal growth factor (EGF) and cell adhesion receptors such as the integrins.  In general, ligand binding of these receptors leads to GTP loading and activation of the small GTPase Ras, which recruits Raf to the membrane where it is activated.  Raf subsequently phosphorylates the dual specificity MAP/ERK kinase (MEK1/2) which in turn phosphorylates and thereby activates ERK1/2.  ERK1/2 is a promiscuous kinase and can phosphorylate >100 different substrates.  Therefore activation of ERK1/2 can affect a broad array of cellular functions including proliferation, survival, apoptosis, motility, transcription, metab., and differentiation.  ERK1/2 activity is controlled by many distinct mechanisms.  Scaffold proteins control when and where ERK1/2 is activated, whereas anchoring proteins can restrain ERK1/2 localization to specific subcellular compartments.  Meanwhile, phosphatases dephosphorylate and inactivate ERK1/2 thereby shutting off the pathway.  Finally, several feedback mechanisms have been identified downstream of ERK1/2 activation.  Here, the authors focus on the diverse mechanisms of ERK1/2 regulation in mammalian cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvF9jKf5C9t7Vg90H21EOLACvtfcHk0ljlTZ17Q9QLpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFaisb7E&md5=dafebb7ddabcf5288d96a45b016b5112</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2008.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2008.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DRamos%26aufirst%3DJ.%2BW.%26atitle%3DThe%2520regulation%2520of%2520extracellular%2520signal-regulated%2520kinase%2520%2528ERK%2529%2520in%2520mammalian%2520cells%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2008%26volume%3D40%26spage%3D2707%26epage%3D2719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="note"><p class="first last">Compounds <b>1</b>–<b>16</b> were found not binding to either phorsphorylated MEK or unphosphorylated MEK in the TdF study.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Seger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munar, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobb, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krebs, E. G.</span><span> </span><span class="NLM_article-title">Purification and characterization of mitogen-activated protein kinase activator(s) from epidermal growth factor-stimulated A431 cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">14373</span><span class="NLM_x">–</span> <span class="NLM_lpage">14381</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=14373-14381&author=R.+Segerauthor=N.+G.+Ahnauthor=J.+Posadaauthor=E.+S.+Munarauthor=A.+M.+Jensenauthor=J.+A.+Cooperauthor=M.+H.+Cobbauthor=E.+G.+Krebs&title=Purification+and+characterization+of+mitogen-activated+protein+kinase+activator%28s%29+from+epidermal+growth+factor-stimulated+A431+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeger%26aufirst%3DR.%26aulast%3DAhn%26aufirst%3DN.%2BG.%26aulast%3DPosada%26aufirst%3DJ.%26aulast%3DMunar%26aufirst%3DE.%2BS.%26aulast%3DJensen%26aufirst%3DA.%2BM.%26aulast%3DCooper%26aufirst%3DJ.%2BA.%26aulast%3DCobb%26aufirst%3DM.%2BH.%26aulast%3DKrebs%26aufirst%3DE.%2BG.%26atitle%3DPurification%2520and%2520characterization%2520of%2520mitogen-activated%2520protein%2520kinase%2520activator%2528s%2529%2520from%2520epidermal%2520growth%2520factor-stimulated%2520A431%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D14373%26epage%3D14381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">English, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobb, M. H.</span><span> </span><span class="NLM_article-title">Pharmacological inhibitors of MAPK pathways</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=40-45&author=J.+M.+Englishauthor=M.+H.+Cobb&title=Pharmacological+inhibitors+of+MAPK+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEnglish%26aufirst%3DJ.%2BM.%26aulast%3DCobb%26aufirst%3DM.%2BH.%26atitle%3DPharmacological%2520inhibitors%2520of%2520MAPK%2520pathways%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2002%26volume%3D23%26spage%3D40%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i46"><a href="/doi/suppl/10.1021/jm500847m">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_22263"></div></div></div></div></div><hr /></hr><p class="last">Crystallization data table and additional kinase selectivity data for <b>4</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500847m/suppl_file/jm500847m_si_001.pdf">jm500847m_si_001.pdf (198.67 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm500847m&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-21%3Barticle%3Aarticle%3A10.1021%2Fjm500847m" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm500847m" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b32b18a393d1e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
